Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3047169	s-iglcl-v	mg/l (mg/l)	11685	36925	0.00%
3047169	s-iglcl-v	— (—)	2872	8845	100.00%	Distribution not available
3047169	s-iglcl-v	mg/l______ (mg/l)	334	1570	0.00%
3047169	s-iglcl-v	MG/L (mg/l)	55	187	0.00%
3047169	s-iglcl-v	mg/L (mg/l)	40	140	0.00%
3047169	s-immunoglobuliini,kevyetketjut,vapaat,lambdaosatutk	mg/l (mg/l)	9	12	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Hypertensive heart and/or renal disease

1257

2729

3.60

322.53

2.5

4.0

54.34

44.03

mg/l

0.95

1069

2343

Oedema, not elsewhere classified

1369

4386

3.21

322.40

3.2

3.1

44.78

44.05

mg/l

0.06

1182

3734

Other heart diseases, wide

2558

6552

2.42

321.91

3.4

46.80

36.58

mg/l

1.25

2123

5659

Asthma, unspecified (mode), excluding more controls

1601

3936

3.01

317.39

2.9

2.7

38.53

34.30

mg/l

0.76

1350

3410

GASTRO-related operations

1913

3416

2.87

316.36

3.4

2.6

50.92

39.90

mg/l

0.63

1591

3048

Any gastric operation

1913

3416

2.87

316.36

3.4

2.6

50.92

39.90

mg/l

0.63

1591

3048

Erysipelas

2127

7550

2.53

313.44

2.9

3.0

45.29

40.51

mg/l

1.19

1789

6430

L04AA Selective immunosuppressants

1004

2789

3.87

312.17

2.4

3.5

47.59

47.71

mg/l

0.01

806

2374

Heart failure and bmi 25plus

1624

3807

3.03

309.36

2.9

3.9

61.12

48.71

mg/l

0.75

1320

3193

Dialysis, with operation codes

1169

1331

10.86

307.65

4.2

3.6

93.12

35.11

mg/l

5.31

971

1144

Unspecified kidney failure

986

1385

8.68

307.65

3.4

3.2

80.73

37.18

mg/l

2.68

844

1188

Renal failure

4723

6196

7.72

307.65

3.2

3.3

64.92

36.27

mg/l

9.33

3925

5288

Transplanted organ and tissue status

738

1083

8.03

307.65

8.4

3.5

48.96

59.73

mg/l

0.32

620

934

Extracorporeal dialysis

576

806

9.06

307.65

3.4

3.7

85.90

76.26

mg/l

0.18

460

684

Anaemias

1024

333

21.18

307.65

3.1

1.5

41.93

22.00

mg/l

10.72

852

288

Condition for Implicit Sepsis (Organ dysfunction codes)

3534

8301

3.09

307.65

3.5

3.2

52.61

34.44

mg/l

4.94

2951

7127

Bacterial Sepsis

2666

6520

3.64

307.65

4.0

3.1

57.89

37.94

mg/l

3.47

2241

5567

Heart failure,strict

2721

5599

3.65

307.65

3.1

3.5

56.21

35.96

mg/l

4.00

2255

4813

Dyspnoea

3139

10545

2.21

307.65

3.5

3.4

49.41

41.40

mg/l

1.04

2606

9019

L04AD Calcineurin inhibitors

653

1134

6.52

307.65

3.2

4.1

53.10

63.92

mg/l

0.33

520

977

Oxycodone

1701

5258

2.91

307.65

7.4

2.7

59.28

45.17

mg/l

0.74

1447

4479

Disorders resulting from impaired renal tubular function

396

463

11.45

307.65

2.3

3.7

57.21

76.82

mg/l

0.34

328

391

Hypertensive diseases

2205

4645

2.75

307.65

2.9

4.0

48.39

37.37

mg/l

1.08

1843

3993

General symptoms and signs

3218

6456

2.57

307.65

3.5

3.1

44.46

41.00

mg/l

0.33

2720

5497

Tramadol

2676

6211

2.68

307.65

3.5

2.7

38.91

42.42

mg/l

0.82

2259

5298

Metabolic disorders

3336

7790

2.66

307.65

3.4

3.3

48.69

40.07

mg/l

0.95

2806

6586

Septicaemia

2155

6202

3.38

307.65

4.4

2.9

63.15

42.27

mg/l

2.40

1757

5261

Oral corticosteroids

3879

8945

2.63

307.65

3.0

3.6

42.20

43.45

mg/l

0.12

3154

7715

Multiple myeloma, including Hilmo

1205

596

57.21

307.65

21.8

1.5

113.11

34.62

mg/l

6.17

1132

501

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3180

7268

2.65

307.65

4.6

2.6

49.15

38.21

mg/l

1.85

2679

6252

Heart failure, not strict

3840

6893

4.02

307.65

3.5

54.77

34.41

mg/l

4.70

3223

5935

First line medication for Crohn's disease

3859

7452

2.88

307.65

4.9

1.8

48.98

39.68

mg/l

1.20

3204

6413

Explicit Sepsis, including avohilmo

2220

6426

3.33

307.65

4.3

3.1

62.74

38.32

mg/l

3.49

1811

5497

Persons encountering health services for specific procedures and health care

3371

8944

2.28

307.65

3.9

3.0

53.64

35.90

mg/l

3.00

2864

7591

Nephropathy related operations

1089

1648

8.08

307.65

4.1

3.6

96.09

51.61

mg/l

2.40

891

1406

Care involving dialysis

832

988

10.82

307.65

3.3

97.72

37.01

mg/l

3.93

683

850

Implicit bacterial Sepsis

2382

6131

3.60

307.65

3.8

3.1

54.99

38.31

mg/l

4.60

2001

5228

Iron deficiency anaemia

2060

7041

3.05

307.65

2.5

3.4

42.57

47.10

mg/l

0.79

1709

5967

Other and unspecified anaemias

3485

6531

5.71

307.65

3.2

3.3

47.29

45.96

mg/l

0.14

2938

5550

Implicit viral Sepsis, including avohilmo

1405

4626

3.22

307.65

4.4

3.0

57.92

38.56

mg/l

1.45

1174

3932

Glomerular disorders in diseases classified elsewhere

1077

1556

8.50

307.65

3.7

3.6

78.37

52.60

mg/l

1.14

884

1345

Fever of other and unknown origin

2697

5964

4.16

307.65

5.4

3.1

50.41

42.18

mg/l

0.83

2244

5080

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3543

9400

2.60

307.65

4.6

2.9

51.15

38.48

mg/l

2.34

2992

8036

Liquid cancers

2697

4414

6.82

307.65

11.2

1.5

73.21

36.10

mg/l

6.09

2429

3709

Implicit Sepsis

3507

8301

3.29

307.65

3.6

3.2

53.23

36.23

mg/l

4.49

2951

7122

Hypertensive diseases (excluding secondary)

1354

1897

4.29

307.65

2.9

3.6

50.73

27.65

mg/l

1.94

1128

1667

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5715

7716

5.39

307.65

3.4

43.42

42.26

mg/l

0.15

4806

6605

Implicit bacterial Sepsis, including avohilmo

2556

6445

3.55

307.65

3.6

3.1

54.40

38.02

mg/l

4.93

2150

5504

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

969

1147

11.44

307.65

3.4

3.3

44.02

45.94

mg/l

0.13

767

980

Pneumonias (Asthma/COPD co-morbidities)

3604

9232

2.64

307.65

4.7

2.8

49.26

38.42

mg/l

2.05

3041

7890

Nutritional anaemias

2336

8150

2.89

307.65

2.6

3.4

42.19

46.18

mg/l

0.79

1948

6931

Explicit Sepsis

2196

6338

3.36

307.65

4.3

3.1

62.83

37.91

mg/l

3.57

1793

5420

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3482

8001

3.06

307.65

3.4

3.3

50.21

34.52

mg/l

3.93

2913

6862

Bacterial infection, other or unspecified, including avohilmo

3103

7375

3.69

307.65

4.4

3.0

53.82

40.53

mg/l

2.08

2655

6289

Erysipelas, including avohilmo

2726

7968

2.63

307.65

2.8

3.1

43.72

39.51

mg/l

1.13

2303

6805

Heart failure, strict

2970

7441

2.96

307.65

3.0

3.6

56.37

42.30

mg/l

2.19

2472

6368

Secondary hypertension

524

535

11.03

307.65

2.3

3.3

60.79

26.04

mg/l

8.58

399

472

Autoimmune diseases excluding thyroid diseases, strict definition

3321

7869

2.36

307.65

2.7

3.7

40.97

45.54

mg/l

0.90

2772

6742

Hypertension, essential

2245

4629

2.83

307.65

3.0

4.0

47.18

37.40

mg/l

0.93

1891

3979

Acute renal failure

1942

3119

7.35

307.65

3.8

3.3

68.61

35.56

mg/l

4.99

1620

2639

Abnormal findings on examination of blood, without diagnosis

2422

7421

3.16

307.65

3.4

52.91

42.68

mg/l

0.80

2042

6275

L04AX Other immunosuppressants

2490

7951

3.31

307.65

9.6

2.1

53.95

39.60

mg/l

1.71

2126

6765

Glomerulonephritis

725

1243

6.83

307.65

3.2

3.7

51.56

64.49

mg/l

0.47

569

1075

Glomerular diseases

1576

2495

7.56

307.65

3.4

3.5

68.53

47.79

mg/l

1.47

1277

2149

Chronic kidney disease

3614

4631

9.31

307.65

2.8

3.2

61.42

38.31

mg/l

6.57

2968

3928

Malaise and fatigue

2176

5476

3.28

307.65

3.1

42.78

43.04

mg/l

0.03

1817

4671

All kidney diseases

5174

7296

5.08

307.65

3.2

3.5

52.55

31.71

mg/l

7.73

4289

6311

Other disorders of fluid, electrolyte and acid-base balance

1564

4737

3.32

307.65

2.9

3.3

48.30

41.99

mg/l

1.01

1272

3989

All pneumoniae

3608

9254

2.62

307.65

4.7

2.9

49.04

38.48

mg/l

1.98

3045

7913

Polyarthropathies

2913

5686

3.46

307.65

3.4

3.7

43.00

45.00

mg/l

0.24

2441

4859

ILD medications

4198

7619

3.08

307.65

4.9

2.0

48.09

40.05

mg/l

1.08

3483

6548

Multiple myeloma

806

378

73.00

307.65

23.8

1.5

133.29

35.08

mg/l

4.65

748

321

Pneumonia, organism unspecified

3389

8890

2.71

307.65

4.6

2.8

50.70

38.47

mg/l

2.09

2843

7601

ILD medications: prednisolone, methylprednisolone, prednisone

3949

7607

2.99

307.65

3.0

2.0

43.09

40.09

mg/l

0.37

3240

6536

Heart failure and antihypertensive medication

1215

1392

6.14

307.65

3.2

4.4

59.71

31.48

mg/l

2.15

990

1213

Other bacterial diseases, including avohilmo

4015

8395

3.11

307.65

3.9

3.1

47.18

38.64

mg/l

1.66

3386

7149

Implicit Sepsis, including avohilmo

3582

8401

3.20

307.65

3.5

3.2

52.74

35.24

mg/l

4.78

3007

7210

Inflammatory bowel disease treatment related agents

3923

8977

2.50

307.65

2.9

3.6

42.82

43.39

mg/l

0.05

3220

7743

Renal tubulo-interstitial diseases

5247

7669

5.44

307.65

3.2

3.6

56.67

32.35

mg/l

9.28

4370

6623

All-cause Heart Failure

2907

7325

2.94

307.65

3.0

3.6

56.44

41.64

mg/l

2.34

2413

6272

Acute tubulo-interstitial nephritis

2363

6657

3.13

307.65

2.9

3.5

46.54

33.54

mg/l

4.27

1936

5745

Infections, IBD-co-morbidities

671

538

9.37

307.65

5.8

4.1

49.83

39.58

mg/l

0.82

567

477

Other heart diseases

1295

1878

4.64

307.65

3.7

3.6

43.04

27.75

mg/l

5.08

1078

1651

All chronic kidney diseases

4730

5524

7.84

307.65

3.0

3.5

61.90

34.20

mg/l

9.07

3925

4762

ILD medications: immunosuppressive drugs

3231

6837

4.57

307.65

7.9

2.0

52.33

38.76

mg/l

2.32

2724

5904

Other bacterial diseases

4156

8816

3.28

307.65

4.1

3.0

49.53

38.55

mg/l

2.37

3495

7518

Influenza and pneumonia

3633

9006

2.57

307.65

4.8

2.7

48.58

38.30

mg/l

1.90

3071

7696

Autoimmune diseases excluding thyroid diseases

3427

8121

2.35

307.65

2.8

3.7

40.59

45.06

mg/l

0.91

2864

6962

Bacterial infection, other or unspecified

2936

7159

3.72

307.65

4.5

3.0

54.11

40.59

mg/l

2.04

2508

6092

Osteopathies and chondropathies

2681

8066

3.22

307.65

4.1

3.2

37.49

44.71

mg/l

1.75

2205

6913

Systemic connective tissue disorders

1684

5531

3.25

307.65

2.5

3.4

35.62

47.72

mg/l

2.95

1398

4694

Osteoporosis

1632

4124

4.01

307.65

2.9

3.2

34.20

50.78

mg/l

2.98

1293

3544

Other septicaemia, including avohilmo

1928

5845

3.30

307.65

3.9

2.9

60.19

42.38

mg/l

3.06

1560

4957

3180

7268

2.65

307.65

4.6

2.6

49.15

38.21

mg/l

1.85

2679

6252

Other systemic involvement of connective tissue (FG)

1198

3189

3.95

307.65

2.4

3.8

34.55

49.33

mg/l

2.70

987

2741

Liquid cancers, including Hilmo

2877

4970

5.84

307.65

10.6

1.5

71.00

35.74

mg/l

6.17

2577

4183

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1335

610

66.42

307.65

8.2

1.3

55.66

34.69

mg/l

4.26

1161

514

Multiple myeloma and malignant plasma cell neoplasms

1230

723

46.58

307.65

21.6

1.7

111.55

35.93

mg/l

5.98

1155

619

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

806

378

73.00

307.65

23.8

1.5

133.29

35.08

mg/l

4.65

748

321

Other septicaemia

1904

5744

3.34

307.65

4.0

2.9

60.26

42.47

mg/l

2.99

1542

4868

Diseases of arteries, arterioles and capillaries (FINNGEN)

941

1300

5.30

307.65

2.9

3.7

44.96

28.70

mg/l

6.19

789

1151

Gout

1665

3929

3.97

307.65

4.4

3.7

48.40

49.40

mg/l

0.09

1407

3341

Second line medication for Crohn's disease

2522

8126

3.28

307.65

9.5

2.1

53.68

39.38

mg/l

1.73

2150

6904

Gout, FINNGEN

1665

5288

3.40

307.65

4.4

3.3

48.40

48.94

mg/l

0.05

1407

4486

Type 2 diabetes, wide definition

2896

7797

2.43

307.65

2.5

4.0

45.64

41.33

mg/l

0.81

2403

6690

Primary_lymphoid and hematopoietic malignant neoplasms

2320

3835

7.33

307.65

12.7

1.5

78.84

36.00

mg/l

6.06

2095

3203

Disorders of mineral metabolism

648

1020

7.43

307.65

4.6

3.6

75.35

41.48

mg/l

0.73

539

874

Hypertension

2204

4645

2.75

307.65

2.9

4.0

48.39

37.37

mg/l

1.08

1842

3993

Other and unspecified iron deficiency

1686

5505

3.26

307.65

2.4

3.4

42.05

46.77

mg/l

0.68

1400

4661

Diabetic nephropathy, excluding more controls

993

1984

4.62

307.65

2.1

2.9

56.83

40.57

mg/l

4.81

830

1685

Disorders of calcium metabolism

581

782

9.09

307.65

5.0

3.6

79.32

40.66

mg/l

0.76

487

668

Other anaemias

3495

6571

5.67

307.65

3.2

3.3

47.31

45.87

mg/l

0.15

2947

5584

Aplastic and other anaemias

3679

6863

5.57

307.65

3.2

3.3

48.02

45.11

mg/l

0.37

3084

5849

Heart failure and coronary heart disease

2033

5736

2.63

302.79

2.7

3.6

51.62

46.33

mg/l

0.65

1664

4909

Hypercalcemia

447

661

8.77

302.69

5.0

3.8

89.77

48.55

mg/l

0.58

376

580

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

194

74.23

301.54

8.3

1.3

55.41

32.57

mg/l

0.69

180

Finngen Rheumatological endpoints

2705

6818

2.31

300.36

3.0

3.7

41.01

44.14

mg/l

0.27

2249

5839

Nephrotic syndrome

316

304

13.68

300.03

3.0

4.1

55.79

37.54

mg/l

1.87

255

268

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3007

8940

2.18

299.66

3.9

3.2

41.42

42.04

mg/l

0.08

2477

7718

Other diseases of blood and blood-forming organs, wide

1089

3328

3.54

293.58

4.3

3.4

42.76

47.80

mg/l

0.38

900

2832

Kidney transplant status

394

519

9.10

290.46

2.1

4.5

66.19

63.02

mg/l

0.05

305

444

Cardiovascular diseases (excluding rheumatic etc)

1226

2047

3.50

290.45

3.3

3.4

49.87

26.89

mg/l

1.65

1029

1793

Viral Sepsis

1027

3049

3.62

288.88

4.9

3.0

51.76

39.13

mg/l

1.96

849

2605

Implicit viral Sepsis

1025

3045

3.61

288.03

4.9

3.0

51.84

39.17

mg/l

1.97

847

2601

Diabetes, varying definitions

3012

8313

2.15

284.98

2.6

3.9

42.79

40.44

mg/l

0.39

2503

7127

Diabetes mellitus

3020

8312

2.15

284.56

2.5

3.9

42.79

40.44

mg/l

0.39

2512

7123

Disorders of lipoprotein metabolism and other lipidaemias

2681

7498

2.24

280.70

3.1

3.4

40.14

40.68

mg/l

0.08

2327

6347

Valvular heart disease excluding rheumatic fever

1755

4859

2.69

280.41

3.4

3.5

48.68

39.58

mg/l

1.42

1426

4211

Non-rheumatic valve diseases

1746

4851

2.68

276.61

3.4

3.5

48.78

39.61

mg/l

1.43

1418

4204

Non-ischemic cardiomyopathy

1456

4177

2.94

276.09

3.3

3.6

62.31

38.67

mg/l

2.04

1219

3603

Covid-19 confirmed case

1631

6404

2.68

275.74

4.4

3.1

56.79

43.73

mg/l

1.02

1382

5396

Pain in limb

2630

7723

2.22

274.87

3.3

3.6

43.04

46.39

mg/l

0.28

2262

6482

Type 2 diabetes

2961

8256

2.13

272.04

2.5

3.9

42.90

40.58

mg/l

0.38

2462

7077

Dental caries

1076

3188

3.37

270.73

6.0

2.8

51.71

41.32

mg/l

2.80

958

2701

Amyloidosis

293

301

13.91

269.20

11.7

3.7

62.92

47.09

mg/l

0.63

259

267

Preparatory care for dialysis

407

619

8.35

267.64

2.6

4.0

67.36

86.50

mg/l

0.32

388

522

Atrial fibrillation and flutter

903

1503

4.03

267.36

3.6

3.7

55.41

28.37

mg/l

1.33

741

1333

Asthma, unspecified (mode)

1678

4696

2.66

266.48

2.8

2.7

38.29

37.59

mg/l

0.09

1409

4058

Gout, idiopatic and unspecified

1324

4812

2.97

265.03

2.5

3.4

47.81

48.30

mg/l

0.04

1102

4074

Certain infectious and parasitic diseases

2657

6104

2.23

263.77

3.6

2.6

45.84

38.73

mg/l

0.74

2246

5193

Abnormalities of breathing

2551

6694

2.23

263.16

3.4

3.3

47.01

39.36

mg/l

0.77

2122

5726

Amyloidosis, other/unspecified

263

244

16.32

260.77

12.6

3.6

63.25

45.75

mg/l

0.63

235

212

Diabetic nephropathy

1000

3113

3.55

260.19

2.1

2.8

56.87

44.10

mg/l

3.75

836

2609

Codeine

2545

6290

2.24

260.19

3.2

2.7

41.10

42.15

mg/l

0.08

2134

5363

Other systemic involvement of connective tissue

1219

4259

3.04

259.93

2.5

3.5

34.34

48.49

mg/l

2.71

1004

3621

Insulin medication

2158

8026

2.31

259.81

2.7

3.8

51.69

43.30

mg/l

1.74

1776

6858

Osteoporosis with pathological fracture (FG)

506

967

6.04

258.83

2.4

3.5

28.85

47.41

mg/l

2.94

390

826

Other arthritis (FG)

1143

3874

3.09

255.25

3.0

3.7

35.42

45.32

mg/l

1.99

929

3326

Provisional assignment of new diseases of uncertain etiology

1918

8299

2.38

255.15

4.3

3.0

54.29

42.10

mg/l

1.18

1649

7005

Caries of dentine

972

2882

3.45

254.72

6.0

2.8

50.32

41.68

mg/l

2.10

865

2434

Codes for special purposes

1919

8312

2.37

254.60

4.3

3.1

54.26

42.09

mg/l

1.18

1650

7016

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

450

462

7.32

251.70

2.7

4.3

43.51

43.26

mg/l

0.01

345

406

Autoimmune diseases

3190

8150

2.03

251.19

3.0

3.7

42.49

44.97

mg/l

0.24

2678

6989

Other soft tissue disorders, not elsewhere classified

2817

7798

2.10

250.73

3.4

3.5

42.35

46.31

mg/l

0.38

2431

6541

Gout, unspecified

1111

3796

3.18

249.58

2.6

3.2

49.29

49.53

mg/l

0.02

919

3230

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2485

10467

2.14

249.44

3.2

3.5

43.21

43.44

mg/l

0.03

2113

8891

Disorders of other endocrine glands

1565

6195

2.59

249.39

3.1

3.3

41.31

45.39

mg/l

0.41

1262

5306

Malignant immunoproliferative diseases

205

143

31.01

248.40

7.8

3.5

50.32

47.05

mg/l

0.06

192

123

Gout, strict definition

1034

3427

3.30

245.79

2.5

3.5

49.27

51.17

mg/l

0.13

853

2925

Disorders of parathyroid gland

1031

3392

3.24

240.44

2.8

3.3

45.94

51.29

mg/l

0.32

847

2885

Atrial fibrillation and flutter with reimbursement

808

1315

4.05

237.49

3.5

3.7

57.65

28.77

mg/l

1.24

663

1169

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2783

8208

2.06

236.73

2.5

3.9

45.14

40.73

mg/l

0.85

2307

7037

Opioids

2569

6311

2.15

235.25

3.6

2.7

49.85

42.13

mg/l

0.58

2181

5382

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2199

8110

2.22

234.26

2.6

3.8

51.69

43.85

mg/l

1.09

1830

6936

Cerebrovascular diseases (FINNGEN)

818

1558

3.81

232.17

2.9

3.7

41.38

28.79

mg/l

3.76

701

1380

Autoimmune diseases related-to ILD

2616

11047

2.03

229.08

2.6

3.6

39.22

43.65

mg/l

0.84

2184

9457

Used for control exclusion in common control thyroid runs

2943

7496

2.02

229.06

3.0

3.7

42.97

46.14

mg/l

0.29

2466

6402

Pure hypercholesterolaemia

2406

7338

2.14

228.84

3.0

3.4

38.34

40.87

mg/l

0.60

2163

6216

Hypertensive Renal Disease

325

454

8.67

228.42

2.2

4.0

70.32

70.41

mg/l

0.00

262

403

Other CVD (FINNGEN)

508

756

5.52

225.64

3.9

3.5

41.75

27.45

mg/l

4.26

431

680

Complications of surgical and medical care, not elsewhere classified

3088

10927

1.93

224.74

3.2

3.4

41.38

43.45

mg/l

0.40

2603

9301

Other disorders of kidney and ureter

721

2032

3.91

222.22

2.7

3.5

66.38

50.11

mg/l

0.46

599

1738

Reimbursement for rheumatic diseases

1917

8840

2.23

219.70

2.1

3.6

39.19

42.73

mg/l

0.34

1560

7574

Other specified/unspecified arthritis

1010

3477

3.05

219.62

3.0

3.7

35.24

46.43

mg/l

2.10

818

2982

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

953

1833

3.36

219.49

3.4

3.7

53.61

27.88

mg/l

1.38

780

1618

Asthma, excluding more controls

1840

4016

2.40

218.29

2.8

2.7

42.69

34.24

mg/l

0.66

1554

3482

Dialysis

281

352

9.49

215.72

3.2

3.6

153.95

32.47

mg/l

2.01

224

302

Low back pain

2310

7605

2.10

213.45

3.7

3.1

42.11

44.75

mg/l

0.26

1949

6440

Symptoms and signs involving the urinary system

2570

9933

2.01

213.42

2.9

3.5

45.82

43.44

mg/l

0.19

2179

8438

Bleeding

2758

10113

1.96

212.55

2.8

3.6

46.45

43.18

mg/l

0.51

2302

8661

Type 2 diabetes, definitions combined

2733

8184

1.99

210.17

2.6

3.9

42.47

40.75

mg/l

0.25

2277

7016

Myelodysplastic syndrome, including Hilmo

286

385

9.37

209.22

2.6

1.4

43.04

35.19

mg/l

0.36

246

322

Ulcer of lower limb, not elsewhere classified

801

2508

3.49

209.08

2.7

3.3

50.84

54.22

mg/l

0.19

669

2138

Diseases of arteries, arterioles and capillaries

2476

9257

2.03

208.79

2.6

3.6

49.04

44.38

mg/l

0.65

2077

7880

Type 2 diabetes, strict (exclude DM1)

2745

8256

1.98

208.51

2.7

3.9

42.51

40.69

mg/l

0.27

2287

7073

Examination and observation for other reasons

1749

4271

2.37

206.18

3.4

3.2

40.66

44.22

mg/l

0.36

1636

3299

Cardiac arrhythmias

1373

3447

2.61

206.04

3.6

4.0

47.85

33.00

mg/l

0.99

1129

3019

Insulin, combination of fast acting with intermediate-acting or long-acting

2159

9685

2.09

205.76

2.7

3.4

51.69

43.95

mg/l

1.72

1776

8255

Asthma (only as main-diagnosis), excluding more controls

1699

4016

2.39

203.69

2.8

2.7

42.74

34.24

mg/l

0.60

1429

3482

Non-Hodgkin lymphoma, all, including Hilmo

676

1933

3.82

203.12

3.3

1.5

38.19

34.86

mg/l

0.49

581

1604

Diabetes, insulin treatment (Kela reimbursement)

3010

9667

1.89

202.39

2.5

3.8

44.73

41.39

mg/l

0.68

2497

8265

Polyneuropathies and other disorders of the peripheral nervous system

1033

3792

2.92

202.20

4.0

3.3

47.39

46.70

mg/l

0.02

907

3214

Spondylopathies

2482

7436

2.02

200.96

3.7

3.2

35.43

45.33

mg/l

3.86

2074

6299

Cardiovascular diseases

990

1672

3.19

200.33

3.3

39.75

27.20

mg/l

2.37

833

1454

Diseases of oesophagus, stomach and duodenum

3084

9926

1.87

200.30

3.1

3.5

44.91

41.56

mg/l

0.34

2645

8375

Symptoms and signs concerning food and fluid intake

525

1265

4.49

199.14

2.4

3.2

42.82

49.95

mg/l

0.26

457

1096

Coagulation defects, purpura and other haemorrhagic conditions

833

2732

3.25

198.79

3.4

3.3

35.21

51.73

mg/l

1.98

690

2345

Codeine or tramadol medication

3202

9643

1.84

193.09

3.3

41.82

44.16

mg/l

0.22

2702

8213

Syncope and collapse

1450

5210

2.40

191.72

3.0

3.2

44.79

43.96

mg/l

0.07

1208

4453

Other and unspecified polyneuropathies, also in other diseases

935

3356

3.00

191.41

3.5

3.3

36.70

48.23

mg/l

2.07

820

2844

Type 2 diabetes, definitions combined, including avohilmo

2667

8133

1.94

190.64

2.6

3.9

42.34

40.45

mg/l

0.28

2223

6967

Other disorders of skin and subcutaneous tissue

2420

10776

1.95

188.62

3.0

3.5

42.34

43.81

mg/l

0.25

2068

9138

Other medical care

1769

7011

2.19

188.28

5.1

3.0

66.31

38.08

mg/l

2.19

1415

5958

Diverticular disease of intestine

2392

7664

2.00

188.27

3.3

3.5

47.63

44.42

mg/l

0.24

2074

6477

Polymyalgia rheumatica

749

2410

3.41

187.44

2.4

3.4

33.22

54.96

mg/l

2.44

609

2048

Insulin, intermediate and long-acting

1927

9185

2.09

186.70

2.6

3.4

52.08

43.83

mg/l

1.73

1596

7830

Hyperkalaemia

401

835

5.48

185.91

3.1

3.4

66.10

46.35

mg/l

1.23

325

708

Genitourinary diseases

1346

2659

2.59

185.32

3.1

3.6

62.68

34.55

mg/l

1.60

1137

2266

Rheumatoid arthritis

1124

3905

2.65

184.76

2.2

3.8

34.08

46.71

mg/l

2.95

947

3341

Hyperparathyroidism

864

2992

3.06

184.14

2.8

3.2

48.73

52.83

mg/l

0.20

723

2536

COPD/asthma related infections

2728

7268

1.92

183.06

4.4

2.6

52.11

38.21

mg/l

1.47

2287

6252

COPD/asthma/ILD related infections

2728

7268

1.92

183.06

4.4

2.6

52.11

38.21

mg/l

1.47

2287

6252

Other diseases of intestines

2779

8373

1.88

181.95

3.2

3.4

45.13

43.08

mg/l

0.16

2344

7072

Endocrine, nutritional and metabolic diseases

1701

3818

2.29

181.40

3.3

3.8

56.47

36.28

mg/l

1.35

1433

3289

Asthma

1953

4791

2.15

179.06

2.9

2.7

42.64

37.54

mg/l

0.36

1649

4143

Hypertensive Heart Disease

955

2629

2.90

176.92

2.6

3.9

47.19

44.65

mg/l

0.18

820

2262

Diabetes medication

2878

9319

1.84

176.65

2.4

3.8

44.34

41.04

mg/l

0.67

2400

7974

Any reimbursement code in KELA

1017

1763

2.94

176.41

3.7

1.8

48.38

30.62

mg/l

0.89

869

1531

Purpura and other haemorrhagic conditions

628

1879

3.61

175.21

3.4

3.5

37.40

57.14

mg/l

1.51

515

1616

Persons encountering health services in other circumstances, wide

3248

9542

1.78

174.79

3.2

3.4

40.00

43.87

mg/l

0.79

2758

8083

Asthma (mode)

1921

4833

2.13

174.00

3.0

2.7

42.31

37.56

mg/l

0.33

1637

4185

Hypothyroidism (congenital or acquired)

378

341

6.32

171.94

4.3

1.5

32.60

22.03

mg/l

4.28

323

294

Malignant neoplasm

2289

6962

1.97

171.87

6.2

1.5

54.22

34.95

mg/l

1.98

1979

5849

Malignant neoplasm, including Hilmo

2296

6949

1.96

171.71

5.8

1.5

53.33

34.87

mg/l

1.91

1986

5834

Complications of medical and surgical care

2314

11192

1.90

171.22

3.4

42.74

43.09

mg/l

0.05

1994

9486

Certain disorders involving the immune mechanism

759

2573

3.13

171.05

3.8

3.3

49.61

50.04

mg/l

0.02

613

2193

Pain in throat and chest

2190

6672

1.98

168.73

3.3

39.73

39.43

mg/l

0.04

1860

5708

Isolated proteinuria

226

296

9.33

168.21

5.1

3.8

45.75

49.47

mg/l

0.12

197

258

Malignant neoplasm

2280

6981

1.95

167.95

6.2

1.5

54.37

34.94

mg/l

2.00

1971

5866

Anaemia in chronic diseases classified elsewhere

217

273

9.99

167.86

2.0

3.9

69.56

52.61

mg/l

0.59

154

239

Enlarged lymph nodes

586

1716

3.60

167.32

2.2

3.2

36.81

46.94

mg/l

0.77

499

1465

Percutaneous Coronary Intervention

2392

7790

1.91

166.36

2.9

3.7

42.87

40.16

mg/l

0.49

1986

6727

Hypothyroidism and >3 levothyroxin purchases

370

340

6.21

165.91

4.2

1.5

32.00

22.03

mg/l

3.87

316

294

Hypothyroidism, levothyroxine purchases

370

340

6.21

165.91

4.2

1.5

32.00

22.03

mg/l

3.87

316

294

Cardiomyopathy

705

2332

3.20

165.44

4.0

3.3

45.42

44.21

mg/l

0.07

606

2020

Pain, not elsewhere classified

868

3200

2.81

165.29

3.7

3.2

37.24

45.12

mg/l

0.89

765

2733

Malignant neoplasm, wide definition

2292

7022

1.94

165.14

5.8

1.5

53.26

34.90

mg/l

1.89

1981

5898

Other disorders involving the immune mechanism, not elsewhere classified

232

319

8.69

164.96

3.6

3.9

70.17

40.75

mg/l

1.00

187

267

Asthma (only as main-diagnosis)

1787

4791

2.13

164.13

2.8

2.7

42.37

37.54

mg/l

0.31

1507

4143

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3104

9504

1.77

163.78

3.2

3.4

41.93

43.35

mg/l

0.20

2748

8056

Chronic nephritic syndrome

272

448

7.17

163.39

2.8

4.0

57.96

49.02

mg/l

0.41

197

388

Acquired haemolytic anaemia

224

304

9.36

163.03

3.3

3.9

28.18

55.04

mg/l

1.53

197

262

Medical observation and evaluation for suspected diseases and conditions

1761

4301

2.14

159.49

3.4

3.2

38.18

44.19

mg/l

0.82

1599

3322

ILD medications: azathioprine

473

1237

4.02

159.35

2.0

1.9

46.79

38.78

mg/l

0.84

396

1053

Intestinal infectious diseases

2683

11354

1.79

158.90

4.4

3.1

41.68

42.89

mg/l

0.18

2276

9639

Coronary revascularization (ANGIO or CABG)

2366

7792

1.89

158.33

2.9

3.7

44.25

40.15

mg/l

0.76

1968

6729

Diarrhoea and gastroenteritis of presumed infectious origin

2037

9625

1.93

158.03

4.1

3.0

41.74

43.05

mg/l

0.16

1705

8156

Antihypertensive medication - note that there are other indications

988

1898

2.76

156.29

3.1

3.9

38.91

28.16

mg/l

2.07

834

1647

Ischemic heart diseases

2418

7911

1.86

154.20

3.2

3.7

46.37

39.95

mg/l

0.62

1995

6828

Insulin, fast-acting

1229

5510

2.31

154.03

2.5

3.3

48.72

44.00

mg/l

0.68

1014

4678

Hyperlipidaemia, other/unspecified

1395

5878

2.21

153.82

3.3

3.4

45.61

41.56

mg/l

0.47

1138

4964

Dorsalgia

2604

7683

1.83

153.77

3.6

3.1

42.19

44.73

mg/l

0.19

2204

6503

Excluding asthma or asthma-COPD overlap

1928

4833

2.04

153.75

3.8

2.7

54.64

37.53

mg/l

1.26

1636

4176

Hypo-osmolality and hyponatraemia

754

2680

2.96

153.49

3.1

3.2

42.78

45.00

mg/l

0.16

596

2264

Emergency coronary revascularization (for ACS)

2613

8904

1.81

153.42

2.9

3.7

44.22

42.44

mg/l

0.25

2170

7625

Haemolytic anaemias

250

407

7.26

151.97

3.2

3.7

34.74

56.36

mg/l

1.07

219

351

Other pulmonary diagnosis

1921

4833

2.03

151.69

3.8

2.7

55.09

37.53

mg/l

1.30

1626

4176

Lower back pain or/and sciatica

3021

11086

1.72

151.67

3.6

3.3

39.83

43.75

mg/l

0.58

2575

9396

Hard cardiovascular diseases

2350

7596

1.87

151.61

3.2

3.8

41.04

41.84

mg/l

0.10

1952

6532

Parasetamol

1599

3795

2.17

150.16

3.5

3.0

58.26

43.41

mg/l

0.77

1350

3247

Disorders of thyroid, IBD co-morbidities

386

553

4.91

149.93

2.7

4.0

63.01

38.69

mg/l

0.38

329

492

Paroxysmal tachycardia

540

1286

3.60

149.89

3.1

3.6

38.29

28.01

mg/l

2.31

439

1137

Other necrotizing vasculopathies (FG)

340

737

5.17

149.63

1.8

4.2

38.27

68.80

mg/l

1.19

282

637

Presence of other functional implants

2026

7359

1.94

149.58

3.2

3.3

44.85

45.11

mg/l

0.02

1472

6370

Other abnormal findings of blood chemistry

285

534

6.06

148.51

4.2

4.0

39.25

50.53

mg/l

0.74

256

456

Explicit bacterial Sepsis, including avohilmo

497

1421

3.76

148.51

6.1

3.1

77.97

37.71

mg/l

1.04

422

1242

Explicit bacterial Sepsis

489

1391

3.78

147.30

6.0

3.1

76.92

37.67

mg/l

0.98

414

1213

Certain infectious and parasitic diseases, including avohilmo

1787

4425

2.06

147.26

3.5

2.6

54.55

37.73

mg/l

1.12

1520

3734

COPD differential diagnosis

1903

4836

2.01

146.25

3.8

2.7

55.06

37.56

mg/l

1.27

1612

4188

ILD differential diagnosis

1902

4833

2.01

146.18

3.8

2.7

55.09

37.56

mg/l

1.28

1611

4185

Disorders of lens

2040

6725

1.93

145.98

3.6

3.5

52.18

42.86

mg/l

0.78

1674

5794

Exposure to unspecified factor

2827

11345

1.72

144.89

3.3

3.4

38.84

43.78

mg/l

1.10

2278

9753

Other dialysis

235

380

7.50

144.69

2.8

4.2

146.68

42.45

mg/l

1.31

191

323

Major coronary heart disease event

2493

8444

1.81

144.51

2.9

3.7

42.09

42.05

mg/l

0.00

2068

7256

Fall on same level

2951

9267

1.72

143.95

3.0

3.6

39.34

43.35

mg/l

0.87

2500

7892

Cardiomyopathy in other diseases

106

34.63

142.64

13.0

2.5

60.19

53.13

mg/l

0.12

Abnormal findings on diagnostic imaging of lung

1771

8842

1.96

142.60

3.0

3.5

45.26

45.01

mg/l

0.02

1512

7495

Continuous positive airway pressure

592

1558

3.30

142.28

2.9

4.1

50.98

37.00

mg/l

1.29

553

1379

Other necrotizing vasculopathies

411

1080

4.26

141.10

2.0

3.8

38.40

70.69

mg/l

1.42

348

924

Streptococcal septicaemia

434

1178

4.00

140.68

5.9

3.2

82.09

53.17

mg/l

0.49

363

1017

Hypothyroidism, drug reimbursement

253

257

7.06

140.68

4.0

1.5

34.10

21.95

mg/l

5.46

209

223

Complications of procedures, not elsewhere classified

2342

10757

1.79

140.36

3.0

3.5

42.69

43.64

mg/l

0.14

1979

9156

Non-invasive ventilation

646

1878

3.06

139.84

3.7

4.3

40.83

35.22

mg/l

0.69

587

1665

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

206

298

8.17

139.83

3.2

3.9

75.93

41.73

mg/l

1.06

166

248

Haemorrhage from respiratory passages

1225

5004

2.24

139.81

2.8

3.3

46.74

42.57

mg/l

0.37

1024

4256

Streptococcal septicaemia, including avohilmo

441

1217

3.93

139.51

6.0

3.2

82.86

52.48

mg/l

0.54

370

1053

Abnormal findings on examination of urine, without diagnosis

281

557

5.80

138.19

4.8

3.5

44.75

89.62

mg/l

0.91

239

488

Fracture of lumbar spine and pelvis

952

4024

2.48

137.65

3.0

3.2

40.30

52.55

mg/l

1.30

788

3403

Other (not insulin) diabetes medications

2683

9227

1.74

136.85

2.5

3.8

44.80

41.29

mg/l

0.69

2239

7893

Insulin, fast-acting or short human

1231

5808

2.19

135.84

2.5

3.3

48.77

45.04

mg/l

0.51

1016

4930

Seropositive rheumatoid arthritis

814

3201

2.63

135.29

2.1

3.9

34.36

49.13

mg/l

2.80

704

2741

Depression medications

365

350

5.32

134.91

2.7

1.5

35.90

21.84

mg/l

5.02

303

Thrombocytopenia, unspecified

389

1013

4.25

134.70

3.0

3.5

35.58

73.75

mg/l

1.66

311

862

Constipation

2621

10498

1.72

133.78

3.8

3.3

43.68

43.66

mg/l

0.00

2169

8979

Unspecified haematuria

1526

6352

2.02

130.80

2.9

3.5

42.18

45.43

mg/l

0.59

1280

5377

Other diseases of pleura

1681

7761

1.95

130.42

3.0

3.3

55.21

45.25

mg/l

0.69

1357

6600

Neoplasms

1504

3842

2.08

130.10

4.4

1.3

59.95

34.33

mg/l

1.68

1292

3152

Postmenopausal osteoporosis with pathological fracture

390

1050

4.18

129.86

2.6

3.1

28.57

46.33

mg/l

3.29

303

910

Other arrhythmias

1584

6091

1.98

128.68

3.2

3.5

35.68

37.26

mg/l

0.26

1314

5276

Azathioprine

473

1432

3.46

128.06

2.0

3.9

46.79

50.53

mg/l

0.16

396

1226

Diseases of the digestive system

1574

8227

1.96

127.68

2.8

3.4

46.81

45.54

mg/l

0.14

1306

6972

Intestinal infectious diseases, including avohilmo, including avohilmo

3127

10812

1.64

126.43

4.2

3.1

42.64

43.20

mg/l

0.07

2671

9170

Spinal stenosis

1709

6716

1.93

126.35

3.1

3.2

36.04

46.86

mg/l

3.55

1500

5684

Other autoimmune haemolytic anaemias

146

163

12.65

126.30

2.4

3.8

27.01

49.85

mg/l

0.91

129

137

Viral pneumonia

514

1658

3.28

126.18

6.7

2.6

46.28

45.23

mg/l

0.04

422

1432

Abnormal weight loss

464

1418

3.56

126.05

2.4

3.5

44.04

64.14

mg/l

0.75

401

1208

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

661

1084

3.11

126.03

3.4

3.2

44.57

30.25

mg/l

1.55

555

929

Weight loss

485

1523

3.45

125.81

2.4

3.5

43.84

61.86

mg/l

0.71

420

1300

Iron deficiency anaemia secondary to blood loss (chronic)

667

2511

2.81

123.90

2.6

3.4

45.25

55.07

mg/l

0.69

549

2153

Other specific joint derangements/joint disorders

1717

5663

1.92

123.47

2.9

3.7

35.21

44.63

mg/l

2.32

1491

4849

Headache

1482

5854

1.99

123.42

2.9

3.1

33.03

41.09

mg/l

1.53

1287

4978

Symptoms and signs involving the circulatory and respiratory systems

2327

6698

1.77

122.04

3.2

3.3

46.64

39.35

mg/l

0.68

1974

5729

Senile cataract

1909

6400

1.86

121.66

3.7

3.5

52.46

43.61

mg/l

0.67

1572

5515

Disorders of choroid and retina

2487

10441

1.70

121.58

3.0

3.5

50.20

41.96

mg/l

1.54

2095

8912

STROKE

1460

4988

2.02

121.43

3.3

4.1

40.47

38.94

mg/l

0.15

1261

4314

3070

9664

1.64

121.41

4.8

2.8

47.24

42.52

mg/l

0.47

2567

8263

Diseases of the skin and subcutaneous tissue

2509

7428

1.72

120.05

3.1

3.4

42.82

44.65

mg/l

0.22

2128

6296

Symptoms and signs involving cognition, perception, emotional state and behaviour

2631

10692

1.67

120.04

3.0

3.5

37.77

43.95

mg/l

1.76

2298

9011

All influenza

846

3618

2.42

118.55

7.3

2.6

51.47

42.69

mg/l

0.64

712

3071

Type 1 diabetes

692

2692

2.65

118.15

2.1

3.6

46.28

48.04

mg/l

0.10

574

2289

Bacterial pneumoniae

1297

5722

2.05

117.80

4.8

2.7

60.81

42.09

mg/l

1.26

1161

4892

Isolated proteinuria with specified morphological lesion

125

124

13.81

117.05

3.8

4.0

47.07

42.56

mg/l

0.11

107

Injuries to the abdomen, lower back, lumbar spine and pelvis

1330

6719

2.01

116.65

3.2

40.17

46.64

mg/l

0.90

1113

5682

IgA nephropathy (IgA glomerulonephritis)

174

258

8.08

115.92

2.1

3.7

58.14

40.87

mg/l

1.28

140

217

Benign neoplasm of colon, rectum, anus and anal canal

2109

10476

1.75

115.74

3.1

3.5

43.55

43.94

mg/l

0.02

1877

8836

Implicit fungal Sepsis, including avohilmo

344

914

4.10

115.25

3.9

3.2

56.72

38.13

mg/l

1.64

284

799

Non-follicular lymphoma

472

1548

3.32

114.46

2.8

3.6

38.19

63.87

mg/l

1.52

398

1315

Volume depletion

436

1356

3.44

114.33

2.5

3.3

74.11

44.87

mg/l

0.51

331

1153

Primary hyperparathyroidism

507

1730

3.17

114.29

3.1

3.4

35.70

55.76

mg/l

1.29

433

1489

Biguanides

2594

9568

1.66

114.04

2.3

3.8

44.05

41.48

mg/l

0.47

2165

8172

Other dorsopathies, not elsewhere classified

2474

7685

1.70

113.60

3.5

3.1

42.66

44.72

mg/l

0.15

2136

6504

Other disorders of urethra and urinary system

1975

7871

1.78

113.43

3.2

3.4

39.91

47.04

mg/l

1.62

1655

6683

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1841

10331

1.79

113.14

3.2

3.4

41.42

43.70

mg/l

0.43

1579

8764

Asthma-related infections

1694

9217

1.83

112.99

3.2

3.4

44.76

43.35

mg/l

0.07

1429

7809

Asthma, hospital admission 2, infections

1694

9217

1.83

112.99

3.2

3.4

44.76

43.35

mg/l

0.07

1429

7809

Hernia of abdominal wall, postoperative

528

1824

2.98

112.11

3.1

3.0

44.75

43.33

mg/l

0.10

455

1620

Other retinal disorders

2089

9339

1.74

111.72

2.8

3.5

50.63

42.84

mg/l

1.12

1746

7959

Other nutritional deficiencies

1756

9059

1.80

111.07

2.4

3.6

43.84

40.75

mg/l

0.44

1423

7751

Infections of the skin and subcutaneous tissue

1615

8796

1.84

110.82

3.4

40.57

42.48

mg/l

0.32

1378

7452

Other bacterial intestinal infections

686

2762

2.60

110.70

5.0

2.9

46.28

50.39

mg/l

0.26

586

2349

Any event in cancer register

2205

7574

1.73

110.69

5.5

2.0

51.82

35.99

mg/l

1.41

1893

6400

Presence of cardiac and vascular implants and grafts

1545

6135

1.91

110.39

2.4

3.3

50.21

46.84

mg/l

0.26

1390

5294

Diseases of liver

1138

5646

2.08

110.24

2.3

3.5

46.23

43.31

mg/l

0.35

936

4803

Conduction disorders

969

3565

2.25

109.85

2.7

3.3

47.81

42.03

mg/l

0.39

802

3094

Type 1 diabetes, wide definition, subgroup 1

552

1991

2.86

109.52

2.1

3.8

45.15

52.43

mg/l

0.38

457

1703

Other diseases of urinary system

2603

9003

1.65

108.86

3.1

3.5

39.39

45.88

mg/l

1.72

2196

7655

Hypokalaemia

478

1619

3.13

108.06

2.6

3.3

41.46

42.01

mg/l

0.06

399

1373

Coxarthrosis [arthrosis of hip](FG)

1573

5879

1.88

107.74

3.0

3.9

42.49

46.79

mg/l

0.39

1334

5049

Bacterial pneumonia, not elsewhere classified

1221

5445

2.03

107.70

4.6

2.7

50.97

42.65

mg/l

1.01

1107

4648

Peripheral artery disease

1601

7010

1.86

106.99

2.3

3.5

50.59

47.60

mg/l

0.26

1352

5963

Other functional intestinal disorders

1349

6481

1.94

105.84

3.7

3.4

48.52

45.21

mg/l

0.14

1147

5472

AV-block

689

2387

2.58

105.74

2.9

3.2

59.33

45.94

mg/l

0.64

574

2060

Asthma (diagnoses ohter than nonallergic)

2336

11610

1.65

105.44

2.6

3.5

35.83

44.41

mg/l

3.18

1986

9855

Ischaemic heart disease, wide definition

2257

8384

1.69

105.22

3.0

3.7

46.72

40.77

mg/l

0.54

1880

7205

Enterocolitis due to Clostridium difficile

481

1665

3.09

105.21

5.3

3.2

48.49

59.28

mg/l

0.50

404

1419

Rheumatoid arthritis, including avohilmo

1211

6242

2.00

105.18

2.2

3.5

33.47

46.37

mg/l

4.09

1016

5290

Acute myeloid leukaemia and myelodysplastic syndromes

173

284

7.20

104.46

2.0

1.4

46.19

34.04

mg/l

0.35

151

242

Coronary atherosclerosis

1939

7113

1.76

104.23

3.0

3.7

47.16

41.27

mg/l

0.44

1613

6135

Adjustment and management of implanted device

736

3155

2.45

103.95

3.3

2.8

50.57

38.69

mg/l

0.77

574

2667

Nausea and vomiting

884

3988

2.23

102.17

3.5

3.3

39.82

47.51

mg/l

0.97

741

3378

COPD (mode)

975

3597

2.18

102.00

2.1

2.7

41.26

39.78

mg/l

0.22

800

3101

Other bacterial intestinal infections, including avohilmo

793

3527

2.33

101.85

4.8

2.9

49.53

47.47

mg/l

0.12

683

2991

Other diseases of the digestive system

1163

5986

2.01

101.81

2.7

3.3

46.67

48.14

mg/l

0.15

972

5058

Myelodysplastic syndrome

127

154

10.68

101.81

2.3

1.3

53.59

37.85

mg/l

0.33

111

129

Neurological diseases, wide definition

428

605

3.61

101.67

3.1

3.8

39.31

37.20

mg/l

0.12

360

537

Obesity due to excess calories

1227

6419

1.96

101.06

2.3

3.7

46.78

40.22

mg/l

0.80

985

5509

Dermatitis

1783

10215

1.74

100.63

3.1

3.5

40.58

42.51

mg/l

0.30

1469

8711

GI-bleeding

1160

6005

2.00

99.79

2.7

3.3

47.29

48.12

mg/l

0.08

967

5072

Non-Hodgkin lymphoma, all

252

596

4.73

99.72

3.6

1.6

43.78

35.81

mg/l

0.81

210

502

Venous thromboembolism

1733

9739

1.76

99.60

4.2

3.2

46.81

43.67

mg/l

0.18

1440

8300

Bacterial intestinal infections, IBD co-morbidities

686

2911

2.47

98.82

5.1

3.1

46.35

49.98

mg/l

0.24

585

2478

Disorders of gallbladder, biliary tract and pancreas

2688

10697

1.59

98.73

3.4

49.17

41.79

mg/l

1.26

2278

9099

Asthma-related pneumonia

1208

6337

1.96

98.38

3.3

41.89

46.96

mg/l

0.73

1024

5334

Asthma, hospital admissions 3, pneumonia

1208

6342

1.95

98.13

3.3

41.89

46.94

mg/l

0.72

1024

5338

Asthma-related pneumonia or sepsis

1208

6342

1.95

98.13

3.3

41.89

46.94

mg/l

0.72

1024

5338

Bronchitis

2848

11078

1.56

97.38

5.1

2.9

46.35

42.19

mg/l

0.39

2366

9476

Other acute lower respiratory infections

1536

8286

1.80

97.25

4.8

3.0

44.11

44.61

mg/l

0.02

1272

7002

Polyarthrosis

704

2710

2.43

97.21

2.8

3.9

36.02

50.92

mg/l

1.84

588

2322

Other diseases of blood and blood-forming organs

326

940

3.78

97.10

4.5

3.7

46.39

74.06

mg/l

0.88

291

807

Other diseases of pericardium

224

493

5.01

96.50

2.7

3.4

43.68

67.80

mg/l

0.50

183

424

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2611

10547

1.59

96.45

3.4

45.42

43.12

mg/l

0.19

2169

9002

Care involving use of rehabilitation procedures

1646

8546

1.76

96.29

3.1

39.51

36.39

mg/l

0.66

1453

7260

Other special examinations and investigations of persons without complaint or reported diagnosis

1549

4302

1.85

95.22

3.4

3.2

42.43

44.19

mg/l

0.15

1350

3323

Pain in joint

1468

4938

1.86

95.16

3.0

3.3

35.48

42.69

mg/l

1.92

1289

4138

Other and unspecified dermatitis

1505

8559

1.80

94.92

3.1

3.5

39.64

42.33

mg/l

0.40

1255

7298

Diabetic retinopathy, excluding more controls

921

2385

2.26

94.91

2.3

2.8

52.57

41.72

mg/l

1.58

749

2018

Spondylosis

1587

7080

1.79

94.79

2.9

3.2

32.98

45.62

mg/l

5.70

1262

5995

Diseases of the musculoskeletal system and connective tissue

1011

2384

2.16

94.53

3.6

3.3

64.49

46.23

mg/l

0.57

867

2039

Major coronary heart disease event excluding revascularizations

1855

7257

1.73

94.13

2.9

3.7

43.52

44.20

mg/l

0.07

1558

6239

Other cataract

1358

5503

1.88

93.88

3.5

3.4

44.29

44.96

mg/l

0.06

1118

4740

Other and unspecified diseases of blood and blood-forming organs

177

330

6.27

93.67

5.9

3.8

52.91

51.40

mg/l

0.04

162

290

Obesity

1601

8723

1.76

93.60

2.3

3.6

44.56

40.75

mg/l

0.53

1306

7453

Obesity and other hyperalimentation

1609

8774

1.76

93.28

2.3

3.6

44.52

40.70

mg/l

0.54

1313

7498

Bacterial pneumonia (organism specified)

1425

7241

1.83

92.94

5.1

3.0

59.63

44.20

mg/l

1.07

1261

6075

Renal tubulo-interstitial disorders in diseases classified elsewhere

14.72

92.81

9.9

4.4

80.20

26.78

mg/l

0.86

Type 1 diabetes, wide definition

562

2230

2.59

92.25

2.1

3.6

45.02

50.56

mg/l

0.31

465

1903

Atherosclerosis, excluding cerebral and coronary sclerosis

1500

6703

1.81

91.98

2.2

3.5

50.92

48.23

mg/l

0.22

1264

5706

Use of hypnotics and sedatives

2746

10221

1.56

91.36

4.0

3.2

47.01

41.87

mg/l

0.51

2333

8675

Injuries to the hip and thigh

1572

8178

1.77

91.18

2.8

3.3

40.62

46.36

mg/l

1.00

1342

6902

Gastrointestinal diseases

1129

2820

2.03

90.96

3.7

3.0

66.12

36.31

mg/l

1.34

968

2364

Idiopathic gout

437

1563

3.02

90.67

2.4

3.4

43.47

62.58

mg/l

1.08

365

1331

Pleural effusion

647

2789

2.45

90.63

2.9

3.2

70.65

50.15

mg/l

0.52

522

2387

Other/unspecified dorsalgia

1024

5168

2.00

90.30

4.2

3.1

31.84

44.81

mg/l

4.26

857

4359

Other disorders of white blood cells

266

703

4.16

90.27

2.5

3.7

37.56

84.61

mg/l

1.33

212

605

Intracranial trauma

1306

4770

1.88

89.73

3.3

3.6

41.86

43.43

mg/l

0.17

1071

4079

Arthropathies

1938

5835

1.70

89.57

3.0

3.6

44.90

44.49

mg/l

0.02

1646

4988

Vocal cord dysfunction

297

718

3.74

89.44

3.5

4.7

66.38

41.33

mg/l

0.57

248

652

DVT of lower extremities and pulmonary embolism

1384

7810

1.81

89.04

4.6

3.2

49.11

45.27

mg/l

0.17

1140

6616

Osteomyelitis

295

844

3.80

88.81

2.9

3.5

49.50

77.51

mg/l

0.80

243

718

Gonarthrosis [arthrosis of knee](FG)

1860

6393

1.70

88.30

3.2

3.8

43.48

45.20

mg/l

0.09

1565

5486

Sulfasalazine

753

3472

2.23

87.98

2.1

3.7

31.83

44.84

mg/l

2.94

622

2996

Nerve, nerve root and plexus disorders

2788

11058

1.53

87.94

3.2

3.4

42.35

43.38

mg/l

0.08

2374

9374

Chronic lower respiratory diseases

2956

10350

1.52

87.67

2.8

3.6

41.33

43.44

mg/l

0.19

2468

8836

Chronic periodontitis, including avohilmo

2638

11032

1.55

87.33

3.6

3.3

42.54

42.43

mg/l

0.01

2274

9351

Periodontitis

2636

11029

1.55

86.60

3.7

3.3

42.53

42.43

mg/l

0.01

2273

9348

Cytomegalovirus infection, IBD co-morbidity

144

237

7.06

86.45

7.7

3.7

42.34

39.08

mg/l

0.14

120

206

Marginal zone B-cell lymphoma, including Hilmo

126

183

8.42

85.99

2.2

1.4

28.50

32.62

mg/l

0.55

112

154

ILD, hospital admission 2, with pulmonary infections

414

1475

2.99

85.92

3.0

2.4

46.87

40.77

mg/l

0.92

313

1270

Chronic apical periodontitis

2811

10450

1.53

85.79

3.7

3.2

46.89

41.03

mg/l

0.46

2329

8926

Calcific aortic valvular stenosis, including rheumatic fever

1152

6018

1.91

85.56

2.9

3.2

51.08

51.07

mg/l

0.00

957

5072

Calcific aortic valvular stenosis, operated

1149

6005

1.91

85.54

2.9

3.2

50.97

51.14

mg/l

0.01

955

5058

Calcific aortic valvular stenosis

1149

6005

1.91

85.54

2.9

3.2

50.97

51.14

mg/l

0.01

955

5058

Operations 2 for CAVS

1148

6001

1.91

85.40

2.9

3.2

51.00

51.17

mg/l

0.01

954

5055

Calcific aortic valvular stenosis, diagnosis (helper)

1148

6001

1.91

85.40

2.9

3.2

51.00

51.17

mg/l

0.01

954

5055

Dorsopathies

2385

7687

1.59

85.17

3.4

3.1

41.01

44.71

mg/l

0.30

2042

6506

Fungal Sepsis

221

534

4.59

84.88

4.8

3.3

60.74

41.42

mg/l

1.24

186

468

Osteopathy in diseases classified elsewhere

14.53

84.62

21.0

5.1

41.36

30.21

mg/l

0.44

Gastro-oesophageal reflux disease

1835

9505

1.66

84.48

3.0

3.6

48.13

41.39

mg/l

0.44

1585

8029

Myocardial infarction

1519

6164

1.77

84.28

2.8

3.7

45.64

41.88

mg/l

0.47

1261

5313

Fracture of femur

1015

4773

1.98

84.03

2.8

3.1

43.71

50.87

mg/l

0.72

861

4018

Cytomegaloviral disease

144

244

6.81

83.86

7.7

3.5

42.34

39.27

mg/l

0.14

120

212

Injuries to the head

2794

11054

1.52

83.82

3.2

3.4

40.00

43.34

mg/l

0.71

2339

9433

General examination and investigation of persons without complaint and reported diagnosis

1470

4297

1.80

83.60

3.4

3.2

45.23

44.19

mg/l

0.04

1343

3320

Soft tissue disorders

2386

7819

1.58

83.54

3.0

3.5

40.10

46.29

mg/l

0.62

2057

6557

Cytomegaloviral disease, including avohilmo

144

245

6.76

83.46

7.7

3.5

42.34

40.03

mg/l

0.10

120

213

Agranulocytosis

414

1502

2.92

82.85

5.7

3.7

40.81

59.36

mg/l

0.77

324

1286

Persons encountering health services in other circumstances

1075

5687

1.91

82.74

3.5

3.4

36.80

44.12

mg/l

1.31

770

4813

Spondylopathies in diseases classified elsewhere

112

150

9.43

82.51

24.1

2.7

28.31

63.56

mg/l

0.89

103

128

Diabetic maculopathy, excluding more controls

372

1275

3.07

82.24

1.9

3.9

57.90

61.37

mg/l

0.08

298

1098

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1662

10080

1.68

82.13

3.0

3.4

41.40

43.98

mg/l

0.49

1419

8566

Coxarthrosis

1408

5171

1.79

81.86

2.9

3.8

43.50

46.72

mg/l

0.25

1197

4434

Seronegative rheumatoid arthritis

392

1389

2.97

81.56

2.6

4.0

28.20

53.54

mg/l

2.30

312

1183

Dizziness and giddiness

2040

10058

1.60

81.26

3.0

3.6

41.12

44.31

mg/l

0.42

1783

8478

Other/unspecified cytomegaloviral diseases

129

203

7.47

81.09

8.4

4.0

43.27

40.42

mg/l

0.11

108

177

Implicit fungal Sepsis

205

485

4.69

80.99

5.0

3.3

61.25

41.95

mg/l

1.11

172

429

Sleep apnoea

2495

10355

1.54

80.81

2.9

3.6

39.75

43.64

mg/l

0.77

1996

8945

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2558

10867

1.53

80.50

3.9

3.1

40.04

43.63

mg/l

0.67

2161

9221

Pacemaker

1322

7069

1.79

80.41

2.7

3.3

55.22

47.03

mg/l

0.58

1060

6021

Benign neoplasm: Colon

1751

10175

1.65

80.18

3.1

3.5

38.71

45.71

mg/l

2.25

1571

8577

Amputation

450

1753

2.74

78.77

2.5

3.5

62.24

60.80

mg/l

0.03

376

1500

Diseases of the respiratory system

1467

4202

1.78

78.66

3.9

2.7

59.62

38.54

mg/l

1.14

1233

3629

Other antidepressants

2611

8829

1.53

78.49

3.0

3.5

34.55

46.76

mg/l

5.53

2183

7546

Any death

1952

8622

1.62

78.48

4.3

3.4

68.59

37.68

mg/l

3.74

1572

7461

Pain (limb, back, neck, head abdominally)

1717

5147

1.69

78.34

3.5

3.2

53.82

43.97

mg/l

0.51

1480

4310

Fibrosis and cirrhosis of liver

342

1158

3.18

78.30

1.7

3.8

57.87

64.69

mg/l

0.19

290

990

Cough

1069

5404

1.88

78.23

3.4

37.73

40.76

mg/l

0.33

926

4623

Disorders of continuity of bone

314

1011

3.26

77.23

4.3

3.3

43.39

52.88

mg/l

0.31

272

877

Symptoms and signs involving the skin and subcutaneous tissue

1906

11448

1.60

77.16

3.7

3.3

45.41

42.09

mg/l

0.22

1684

9665

Other abnormalities of plasma proteins

121

189

7.74

77.11

5.4

4.7

91.58

55.01

mg/l

0.44

163

Drug-induced osteoporosis with pathological fracture

133

230

7.10

77.09

2.0

4.3

28.88

42.52

mg/l

0.75

102

199

1126

6196

1.84

77.06

3.5

3.4

47.48

43.55

mg/l

0.14

941

5248

Other respiratory diseases principally affecting the interstitium

700

3330

2.20

77.02

3.0

3.2

44.90

52.34

mg/l

0.72

542

2847

Malignant neoplasm of bone and articular cartilage, including Hilmo

116

172

7.81

76.82

10.4

1.3

38.08

33.70

mg/l

0.15

101

148

Dermatitis and eczema

2808

11308

1.49

76.53

3.0

3.4

40.53

43.56

mg/l

0.60

2361

9634

Hydronephrosis

366

1298

2.95

75.93

2.3

3.4

45.39

35.26

mg/l

1.92

290

1129

Hernia

2375

10445

1.53

75.73

3.4

3.3

50.43

40.14

mg/l

0.80

2059

8810

Chronic tubulo-interstitial nephritis

166

348

5.21

75.64

2.5

3.5

50.49

37.69

mg/l

0.75

140

306

Acute bronchitis

1183

6589

1.80

74.97

5.0

3.0

47.53

45.90

mg/l

0.06

965

5563

Benign neoplasms

2274

8059

1.55

74.79

3.3

3.2

45.36

43.84

mg/l

0.10

1950

6744

Other CVD

784

3936

2.08

74.41

3.4

3.1

43.58

53.33

mg/l

1.16

657

3326

Arthrosis

1686

5614

1.67

74.22

2.9

3.7

42.21

45.33

mg/l

0.17

1414

4800

Urinary track infection

1154

3125

1.88

73.97

3.0

3.3

32.84

36.82

mg/l

0.69

979

2672

Osteonecrosis

269

817

3.56

73.84

11.4

3.4

38.99

73.01

mg/l

1.03

240

710

Other arthrosis

1361

5305

1.75

73.82

2.8

3.8

30.72

45.84

mg/l

6.13

1183

4548

Fracture of rib(s), sternum and thoracic spine

1022

5605

1.88

73.70

3.6

3.2

41.27

46.02

mg/l

0.56

866

4734

Malignant neoplasm of bone and articular cartilage

11.76

73.61

11.8

1.2

32.55

30.63

mg/l

0.05

Statin medication

1343

4329

1.77

73.54

2.8

4.3

41.26

43.29

mg/l

0.17

1150

3625

Missing teeth due to accident, extraction or parodontitis

1841

10493

1.60

73.47

3.3

3.5

45.59

42.84

mg/l

0.16

1565

8943

Peripheral artery operations in Hilmo

512

2187

2.46

73.10

2.5

3.3

47.83

56.69

mg/l

0.56

425

1873

Retention of urine

1152

5252

1.82

73.05

2.8

3.5

58.07

46.45

mg/l

0.52

952

4462

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

544

2388

2.39

73.00

1.6

3.6

52.03

53.73

mg/l

0.09

450

2028

Falls/tendency to fall

2410

7973

1.53

72.96

3.0

3.6

39.75

43.99

mg/l

0.71

2033

6802

Injuries to the thorax

1389

8315

1.71

72.96

3.4

3.3

41.61

45.73

mg/l

0.65

1175

7030

Amputation of toe

337

1187

3.07

72.19

2.4

3.6

50.36

69.55

mg/l

0.73

283

1006

Pulmonary heart disease, diseases of pulmonary circulation

1065

5960

1.84

71.88

3.9

3.2

49.48

45.18

mg/l

0.15

860

5040

Hypotension

706

3459

2.14

71.86

3.4

3.1

41.94

53.74

mg/l

1.41

592

2923

Other (seronegative) rheumatoid arthritis, wide

631

2958

2.22

71.73

2.3

3.4

30.84

49.65

mg/l

2.81

520

2504

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2255

11705

1.52

71.31

4.3

3.2

47.98

41.38

mg/l

0.42

1915

9944

Other joint disorders

1797

5833

1.62

70.84

2.8

3.6

44.59

44.50

mg/l

0.00

1496

4986

Disorders of eyelid, lacrimal system and orbit

2285

11211

1.51

70.28

3.4

41.38

43.79

mg/l

0.28

1937

9517

Factors influencing health status and contact with health services

655

1464

2.28

70.13

3.7

2.6

66.16

34.37

mg/l

1.09

560

1178

Cardiomyopathies, Primary/intrinsic

402

1561

2.70

70.12

2.6

3.3

44.35

47.77

mg/l

0.16

341

1347

Obesity related asthma

965

5274

1.88

69.96

2.3

3.6

40.15

41.34

mg/l

0.10

783

4505

Other intervertebral disc disorders

1969

7574

1.57

69.04

3.2

3.1

34.11

44.96

mg/l

3.98

1730

6415

Myalgia

618

2907

2.18

68.77

3.1

3.5

29.76

46.41

mg/l

3.09

548

2422

Arthropathies in other diseases classified elsewhere

168

386

4.78

68.70

2.4

4.3

49.78

77.23

mg/l

0.45

141

339

Other and unspecified disorders of white blood cells

194

504

4.24

67.63

2.6

4.0

37.58

76.13

mg/l

0.94

164

436

Cutaneous abscess, furuncle and carbuncle

697

3460

2.07

67.30

2.9

3.3

41.09

47.01

mg/l

0.57

609

2934

Endocarditis

166

385

4.72

67.03

2.7

3.3

55.60

78.01

mg/l

0.34

136

333

Undetermined asthma, excluding more controls

345

1264

2.82

66.77

2.8

2.4

34.26

33.16

mg/l

0.11

279

1096

Hypoparathyroidism

189

488

4.31

66.72

2.7

3.7

29.55

55.04

mg/l

2.16

141

430

ILD, hospital admissions 3, with pneumonia sepsis

356

1341

2.83

66.69

3.0

2.7

47.19

49.78

mg/l

0.10

267

1154

Abnormalities of heart beat

926

4905

1.87

66.55

3.0

3.3

49.68

41.10

mg/l

0.59

779

4172

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

15.92

66.50

13.3

1.3

34.66

29.58

mg/l

0.12

Cerebrovascular diseases

2144

9936

1.52

66.46

3.0

3.6

44.82

44.67

mg/l

0.01

1850

8426

Sleep apnoea, including avohilmo

2506

10389

1.48

66.12

2.9

3.6

39.31

43.57

mg/l

0.88

2005

8984

ILD, hospital admissions

587

2772

2.22

66.08

2.8

3.4

42.90

54.67

mg/l

1.10

448

2383

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

120

9.06

66.01

10.9

1.2

34.67

33.78

mg/l

0.02

105

Other interstitial pulmonary diseases

594

2820

2.21

65.93

2.8

3.3

42.86

54.10

mg/l

1.06

452

2422

Cardiomyopathy (excluding other)

409

1650

2.59

65.91

2.6

3.3

44.28

47.21

mg/l

0.14

347

1429

Seropositive rheumatoid arthritis, wide

814

4307

1.95

65.81

2.1

3.4

34.36

47.50

mg/l

2.59

704

3661

Interstitial lung disease

594

2830

2.20

65.34

2.8

3.3

42.86

54.28

mg/l

1.08

452

2427

Interstitial lung disease endpoints

594

2830

2.20

65.34

2.8

3.3

42.86

54.28

mg/l

1.08

452

2427

Concussion

1080

4753

1.79

65.28

3.0

3.6

36.98

43.53

mg/l

1.30

865

4064

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

793

4172

1.96

65.26

2.1

3.5

34.71

47.86

mg/l

2.46

686

3542

Viral infections characterized by skin and mucous membrane lesions

1108

6443

1.75

64.66

5.3

3.1

42.60

44.30

mg/l

0.15

927

5457

Organ-limited amyloidosis

18.11

64.46

5.8

2.4

59.73

34.10

mg/l

0.95

Charcot foot

110

186

6.83

64.29

2.2

4.7

59.09

118.70

mg/l

0.46

161

Secondary and unspecified malignant neoplasm of lymph nodes

311

1113

2.96

64.00

2.0

1.5

35.89

35.66

mg/l

0.02

253

936

Other/unspecified seropositive rheumatoid arthritis

802

4264

1.94

63.91

2.1

3.5

34.55

47.63

mg/l

2.53

694

3623

Pulmonary embolism

958

5395

1.83

63.38

4.1

3.2

50.29

46.30

mg/l

0.12

776

4572

Symptoms and signs involving the digestive system and abdomen

2389

8137

1.49

63.23

3.2

3.4

44.54

43.67

mg/l

0.06

2027

6908

Cirrhosis of liver, NAS

255

828

3.35

63.18

1.7

4.0

57.39

75.66

mg/l

0.44

214

717

Later onset COPD, excluding more controls

713

2744

2.05

63.12

2.1

2.7

43.73

40.98

mg/l

0.36

585

2381

Pulmonary heart disease

958

5409

1.82

62.84

4.1

3.2

50.29

46.40

mg/l

0.12

776

4578

Giant cell arteritis

223

673

3.68

62.71

1.9

3.7

30.98

70.80

mg/l

1.53

188

583

Sicca syndrome [Sjögren]

299

1060

2.99

62.62

2.2

3.7

36.96

43.82

mg/l

0.66

250

912

Gonarthrosis

1556

5482

1.63

62.52

3.0

3.8

45.27

45.59

mg/l

0.01

1304

4690

Persons encountering health services for examination and investigation

1418

4302

1.67

62.17

3.4

3.2

49.71

44.19

mg/l

0.27

1250

3323

Sub-endpoint used in defining T1D endpoints

749

3851

1.96

62.09

2.0

3.2

46.47

50.64

mg/l

0.38

621

3253

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

162

395

4.59

61.90

2.5

1.5

37.55

33.36

mg/l

0.30

150

338

Chronic lymphocytic leukaemia, helper endpoint

162

395

4.59

61.90

2.5

1.5

37.55

33.36

mg/l

0.30

150

338

Chronic lymphocytic leukaemia

162

395

4.59

61.90

2.5

1.5

37.55

33.36

mg/l

0.30

150

338

Myocardial infarction, strict

1357

5891

1.67

61.70

2.6

3.7

45.73

42.35

mg/l

0.37

1145

5070

Diaphragmatic hernia

1112

6581

1.73

61.62

3.2

3.3

47.21

42.39

mg/l

0.34

992

5503

Failure and rejection of transplanted organs and tissues

118

8.52

61.17

8.7

3.9

52.88

32.54

mg/l

1.69

101

Angina pectoris

1586

6698

1.60

60.96

3.1

3.7

43.88

41.96

mg/l

0.23

1343

5778

Benzodiazepine use

2472

11637

1.45

60.74

3.3

3.4

40.19

42.98

mg/l

0.37

2034

9945

Cardiomyopathy, other and unspecified

268

909

3.12

60.69

3.1

3.4

44.14

54.72

mg/l

0.37

236

795

Noninfective enteritis and colitis

1155

6904

1.70

60.65

3.2

39.91

44.16

mg/l

0.56

960

5858

Diffuse large B-cell lymphoma

215

647

3.61

60.15

2.0

1.5

30.94

34.93

mg/l

0.67

176

540

Diffuse large B-cell lymphoma, including Hilmo

215

647

3.61

60.15

2.0

1.5

30.94

34.93

mg/l

0.67

176

540

Diffuse large B-cell lymphoma, helper endpoint

215

647

3.61

60.15

2.0

1.5

30.94

34.93

mg/l

0.67

176

540

ILD, hospital admissions 1, main diag only

528

2485

2.23

60.10

2.9

3.4

43.51

55.99

mg/l

1.04

407

2140

Other noninfective gastroenteritis and colitis

685

3520

2.00

59.98

3.6

3.3

41.72

48.52

mg/l

0.52

576

2995

Solid cancers, including Hilmo

1832

6990

1.55

59.83

3.3

1.5

52.23

34.91

mg/l

1.22

1551

5874

Other diseases of intestine

508

2350

2.25

59.71

2.8

3.4

42.02

43.61

mg/l

0.10

432

1988

Myocardial infarction, without ST-elevation

1354

7639

1.64

59.69

2.7

3.3

44.11

48.36

mg/l

0.70

1113

6484

Other gastritis (incl. Duodenitis)

701

3653

1.98

59.39

3.0

3.3

50.03

43.27

mg/l

0.51

605

3062

Abnormal findings on diagnostic imaging of other body structures

474

2140

2.31

59.29

3.6

44.78

50.95

mg/l

0.28

413

1834

Symptoms and signs involving the nervous and musculoskeletal systems

1552

10055

1.57

58.77

3.2

3.4

35.21

43.59

mg/l

2.47

1308

8553

Lymphoid leukaemia

252

848

3.22

58.69

3.8

3.6

39.88

79.40

mg/l

1.28

228

721

Methotrexate

394

1646

2.48

58.64

2.4

3.8

50.93

47.99

mg/l

0.07

329

1423

Viral hepatitis, IBD co-morbidity

103

174

6.11

58.53

2.4

4.2

41.76

41.44

mg/l

0.01

147

Other external causes of accidental injury

1777

5780

1.56

58.34

3.2

3.4

39.81

45.87

mg/l

0.91

1507

4950

Diseases of the eye and adnexa

1482

4618

1.62

58.17

3.6

3.2

53.19

42.89

mg/l

0.61

1248

3945

Chronic ulcer of skin, not elsewhere classified

285

1028

2.96

58.14

2.3

3.5

41.35

71.54

mg/l

1.18

247

876

Secondary uncertain malignant neoplasm

441

1948

2.36

58.11

2.0

1.5

35.62

34.99

mg/l

0.09

356

1624

SLE (Finngen)

140

318

4.77

57.88

1.9

3.8

39.25

58.92

mg/l

0.86

117

280

Abdominal and pelvic pain

2347

8137

1.46

57.43

3.4

39.16

43.67

mg/l

0.94

1979

6908

Other disorders of skin and subcutaneous tissue, not elsewhere classified

466

2123

2.28

56.99

2.6

3.4

39.00

53.79

mg/l

1.15

411

1810

Sciatica+with lumbago

1245

6803

1.65

56.80

3.2

31.51

44.17

mg/l

5.62

1097

5759

Pneumonia due to other infectious organisms, not elsewhere classified

148

359

4.50

56.45

7.7

2.9

58.52

70.02

mg/l

0.14

117

309

Cellulitis

630

3218

2.01

56.41

3.4

3.3

42.64

49.03

mg/l

0.55

527

2722

Zoster [herpes zoster], including avohilmo

1476

9217

1.57

56.18

4.5

3.2

45.87

42.37

mg/l

0.17

1268

7826

Glucagon-like peptide-1 (GLP-1) analogues

795

4385

1.86

56.05

2.1

4.0

44.02

41.47

mg/l

0.25

655

3754

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

795

4385

1.86

56.05

2.1

4.0

44.02

41.47

mg/l

0.25

655

3754

Viral pneumonia (known virus, not influenza)

148

363

4.54

56.03

10.1

3.8

35.99

46.15

mg/l

0.59

129

315

Follow-up examination after treatment for conditions other than malignant neoplasms

973

3706

1.77

55.87

3.2

41.18

44.81

mg/l

0.29

909

2848

Cystitis

2017

8149

1.49

55.67

3.0

3.4

37.67

46.72

mg/l

2.58

1708

6924

Vascular disorders of the intestines

289

1074

2.86

55.64

2.2

3.2

44.78

55.00

mg/l

0.42

235

912

Immunodeficiency with predominantly antibody defects

119

247

5.32

55.18

6.7

3.7

25.25

37.17

mg/l

0.74

212

Deforming dorsopathies

697

3702

1.92

55.18

3.6

3.3

34.14

47.15

mg/l

2.66

583

3119

Hypocalcemia

132

302

4.95

54.92

5.9

3.9

47.63

45.96

mg/l

0.06

114

264

Rare circulating lymphoid malignancy, including Hilmo

131

297

4.84

54.53

7.3

1.4

70.84

34.17

mg/l

0.83

110

250

Injuries to the shoulder and upper arm

2169

11692

1.45

54.18

3.7

3.3

42.33

43.42

mg/l

0.13

1836

9940

Sleep disorders (combined)

2645

9873

1.41

54.14

2.8

3.5

39.60

44.53

mg/l

0.96

2160

8497

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1298

5473

1.63

54.10

3.7

1.5

48.55

36.05

mg/l

2.61

1121

4611

337

1359

2.55

53.92

3.1

3.6

38.46

56.80

mg/l

0.77

284

1164

Asthma, hospital admissions , main diagnosis only

1936

11566

1.47

53.85

2.7

3.5

42.00

42.82

mg/l

0.05

1631

9814

Gout due to impairment of renal function

159

7.18

53.60

2.6

4.6

55.15

52.93

mg/l

0.06

139

Haemorrhage, not elsewhere classified

172

482

3.86

53.56

2.6

3.3

47.58

73.30

mg/l

0.54

143

421

Nonischemic cardiomyopathy

348

1440

2.53

53.33

3.3

3.4

49.37

50.92

mg/l

0.05

288

1243

Peripheral arterial reconstruction

634

3330

1.98

53.10

2.3

3.3

46.14

55.19

mg/l

0.90

525

2825

Meniscus derangement

1294

5378

1.62

52.94

3.4

3.8

43.84

45.89

mg/l

0.08

1043

4608

Sequelae of external causes of morbidity and mortality

767

4272

1.85

52.72

3.2

3.3

41.22

47.28

mg/l

0.61

632

3616

Other pleural conditions

399

1771

2.37

52.51

3.5

3.4

55.01

52.82

mg/l

0.10

331

1540

Accidents

1742

5780

1.53

52.31

3.2

3.4

40.01

45.87

mg/l

0.86

1478

4950

Malignant neoplasm of skin, including Hilmo

1357

5784

1.60

52.22

3.8

1.5

50.33

35.87

mg/l

2.59

1163

4878

Other disorders of veins

1088

6565

1.66

52.18

2.8

3.4

35.76

42.28

mg/l

1.71

926

5595

Other and unspecified types of non-Hodgkin lymphoma, hilmo

197

616

3.50

52.16

3.7

3.9

38.54

74.39

mg/l

1.10

172

526

Other and unspecified aplastic anaemias

103

8.45

52.08

2.5

5.0

34.88

33.13

mg/l

0.12

Asthma/COPD (KELA code 203)

2203

10348

1.44

51.83

2.7

3.6

39.94

43.44

mg/l

0.27

1851

8834

Hypothyroidism, strict autoimmune

1601

6932

1.53

51.81

3.1

3.7

43.19

46.54

mg/l

0.17

1340

5917

Undetermined asthma

345

1434

2.48

51.70

2.8

2.4

34.26

36.05

mg/l

0.18

279

1242

Marginal zone B-cell lymphoma

8.92

51.49

1.7

1.4

28.90

32.64

mg/l

0.37

Pericarditis

144

369

4.21

50.85

2.6

3.1

46.18

81.01

mg/l

0.55

120

316

Zoster [herpes zoster]

608

3188

1.97

50.84

5.9

3.2

38.87

48.90

mg/l

1.05

519

2719

Chronic gastritis

836

4829

1.78

50.77

2.7

3.4

44.97

45.25

mg/l

0.02

743

4039

Other disorders of lacrimal gland

979

5894

1.70

50.68

3.9

3.4

36.82

44.37

mg/l

0.93

838

5022

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1248

5331

1.62

50.62

3.7

1.5

47.99

35.41

mg/l

2.53

1070

4491

Solid cancers

1758

6940

1.50

50.51

3.2

1.5

52.04

34.87

mg/l

1.13

1486

5829

Diseases of spleen

106

217

5.58

50.50

2.2

3.8

44.31

41.40

mg/l

0.09

186

Biological medication for rheuma

394

1755

2.30

50.37

2.0

3.6

34.48

46.20

mg/l

0.96

322

1485

Pneumocystosis, including avohilmo

115

254

5.22

50.29

9.6

3.9

58.69

60.51

mg/l

0.04

219

Pneumocystosis

115

254

5.22

50.29

9.6

3.9

58.69

60.51

mg/l

0.04

219

Polycystic kidney disease

122

280

4.82

50.22

1.9

3.9

64.57

49.01

mg/l

0.56

240

Cystic kidney disease

139

352

4.31

50.15

1.9

3.9

60.37

46.73

mg/l

0.61

108

306

Hepatomegaly and splenomegaly, not elsewhere classified

8.59

50.10

2.9

4.6

28.38

36.16

mg/l

0.77

Paralytic ileus and intestinal obstruction

760

4281

1.82

50.03

3.5

3.4

44.99

45.30

mg/l

0.02

635

3596

Neurological diseases

1740

5841

1.51

49.98

3.1

3.6

52.53

44.03

mg/l

0.41

1467

4993

Congenital malformations of the urinary system

188

582

3.42

49.78

1.9

3.7

57.28

67.55

mg/l

0.20

147

497

Immunodeficiencies

171

502

3.64

49.46

6.5

3.8

26.86

47.99

mg/l

1.79

138

435

Congenital malformations of the urinary system, including avohilmo

197

632

3.29

49.16

1.9

3.9

57.32

67.76

mg/l

0.22

154

542

Other diseases of liver

512

2557

2.06

49.08

2.9

3.5

38.58

48.88

mg/l

0.87

411

2172

Cystic kidney disease, including avohilmo

142

371

4.15

48.98

1.9

3.8

60.34

45.45

mg/l

0.72

110

323

Dental operations

1603

5458

1.53

48.90

3.5

2.8

41.67

48.29

mg/l

0.86

1355

4654

Malignant neoplasm of skin

1301

5641

1.59

48.83

3.7

1.5

51.46

35.96

mg/l

2.67

1113

4756

Episodal and paroxysmal disorders

2434

8851

1.41

48.58

2.8

3.6

38.67

45.43

mg/l

1.45

2035

7589

Systemic lupus erythematosus

140

364

4.15

48.52

1.9

4.2

39.25

54.22

mg/l

0.71

117

319

Valvular operations

415

1927

2.23

48.32

2.2

3.3

45.45

47.16

mg/l

0.09

350

1662

Basal cell carcinoma, including Hilmo

1244

5358

1.60

48.26

3.7

1.5

48.24

35.41

mg/l

2.61

1068

4516

Other and unspecified acquired haemolytic anaemias

120

7.76

48.19

3.2

2.8

27.70

53.54

mg/l

0.82

103

Gastroduodenal ulcer

813

4716

1.76

48.07

2.7

3.3

48.32

45.92

mg/l

0.19

676

3950

Fracture of shoulder and upper arm

983

5997

1.67

48.05

3.9

3.2

40.41

46.79

mg/l

0.94

819

5061

Discitis, unspecified

101

208

5.54

47.80

3.4

3.2

39.31

60.21

mg/l

0.67

179

Cholelithiasis, broad definition with cholecystitis

2163

10246

1.42

47.68

3.5

3.4

48.24

42.20

mg/l

0.83

1841

8716

Disorders of lacrimal system

1155

7236

1.60

47.33

3.7

3.4

40.25

44.87

mg/l

0.34

982

6151

Crystal arthropathies, rheuma endpoint

111

250

5.02

47.14

2.7

4.5

46.26

67.61

mg/l

0.55

223

Early onset COPD, excluding more controls

500

2505

2.04

47.11

2.1

2.7

35.65

35.73

mg/l

0.01

417

2151

Diseases of the myoneural junction and muscle

403

1874

2.24

47.08

2.6

3.4

36.83

57.70

mg/l

1.60

337

1598

Other diseases of anus and rectum

836

4904

1.73

47.06

3.3

3.4

37.33

45.91

mg/l

1.79

704

4133

Temporal arteritis

182

579

3.46

47.06

1.9

3.8

31.64

75.25

mg/l

1.42

149

505

Spondyloarthritis

462

2254

2.10

47.01

2.6

3.4

35.79

54.37

mg/l

1.78

380

1922

Asthma, including avohilmo

2747

11159

1.37

46.87

2.8

3.5

39.99

43.93

mg/l

0.39

2327

9483

Chronic periodontitis, complicated

1516

10002

1.50

46.72

3.5

43.49

42.23

mg/l

0.15

1295

8542

Elevated blood glucose level

261

1004

2.72

46.62

3.0

3.5

37.89

47.12

mg/l

1.18

210

857

Myeloproliferative diseases

308

1289

2.53

46.51

3.2

3.6

36.90

65.02

mg/l

1.46

277

1095

Diseases of oral cavity, salivary glands and jaws

1471

4982

1.54

46.39

3.6

2.8

56.31

47.43

mg/l

0.36

1254

4189

Decubitus ulcer and pressure area

257

991

2.76

46.19

2.0

3.4

47.40

73.07

mg/l

0.86

216

842

Convulsions, not elsewhere classified

490

2421

2.04

46.10

2.3

3.1

52.09

44.99

mg/l

0.36

410

2052

Myocarditis

117

274

4.45

45.97

4.1

3.2

31.45

29.08

mg/l

0.18

245

Unspecified fall

1341

8716

1.53

45.95

3.2

3.3

45.63

43.95

mg/l

0.15

1100

7407

Obesity, other/unspecified

713

4038

1.80

45.83

2.0

3.5

39.68

42.73

mg/l

0.30

611

3462

Other disorders of bone

437

2111

2.12

45.59

6.9

3.0

34.39

49.79

mg/l

1.13

379

1812

Other viral diseases

581

3083

1.91

45.56

5.5

3.2

56.20

43.11

mg/l

0.29

490

2626

Small fibre neuropathy

147

417

3.89

45.46

4.1

3.8

26.41

54.31

mg/l

2.27

135

362

Supplementary factors related to causes of morbidity and mortality classified elsewhere

790

4638

1.74

44.96

2.9

3.2

37.14

46.69

mg/l

1.50

670

3935

Type of accident

745

4311

1.77

44.71

2.8

3.2

36.55

46.44

mg/l

1.46

630

3663

Other crystal arthropathies

111

262

4.78

44.48

2.7

3.7

46.26

63.46

mg/l

0.46

233

COPD

1349

7288

1.53

44.41

2.1

3.6

43.05

46.78

mg/l

0.56

1106

6207

L01XX Other antineoplastic agents

247

956

2.77

44.36

6.5

3.6

42.98

74.60

mg/l

1.04

229

829

Shoulder lesions

1800

7500

1.45

44.32

3.1

3.6

39.85

46.24

mg/l

0.45

1583

6297

Basal cell carcinoma

1196

5246

1.58

44.31

3.7

1.5

47.69

35.45

mg/l

2.29

1025

4420

Diabetic retinopathy

1158

4591

1.61

44.27

2.3

2.7

51.56

44.81

mg/l

1.20

946

3866

Viral pneumonia (unknown virus, not influenza)

221

804

2.89

44.13

6.3

3.7

48.96

74.26

mg/l

0.61

173

685

Malignant neoplasm of urinary organs, including Hilmo

371

1717

2.25

43.89

2.5

1.5

67.08

35.82

mg/l

1.63

314

1428

Eosinophilic disease (BM)

126

6.64

43.84

2.5

2.3

38.74

41.06

mg/l

0.06

115

Complications of internal orthopaedic prosthetic devices, implants and grafts

713

4114

1.78

43.72

2.5

3.3

36.16

49.47

mg/l

2.19

594

3476

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

328

1448

2.37

43.57

2.2

1.5

66.05

36.13

mg/l

1.29

279

1208

Depression or dysthymia

1601

5946

1.49

43.44

3.1

3.7

36.62

49.02

mg/l

2.66

1327

5128

Open wound of head

1430

9105

1.50

43.41

3.0

3.4

44.78

45.11

mg/l

0.02

1182

7772

External causes of morbidity and mortality

1339

4374

1.55

43.38

3.5

3.4

40.68

46.31

mg/l

0.59

1138

3757

Sequelae with surgical and medical care as external cause

611

3377

1.86

43.34

3.0

3.4

42.55

48.11

mg/l

0.42

496

2889

Myeloproliferative diseases (CML excluded)

282

1172

2.55

43.33

3.3

3.6

37.24

67.97

mg/l

1.46

255

1000

Osteonecrosis due to drugs

212

5.34

43.19

21.3

4.2

37.92

53.52

mg/l

0.47

182

Other specified/unspecified systemic involvement of connective tissue

187

629

3.14

43.17

2.1

4.2

36.38

50.61

mg/l

1.14

159

546

Giant cell arteritis with polymyalgia rheumatica

182

610

3.28

43.16

1.9

3.6

31.64

72.97

mg/l

1.43

149

537

Disturbances of skin sensation

613

3384

1.85

43.09

3.1

3.4

29.09

42.73

mg/l

2.91

541

2853

SLE, strict definition

130

352

3.98

42.61

1.9

3.8

39.43

51.63

mg/l

0.52

108

305

SLE, ICD10

130

352

3.98

42.61

1.9

3.8

39.43

51.63

mg/l

0.52

108

305

Other/unspecified rheumatoid arthritis

401

1938

2.15

42.50

2.0

3.3

33.98

56.23

mg/l

1.89

343

1640

Polyuria

680

3901

1.79

42.49

2.6

3.6

34.17

46.05

mg/l

2.79

593

3317

Idiopathic thrombocytopenic purpura

129

349

4.02

42.49

4.0

3.5

38.54

49.76

mg/l

0.56

111

303

Other disorders of adrenal gland

157

481

3.47

42.46

3.4

3.9

30.50

49.42

mg/l

1.43

106

421

Persons with potential health hazards related to communicable diseases

624

3439

1.82

42.40

3.6

3.1

58.86

40.80

mg/l

0.45

504

2923

Sarcoidosis

379

1791

2.19

42.40

2.6

3.5

46.14

55.77

mg/l

0.40

306

1533

Dysphagia

738

4333

1.74

42.27

3.2

3.4

48.80

47.46

mg/l

0.03

627

3655

Other diseases of arteries and capillaries

299

1287

2.43

42.14

3.0

3.6

53.03

63.31

mg/l

0.35

250

1100

Unspecified acute lower respiratory infection

409

1990

2.11

42.11

4.4

3.1

34.33

50.53

mg/l

1.89

352

1696

Other viral diseases, including avohilmo

706

4047

1.75

41.85

5.0

3.1

51.34

40.85

mg/l

0.29

599

3435

Adrenocortical insufficiency

139

399

3.74

41.78

3.6

4.2

28.90

51.80

mg/l

1.48

349

Any mental disorder

2529

9372

1.36

41.68

3.0

3.6

36.05

44.19

mg/l

2.60

2101

8033

Other and unspecified immunodeficiencies with predominantly antibody defects

103

7.30

41.65

7.2

4.0

18.54

28.17

mg/l

1.83

Mycoses

732

4306

1.74

41.53

4.0

3.4

46.02

45.34

mg/l

0.05

624

3650

Candidiasis, including avohilmo

726

4262

1.74

41.35

3.6

3.2

43.78

43.91

mg/l

0.01

616

3629

Cholelithiasis

2048

10114

1.40

41.26

3.5

3.4

46.27

42.34

mg/l

0.49

1735

8600

Gingivitis and periodontal diseases

2352

8911

1.38

41.25

3.3

3.1

41.62

44.71

mg/l

0.42

1983

7540

Diseases of pulp and periapical tissues and dental caries

1661

5895

1.46

40.76

3.2

3.1

54.27

44.81

mg/l

0.44

1380

5056

Other coagulation defects

223

852

2.73

40.44

3.5

30.94

75.70

mg/l

1.69

192

742

Insulin, fast-acting (human)

311

1378

2.32

40.41

2.0

3.3

41.92

56.86

mg/l

0.65

259

1163

Stroke, including SAH

1779

9085

1.43

40.25

2.9

3.6

43.91

46.08

mg/l

0.24

1519

7684

Other or unspecified ileus, impaction or obstruction

547

2986

1.88

40.24

3.7

3.3

47.32

46.99

mg/l

0.02

455

2507

Noninfectious colitis NAS

367

1746

2.17

40.18

3.8

3.3

45.84

56.48

mg/l

0.42

315

1487

Other reaction to severe stress, and adjustment disorders

654

3748

1.77

40.13

4.2

3.3

35.83

44.51

mg/l

0.94

551

3190

Fentanyl

317

1422

2.30

40.11

8.7

2.5

41.76

40.45

mg/l

0.07

277

1202

Other diseases of hard tissues of teeth

1412

4928

1.50

39.81

3.2

2.8

37.64

47.46

mg/l

2.11

1213

4151

Pyogenic arthritis

208

774

2.81

39.75

3.4

4.1

45.46

66.71

mg/l

0.75

177

665

All influenza (not pneumonia)

352

1652

2.19

39.74

6.7

2.7

53.90

44.99

mg/l

0.32

295

1407

Exclusions for E4_PCOS_BROAD

408

2029

2.06

39.41

3.8

3.5

31.92

54.64

mg/l

2.06

319

1717

Disorder of lipoprotein metabolism, unspecified

399

1978

2.09

39.36

2.5

3.2

51.18

42.18

mg/l

0.45

346

1669

Protozoal diseases

134

393

3.73

39.35

9.1

3.9

56.55

51.40

mg/l

0.17

111

343

Diagnoses used for exclusion with ILD

728

4359

1.71

38.86

2.7

3.2

44.70

47.74

mg/l

0.23

572

3681

Microscopic polyangiitis

9.12

38.86

1.3

4.5

61.58

34.81

mg/l

3.78

Other disorders of ear

2213

10563

1.37

38.84

3.5

3.4

47.06

42.59

mg/l

0.34

1844

9006

Tubulo-interstitial nephritis, not specified as acute or chronic

190

684

2.89

38.57

3.7

3.2

51.66

37.95

mg/l

1.01

155

596

Other metabolic disorders

299

1332

2.30

38.42

5.1

3.2

33.00

36.46

mg/l

0.44

252

1133

Diseases of pulp and periapical tissues, including avohilmo

2379

9146

1.36

38.34

3.4

3.2

51.97

41.93

mg/l

0.73

1947

7838

Mood disorders, excluding more controls

2124

9158

1.38

38.19

3.0

3.6

36.42

43.47

mg/l

1.85

1783

7846

Unspecified nephritic syndrome

102

253

4.44

38.08

3.0

4.3

48.39

45.25

mg/l

0.10

220

Other chronic obstructive pulmonary disease

1275

7090

1.50

37.98

2.1

3.6

42.76

47.11

mg/l

0.67

1043

6040

Persons encountering health services for specific procedures, not carried out

218

848

2.66

37.92

2.6

3.3

61.60

34.50

mg/l

1.02

189

725

Lumbar disc prolapse

1415

7226

1.47

37.90

3.2

31.68

44.87

mg/l

6.21

1245

6128

Stroke, excluding SAH

1712

8838

1.42

37.73

2.9

3.5

44.09

46.62

mg/l

0.28

1462

7484

Fibromyalgia

214

827

2.67

37.65

3.1

3.3

26.10

45.37

mg/l

2.93

176

696

Hypertrophic cardiomyopathy

175

618

3.05

37.56

4.5

3.8

38.86

68.25

mg/l

0.86

155

524

DVT of lower extremities

547

3055

1.84

37.51

5.5

3.3

45.92

45.16

mg/l

0.04

456

2619

Visual disturbances and blindness

1318

9064

1.47

37.49

3.5

3.3

42.81

43.09

mg/l

0.02

1144

7687

Other diseases of pancreas

290

1300

2.34

37.38

2.7

3.6

40.34

61.24

mg/l

0.94

236

1108

Acute sinusitis

1068

6381

1.54

37.36

5.2

2.9

37.34

40.72

mg/l

0.32

913

5436

Amputation of foot

132

399

3.66

37.21

2.9

3.9

49.96

81.98

mg/l

0.56

111

349

Systemic lupus erythematosus, unspecified

111

297

4.03

37.07

1.7

3.6

40.02

54.79

mg/l

0.52

253

Infection of intervertebral disc (pyogenic)

173

5.35

36.86

1.8

3.2

39.81

47.89

mg/l

0.30

153

Protozoal diseases, including avohilmo

134

410

3.55

36.80

9.1

3.9

56.55

50.17

mg/l

0.22

111

358

Substance abuse, excluding more controls

1272

7252

1.48

36.74

2.1

3.6

40.10

45.05

mg/l

1.05

1056

6210

Dental caries, including avohilmo

1812

6652

1.41

36.61

3.2

50.63

44.58

mg/l

0.29

1510

5684

Caries of dentine, including avohilmo

1913

7076

1.40

36.59

3.2

3.3

52.26

44.30

mg/l

0.42

1593

6053

Abnormal results of function studies

253

1076

2.44

36.55

3.8

3.9

37.75

65.49

mg/l

1.16

199

934

Acute upper respiratory infections of multiple and unspecified sites

1696

8880

1.41

36.20

5.9

2.9

45.24

42.59

mg/l

0.26

1396

7554

Vitreous haemorrhage

316

1484

2.22

36.15

2.8

3.6

53.35

59.73

mg/l

0.20

262

1262

Other infectious diseases, including avohilmo

285

1285

2.31

36.07

3.8

3.4

51.20

65.63

mg/l

0.48

228

1094

Chronic pancreatitis

373

1866

2.07

35.98

2.5

3.5

44.47

53.74

mg/l

0.49

311

1586

Spondylopathies (FG)

278

1238

2.30

35.72

2.4

3.9

30.86

54.20

mg/l

1.68

227

1054

Other and unspecified coagulation defects

153

512

3.14

35.65

3.3

3.9

31.28

41.86

mg/l

0.86

135

449

Folate deficiency anaemia

140

5.94

35.63

2.6

4.1

46.38

52.36

mg/l

0.15

122

Other neurological diseases

1884

10730

1.38

35.57

3.2

3.5

34.90

45.18

mg/l

5.18

1619

9112

Pruritus

317

1496

2.19

35.56

2.6

3.4

34.66

53.89

mg/l

1.07

269

1285

Allergic asthma (mode), excluding more controls

353

1680

2.08

35.52

2.4

2.5

26.33

31.16

mg/l

1.64

317

1440

Malignant neoplasm of urinary organs

304

1418

2.23

35.37

2.4

1.5

69.81

36.30

mg/l

1.35

257

1180

Soft tissue disorders related to use, overuse and pressure

702

4265

1.68

35.30

2.8

3.6

34.22

47.45

mg/l

3.23

613

3567

Pain in thoracic spine

354

1747

2.07

35.04

4.3

3.1

30.38

49.62

mg/l

1.61

302

1456

Tumor necrosis factor alpha inhibitors

319

1517

2.15

34.80

2.0

3.6

34.26

46.97

mg/l

0.90

264

1281

Intracranial injury

1407

9240

1.44

34.77

3.2

3.3

41.84

44.73

mg/l

0.36

1143

7882

Misadventures to patients during surgical and medical care

398

2070

1.98

34.20

3.0

3.4

47.35

53.53

mg/l

0.28

346

1772

Acute upper respiratory infections

2435

11119

1.32

34.16

5.1

2.9

44.81

43.08

mg/l

0.19

2034

9489

Essential (haemorrhagic) thrombocythaemia

137

443

3.30

34.14

2.9

1.5

33.93

33.34

mg/l

0.06

127

373

Abnormalities of gait and mobility

396

2066

1.99

34.01

2.5

3.4

36.73

56.31

mg/l

1.71

345

1776

Iridocyclitis

560

3246

1.76

33.66

3.2

36.39

48.13

mg/l

1.38

450

2758

Leisure time condition

467

2568

1.86

33.64

2.6

3.3

37.91

52.11

mg/l

1.26

391

2192

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

297

1402

2.20

33.55

4.0

3.6

41.72

62.43

mg/l

1.05

258

1206

Acute posthaemorrhagic anaemia

127

396

3.41

33.54

3.3

3.9

55.07

106.78

mg/l

0.68

344

Vitamin deficiency, wide

159

564

2.97

33.48

3.2

3.8

39.21

66.56

mg/l

0.72

124

487

Vitamin deficiency

159

564

2.97

33.48

3.2

3.8

39.21

66.56

mg/l

0.72

124

487

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

122

6.22

33.45

5.1

4.0

47.22

46.00

mg/l

0.02

104

Ischaemic Stroke, excluding all haemorrhages

1609

8567

1.40

33.38

2.9

3.5

45.17

46.31

mg/l

0.11

1371

7248

Ascites

255

1136

2.35

33.38

1.6

3.5

54.92

54.09

mg/l

0.03

209

960

Malignant neoplasm of kidney, except renal pelvis

277

1279

2.25

33.13

2.3

1.5

70.30

36.09

mg/l

1.23

236

1073

Gastric ulcer

533

3069

1.78

33.02

2.8

3.3

45.47

45.79

mg/l

0.02

457

2570

Benign neoplasm: Colon, unspecified

764

4836

1.62

32.90

3.0

3.4

39.94

46.76

mg/l

0.95

687

4087

Intestinal malabsorption

155

548

2.99

32.89

2.0

4.0

56.08

72.71

mg/l

0.25

129

472

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

419

2254

1.91

32.52

2.4

1.5

35.45

34.82

mg/l

0.09

342

1892

Abnormality of white blood cells, not elsewhere classified

7.03

32.52

2.6

4.1

30.87

27.75

mg/l

0.25

Postprocedural endocrine and metabolic disorders, not elsewhere classified

269

1234

2.24

32.29

5.4

3.2

29.67

36.08

mg/l

1.19

224

1048

Open wound of lower leg

404

2153

1.93

32.20

3.0

3.4

42.42

55.66

mg/l

0.90

336

1812

Problems related to lifestyle

228

977

2.39

32.17

2.4

3.8

52.89

66.00

mg/l

0.24

177

835

Rheumatism, unspecified

344

1738

2.04

32.13

2.4

3.8

29.54

51.15

mg/l

2.13

291

1452

Other disorders of glucose regulation and pancreatic internal secretion

232

1006

2.39

32.12

2.0

3.5

46.22

72.70

mg/l

0.94

200

859

Other and unspecified myopathies

287

1366

2.19

31.87

2.8

3.4

39.47

64.18

mg/l

1.30

231

1160

Psychiatric diseases

2204

8341

1.33

31.79

3.0

3.7

37.21

45.44

mg/l

2.14

1824

7177

Myeloid leukaemia

116

356

3.54

31.76

3.2

4.0

26.99

54.56

mg/l

1.79

310

Psoriatic and enteropathic arthropathies

259

1179

2.26

31.73

2.1

3.9

56.18

54.97

mg/l

0.02

208

1003

1350

8569

1.42

31.70

2.1

3.5

44.93

43.74

mg/l

0.12

1088

7320

Cardiodefibrillation

1068

7297

1.49

31.69

3.1

3.4

48.49

47.39

mg/l

0.06

860

6245

Budesonide

307

1494

2.10

31.62

3.0

3.8

31.49

50.20

mg/l

1.65

259

1286

Other symptoms and signs involving cognitive functions and awareness

1290

8078

1.44

31.57

2.8

3.5

37.89

46.21

mg/l

1.85

1114

6801

Acute peritonitis

212

894

2.49

31.55

2.7

3.7

65.17

76.78

mg/l

0.25

174

758

Seropositive rheumatoid arthritis, strict definition

409

2206

1.91

31.55

2.0

3.4

36.08

51.67

mg/l

1.31

360

1869

Other chronic obstructive pulmonary disease, including avohilmo

1521

9063

1.40

31.54

2.1

3.6

41.79

46.18

mg/l

0.78

1237

7737

Phlebitis and thrombophlebitis (not including DVT)

576

3432

1.72

31.38

4.6

3.3

57.24

44.25

mg/l

0.28

481

2928

Oesophageal varices

155

565

2.92

31.31

1.6

3.7

52.83

45.66

mg/l

0.46

131

485

Degeneration of macula and posterior pole

1441

7999

1.41

31.30

3.0

3.4

51.15

44.55

mg/l

0.64

1198

6816

1399

8730

1.41

31.00

2.1

3.6

45.24

43.31

mg/l

0.22

1132

7450

Candidiasis

359

1864

1.98

30.97

4.4

3.4

50.48

53.16

mg/l

0.09

309

1592

Disorders of sclera, cornea, iris and ciliary body

1265

8957

1.43

30.93

3.2

3.4

37.50

43.22

mg/l

1.50

1053

7612

Eosinophilia

173

4.80

30.86

2.5

4.3

38.74

30.37

mg/l

0.80

151

Disorders of the thyroid gland

2128

10497

1.33

30.76

3.2

3.5

41.04

44.85

mg/l

0.29

1803

8921

L04AC Interleukin inhibitors

160

594

2.79

30.70

2.1

3.8

42.19

60.65

mg/l

0.43

127

504

Acidosis

257

3.99

30.69

1.9

3.7

51.50

47.71

mg/l

0.11

223

Vasculitis limited to skin, not elsewhere classified

110

334

3.57

30.60

3.1

4.1

40.91

63.12

mg/l

0.95

292

Cardiac arrest

158

485

2.85

30.60

2.7

3.2

57.04

28.30

mg/l

3.07

132

435

Other skin changes

565

3393

1.71

30.05

4.6

3.4

49.36

45.98

mg/l

0.20

508

2859

Alcohol use disorder, Swedish definition

1282

8295

1.42

29.98

2.0

3.5

46.16

43.59

mg/l

0.28

1051

7065

Acute and subacute iridocyclitis

463

2632

1.80

29.90

3.5

3.3

34.99

50.92

mg/l

1.72

369

2234

Nonalcoholic fatty liver disease

257

1198

2.21

29.87

2.6

3.9

37.94

52.36

mg/l

0.78

216

1023

Injury, poisoning and certain other consequences of external causes

1049

3532

1.50

29.80

3.4

3.5

41.07

49.00

mg/l

0.68

900

3012

Non-allergic asthma (mode), excluding more controls

364

1900

1.93

29.73

2.9

2.5

66.15

35.75

mg/l

0.46

304

1634

Other infectious diseases

240

1095

2.28

29.67

3.8

3.5

52.96

70.46

mg/l

0.50

186

936

Diabetic retinopathy, strict definition

538

2836

1.74

29.66

2.0

2.8

57.55

41.97

mg/l

1.40

432

2370

Mycoses, including avohilmo

2047

11891

1.32

29.63

3.3

3.4

40.84

42.37

mg/l

0.17

1746

10102

Other and unspecified vasculitis limited to skin

100

292

3.72

29.58

3.3

3.9

42.79

57.05

mg/l

0.49

254

Acute nephritic syndrome

223

4.14

29.37

3.0

4.1

49.87

40.67

mg/l

0.39

190

Visual disturbances

1176

8304

1.44

29.33

3.6

3.3

38.98

42.69

mg/l

0.36

1014

7057

Collagenous colitis

264

1257

2.18

29.20

3.6

3.5

36.88

63.58

mg/l

1.32

216

1086

Conductive and sensorineural hearing loss

1982

9998

1.33

29.16

3.5

3.4

46.70

43.43

mg/l

0.21

1650

8536

Heart failure and hypertrophic cardiomyopathy

273

3.88

29.13

4.4

4.1

47.04

59.93

mg/l

0.38

235

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

255

3.77

28.93

1.8

3.3

42.16

36.29

mg/l

0.31

220

Rotator cuff syndrome

1456

7290

1.39

28.80

3.2

3.7

41.73

45.85

mg/l

0.21

1293

6126

Irritable bowel syndrome

558

3371

1.68

28.64

3.2

3.4

29.26

43.33

mg/l

3.00

479

2861

Intestinal stricture

857

5733

1.52

28.60

3.4

3.3

45.02

46.35

mg/l

0.11

726

4806

Other diseases of the respiratory system

604

3741

1.65

28.51

2.6

3.2

43.12

50.42

mg/l

0.69

481

3173

Other respiratory disorders and diseases

604

3741

1.65

28.51

2.6

3.2

43.12

50.42

mg/l

0.69

481

3173

Other renal tubulo-interstitial diseases

174

4.45

28.41

2.0

3.3

42.79

28.98

mg/l

1.46

153

Cyst of kidney

243

1137

2.24

28.39

3.8

3.7

88.07

60.32

mg/l

0.25

206

976

Suppurative and necrotic conditions of lower respiratory tract

192

814

2.48

28.36

3.7

3.8

99.61

64.10

mg/l

0.26

163

687

Mixed hyperlipidaemia

134

478

2.96

28.07

2.2

3.7

45.44

44.71

mg/l

0.03

118

411

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

236

1092

2.23

28.00

5.4

3.4

47.79

68.47

mg/l

0.61

204

933

Alcoholic liver disease

292

1470

2.06

27.84

1.4

3.7

51.41

60.51

mg/l

0.36

232

1253

Open wound of ankle and foot

261

1258

2.14

27.82

3.1

3.5

41.77

66.84

mg/l

1.19

230

1071

Urticaria and erythema

726

4707

1.56

27.71

3.9

3.2

36.07

43.05

mg/l

0.97

618

3998

Other embolism and thrombosis

346

1846

1.93

27.66

4.3

3.4

41.81

48.56

mg/l

0.43

287

1581

Other specified/unspecified necrotizing vasculopathies

147

4.91

27.47

2.4

4.6

33.13

29.71

mg/l

0.38

127

Pneumonia derived septicemia

122

420

3.08

27.34

8.0

3.6

168.98

44.15

mg/l

0.69

101

362

Need for other prophylactic measures

173

711

2.54

27.24

3.0

3.6

90.23

47.85

mg/l

0.33

164

603

Other symptoms and signs involving the nervous and musculoskeletal systems

948

6522

1.47

27.22

3.4

33.81

45.03

mg/l

2.48

782

5538

Spondylolisthesis/Spondylolysis

434

2490

1.78

27.18

3.9

3.2

35.17

50.01

mg/l

1.90

368

2092

Allergic asthma (mode)

353

1847

1.89

27.16

2.4

2.5

26.33

33.71

mg/l

3.04

317

1581

COPD related to multimorbidity

1178

7114

1.42

27.15

2.1

3.4

43.13

47.84

mg/l

0.64

960

6052

Abnormal serum enzyme levels

823

5324

1.52

27.09

3.0

3.5

65.31

44.59

mg/l

0.59

752

4499

Delirium, not induced by alcohol and other psychoactive substances

420

2396

1.81

26.97

2.4

3.2

58.64

59.49

mg/l

0.02

329

2035

Etanercept

156

611

2.64

26.97

2.1

3.8

35.16

45.98

mg/l

0.76

127

523

Benign neoplasm of other and ill-defined parts of digestive system

500

2998

1.71

26.90

3.1

3.4

49.99

48.01

mg/l

0.07

446

2547

Artificial joint operation, meniscal resection

2226

11103

1.29

26.81

3.2

3.5

43.33

43.81

mg/l

0.03

1837

9492

Mental and behavioural disorders due to psychoactive substance use

1324

8853

1.38

26.67

2.1

3.5

40.24

43.36

mg/l

0.66

1086

7536

Sulfonylureas

998

5511

1.46

26.60

2.1

3.6

52.20

48.39

mg/l

0.43

843

4672

Unstable angina pectoris

1005

5497

1.46

26.41

3.0

3.6

43.10

46.69

mg/l

0.32

858

4700

Anterior Iridocyclitis

478

2842

1.72

26.34

3.4

3.3

34.98

49.84

mg/l

1.73

381

2416

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

356

1884

1.87

26.28

2.3

3.6

57.91

55.99

mg/l

0.05

289

1611

Other and unspecified local infections of skin and subcutaneous tissue

257

1260

2.10

26.27

4.4

3.7

37.01

64.90

mg/l

1.43

224

1081

Membranous nephropathy

9.33

26.26

2.2

3.2

62.91

25.98

mg/l

1.74

Dermatitis due to substances taken internally

152

598

2.65

26.16

5.2

4.0

39.43

77.87

mg/l

0.76

125

525

Disorders of synovium and tendon

1122

6769

1.42

26.10

2.6

3.7

32.82

45.84

mg/l

4.93

958

5679

Extreme obesity with alveolar hypoventilation

136

509

2.82

26.09

2.3

4.1

58.72

89.39

mg/l

0.45

438

Non-selective monoamine reuptake inhibitors

889

5843

1.48

26.05

2.9

3.6

37.40

48.76

mg/l

2.37

750

5006

Sensorineural hearing loss

1906

9761

1.31

26.01

3.4

47.12

43.67

mg/l

0.22

1582

8329

Bipolar affective disorders

321

1699

1.92

25.96

2.3

3.6

33.95

53.31

mg/l

1.27

277

1454

Acute pancreatitis

505

3064

1.68

25.83

3.0

3.2

53.78

48.09

mg/l

0.25

413

2598

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

332

1726

1.90

25.80

2.3

3.6

59.83

57.72

mg/l

0.05

268

1482

Fluid overload

11.23

25.73

3.0

3.7

56.95

26.94

mg/l

1.16

Pneumococcal septicemia

116

402

3.06

25.72

8.0

3.5

174.88

38.09

mg/l

0.73

347

Other disorders of bladder

350

1922

1.88

25.69

2.7

3.5

37.87

60.16

mg/l

1.74

262

1647

Selective serotonin reuptake inhibitors

2183

8832

1.29

25.65

3.0

3.5

38.56

46.75

mg/l

1.84

1821

7548

Injuries to the elbow and forearm

1549

9972

1.34

25.64

2.9

3.5

36.32

42.65

mg/l

1.32

1305

8471

Primary biliary cholangitis, wide definition

240

3.75

25.60

1.4

4.1

39.43

64.40

mg/l

0.83

210

Diabetic neuropathy

408

2349

1.80

25.48

2.5

2.6

48.09

45.02

mg/l

0.49

341

1958

Injuries to the knee and lower leg

2607

11237

1.26

25.27

2.9

3.5

37.89

44.23

mg/l

1.42

2201

9563

Unspecified privation

273

1388

2.02

25.23

3.0

3.5

43.19

63.32

mg/l

0.94

244

1192

Other local infections of skin and subcutaneous tissue

267

1347

2.04

25.22

4.4

3.6

36.62

63.03

mg/l

1.45

233

1152

Coxarthrosis, primary

1633

10302

1.33

25.14

3.0

3.5

38.39

46.05

mg/l

2.15

1404

8742

Polycythaemia vera

115

406

3.00

24.69

2.5

1.5

33.70

34.78

mg/l

0.10

102

341

COPD, early/later onset

1289

7971

1.38

24.61

2.1

3.5

42.73

46.93

mg/l

0.62

1052

6781

Haemorrhoids and perianal venous thrombosis

818

5545

1.49

24.53

3.2

3.4

41.58

44.90

mg/l

0.38

681

4666

Gonarthrosis,primary

2230

10599

1.28

24.52

3.2

3.5

44.87

43.80

mg/l

0.07

1879

8998

Drug-induced adrenocortical insufficiency

210

3.93

24.48

5.2

3.7

30.79

39.57

mg/l

0.38

178

Vitamin B12 deficiency anaemia

299

1588

1.94

24.38

3.0

3.4

39.33

59.61

mg/l

1.22

260

1365

Reactive arthropathies

195

885

2.26

24.25

2.9

4.0

34.06

60.49

mg/l

1.24

164

752

Invasive ventilation

215

1021

2.19

24.12

3.0

3.7

55.64

72.74

mg/l

0.46

140

865

Acute myeloid leukaemia, including Hilmo

133

4.79

24.06

1.3

1.2

26.54

35.72

mg/l

1.59

116

Acute myeloid leukaemia

133

4.79

24.06

1.3

1.2

26.54

35.72

mg/l

1.59

116

Acute myeloid leukaemia, helper endpoint

133

4.79

24.06

1.3

1.2

26.54

35.72

mg/l

1.59

116

Other complications of surgical and medical care, not elsewhere classified

242

1199

2.08

24.04

3.2

3.5

33.31

61.89

mg/l

1.40

200

1028

Anxiety disorders, excluding more controls

1689

8235

1.32

23.90

3.4

3.6

33.00

42.92

mg/l

3.54

1439

7064

Exposure to other specified factors

1697

11194

1.31

23.88

3.0

3.5

38.31

41.74

mg/l

0.55

1481

9483

Artrosis, including avohilmo

1766

7403

1.32

23.77

2.9

3.7

43.82

44.39

mg/l

0.03

1488

6251

Substance abuse

1272

8738

1.37

23.75

2.1

3.5

40.10

43.62

mg/l

0.76

1056

7428

Mood [affective] disorders

2181

11028

1.27

23.74

2.9

3.5

36.26

43.19

mg/l

2.01

1832

9396

Superficial injury of hip and thigh

406

2380

1.74

23.67

2.5

3.2

36.73

54.45

mg/l

1.59

339

2013

Personality disorders, excluding more controls

387

2224

1.76

23.67

2.5

3.5

35.66

50.04

mg/l

1.17

327

1931

COPD, hospital admissions

1271

7923

1.37

23.64

2.1

3.5

42.76

46.84

mg/l

0.59

1035

6743

5-aminosalicylic acid

374

2138

1.78

23.60

2.6

3.6

37.33

46.97

mg/l

0.87

317

1833

Late syphilis

166

4.34

23.55

2.3

3.9

57.82

47.78

mg/l

0.32

140

Inflammatory bowel disease

637

4167

1.55

23.52

2.6

3.4

39.65

45.56

mg/l

0.55

525

3544

Mood disorders

2185

11047

1.27

23.47

2.9

3.5

36.25

43.17

mg/l

2.01

1836

9411

Bronchiectasis

253

1291

2.04

23.45

2.8

3.6

38.73

52.87

mg/l

0.79

206

1115

Other or ill-defined heart diseases

132

513

2.66

23.23

2.7

3.1

67.98

67.33

mg/l

0.01

102

438

Juvenile arthritis (FINNGEN)

210

3.67

23.15

2.6

4.2

36.27

56.59

mg/l

0.62

186

Carpal tunnel syndrome

1386

9034

1.34

22.90

3.3

3.5

37.37

42.08

mg/l

1.04

1205

7681

Diseases of peritoneum

275

1454

1.95

22.78

2.4

3.6

57.80

60.77

mg/l

0.09

227

1236

Injuries to unspecified part of trunk, limb or body region

264

1376

1.97

22.76

2.7

3.5

35.74

63.06

mg/l

1.55

234

1170

Superficial injury of head

580

3745

1.57

22.72

2.4

3.2

37.67

50.35

mg/l

1.80

488

3198

Familial hypercholesterolemia

403

2388

1.73

22.72

3.5

3.2

38.08

41.93

mg/l

0.63

368

2017

1216

8106

1.37

22.69

3.8

3.2

44.76

46.98

mg/l

0.24

1028

6880

In situ neoplasms

1016

7328

1.41

22.67

3.7

3.3

42.96

45.66

mg/l

0.29

854

6213

Reactive arthropathies, FINNGEN

154

651

2.44

22.65

3.3

4.2

33.75

65.32

mg/l

1.05

132

562

Other diseases of stomach and duodenum

198

935

2.20

22.59

3.1

3.8

50.18

55.59

mg/l

0.16

174

795

Polyarthritis, unspecified

107

381

2.94

22.51

2.9

4.0

32.84

82.75

mg/l

1.00

333

Other hammer toe(s) (acquired)

412

2228

1.72

22.47

2.8

3.9

32.73

52.27

mg/l

2.46

354

1905

Polyarteritis nodosa and related conditions

132

4.62

22.39

2.7

4.1

37.25

67.85

mg/l

0.57

110

Aortic aneurysm

660

4323

1.53

22.33

3.2

3.4

48.38

50.28

mg/l

0.10

523

3688

Pneumonia due to Streptococcus pneumoniae

115

428

2.80

22.20

7.4

2.5

173.97

73.32

mg/l

0.46

368

Acute pancreatitis (for exclusion)

505

3187

1.62

22.12

3.0

3.3

53.78

50.18

mg/l

0.15

413

2719

Dilated cardiomyopathy

342

1955

1.80

22.11

2.4

3.5

45.05

58.64

mg/l

0.78

286

1664

Adalimumab

189

879

2.20

22.09

1.7

3.9

33.97

54.01

mg/l

0.84

159

748

Psoriatic arthropathies

218

1072

2.08

22.08

2.3

4.1

61.45

55.34

mg/l

0.08

174

918

Late syphilis, including avohilmo

202

3.83

21.99

2.2

3.8

56.64

43.31

mg/l

0.57

174

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

731

4994

1.48

21.96

3.2

3.4

32.34

45.05

mg/l

2.98

637

4231

Hypoglycaemia, other or unspecified

175

794

2.28

21.94

1.8

3.4

45.55

78.95

mg/l

0.93

150

673

Hypothyroidism, other/unspecified

1901

9808

1.28

21.90

3.2

3.4

41.06

44.94

mg/l

0.26

1600

8319

Substance use, excluding alcohol

372

2177

1.74

21.70

2.1

3.6

35.99

51.96

mg/l

1.33

322

1862

Pyothorax

147

627

2.47

21.59

4.0

3.8

120.27

71.45

mg/l

0.27

125

526

Hypothyroidism, strict autoimmune, 3 medication purchases required

1802

9462

1.29

21.59

3.2

3.4

41.75

43.60

mg/l

0.10

1506

8043

Other symptoms and signs involving the circulatory and respiratory systems

164

729

2.32

21.55

3.1

3.6

64.39

56.45

mg/l

0.08

140

628

Stomatitis and related lesions

436

2669

1.66

21.54

3.5

3.3

39.64

49.21

mg/l

0.74

380

2268

Diseases of external ear

838

5899

1.44

21.50

3.4

3.3

46.12

43.14

mg/l

0.21

738

4983

Disease of hard tissues of teeth, NOS

1232

4756

1.37

21.42

3.2

2.8

33.26

45.70

mg/l

5.10

1050

4015

Nonhereditary hypogammaglobulinemia

108

5.01

21.40

4.6

3.8

26.70

28.02

mg/l

0.06

Scoliosis

179

827

2.22

21.33

3.1

25.29

59.45

mg/l

1.74

151

705

Diseases of salivary glands

711

4862

1.48

21.28

3.2

3.3

36.37

45.13

mg/l

1.31

609

4135

Congenital malformations, deformations and chromosomal abnormalities

1036

7157

1.38

21.22

2.8

3.4

43.94

40.18

mg/l

0.32

858

6086

Acute generalized exanthematous pustulosis

130

528

2.57

21.12

5.6

4.1

39.18

75.39

mg/l

0.83

108

457

Collapsed vertebra, not elsewhere classified

5.44

21.10

15.1

3.7

53.44

62.78

mg/l

0.09

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1174

7952

1.35

21.04

2.8

3.4

43.31

41.74

mg/l

0.13

980

6771

Benign neoplasm: Transverse colon

326

1867

1.80

21.01

3.7

3.6

39.40

57.87

mg/l

1.25

296

1598

Somatoform disorder

334

1918

1.77

20.94

3.3

3.4

27.07

52.74

mg/l

2.37

281

1632

Traumatic subdural haemorrhage

398

2242

1.70

20.93

3.1

3.5

55.21

49.22

mg/l

0.30

330

1890

Hypothyreosis and Thyroxine purchase for inclusion criteria

1979

10281

1.27

20.91

3.2

3.4

40.85

44.35

mg/l

0.24

1662

8740

Other diseases of lip and oral mucosa

935

6742

1.40

20.85

4.1

3.4

36.75

43.25

mg/l

1.20

794

5726

Other and unspecified drugs and medicaments

220

1112

2.04

20.83

5.5

3.5

49.28

68.03

mg/l

0.53

190

955

Drug-induced osteoporosis

168

4.07

20.73

1.5

4.1

24.51

52.91

mg/l

1.02

145

Dermatopolymyositis (FG)

137

4.35

20.48

5.2

5.3

33.19

56.64

mg/l

0.60

124

Functional dyspepsia

578

3821

1.53

20.46

3.6

3.4

36.75

42.61

mg/l

0.40

493

3234

Other nutritional anaemias

121

4.68

20.36

2.0

3.5

38.99

30.74

mg/l

0.80

101

Thiazolidinediones

316

1811

1.80

20.27

2.1

3.8

53.54

54.62

mg/l

0.03

273

1560

Skin changes due to chronic exposure to nonionizing radiation

1156

7837

1.36

20.24

3.8

3.2

44.93

47.36

mg/l

0.26

982

6659

Benign neoplasm of other and unspecified endocrine glands

334

1943

1.76

20.21

3.1

3.5

36.23

54.99

mg/l

1.37

280

1653

Wegener granulomatosis

157

4.07

20.10

2.0

5.0

46.83

44.88

mg/l

0.04

129

Amputation of ankle bones

303

3.12

19.98

2.5

3.9

48.19

52.20

mg/l

0.15

267

Hyperplasia of prostate

923

3713

1.42

19.98

3.5

3.7

42.25

50.52

mg/l

0.90

798

3126

Other headache syndromes

811

5727

1.43

19.92

3.1

3.7

30.32

44.06

mg/l

4.03

693

4912

Ulcerative colitis

486

3112

1.58

19.88

2.8

3.3

37.22

47.98

mg/l

1.16

408

2642

Viral and other specified intestinal infections, including avohilmo

423

2514

1.63

19.85

3.7

3.0

41.25

48.43

mg/l

0.40

358

2130

Psoriasis

629

4261

1.50

19.83

2.5

3.4

47.07

45.54

mg/l

0.06

518

3612

Amiodarone users

304

1737

1.81

19.83

2.6

3.6

41.59

59.45

mg/l

1.03

273

1480

Chronic myeloproliferative disease

188

3.82

19.82

4.2

40.82

56.34

mg/l

0.37

165

Depression

1957

10434

1.26

19.81

3.0

3.5

36.08

42.49

mg/l

1.62

1640

8880

Actinic keratosis

1132

7715

1.36

19.79

3.8

3.2

45.31

47.54

mg/l

0.23

960

6553

Non-allergic asthma (mode)

364

2156

1.70

19.63

2.9

2.6

66.15

36.29

mg/l

0.45

304

1857

Asthma and allergy, excluding more controls

156

693

2.25

19.61

3.1

2.1

23.46

30.82

mg/l

1.40

136

598

Other diseases of upper respiratory tract

2450

10402

1.23

19.55

3.2

3.4

36.69

45.47

mg/l

2.99

2111

8799

Other juvenile arthritis

186

3.59

19.49

2.8

3.8

36.42

51.35

mg/l

0.39

166

Conjunctivitis (acute, non atopic)

547

3594

1.53

19.47

4.6

3.2

34.54

45.12

mg/l

1.38

477

3048

Squamous cell neoplasms and carcinomas of the skin

297

1692

1.80

19.40

2.9

1.5

48.49

36.19

mg/l

0.99

250

1415

Carcinoma in situ of skin of other and unspecified parts of face

299

1714

1.81

19.39

2.9

3.1

45.13

60.93

mg/l

0.68

240

1475

Respiratory insufficiency

212

1081

2.01

19.39

2.5

2.4

43.33

40.47

mg/l

0.17

158

933

Crohn disease

252

1363

1.88

19.33

1.8

3.6

46.37

60.73

mg/l

0.48

199

1172

Malnutrition

250

3.29

19.27

2.3

3.6

41.91

60.62

mg/l

0.55

216

Special screening examination for other diseases and disorders

254

1377

1.88

19.27

3.2

40.02

53.42

mg/l

0.69

227

1055

Trochanteric bursitis

347

2068

1.71

19.15

2.8

3.6

30.14

51.82

mg/l

2.76

301

1719

Other symptoms and signs involving the digestive system and abdomen

384

2349

1.66

19.11

3.5

3.4

41.33

47.77

mg/l

0.48

321

1990

Other viral diseases, not elsewhere classified

338

1994

1.72

18.98

5.6

3.2

70.01

48.18

mg/l

0.29

291

1700

Dermatopolymyositis

145

4.09

18.97

5.2

4.8

33.19

45.21

mg/l

0.36

126

Ankylosing spondylitis

182

887

2.10

18.97

2.1

3.4

32.99

59.66

mg/l

1.24

150

733

Other obstructive and reflux uropathy

336

2.86

18.96

1.6

3.4

55.78

39.68

mg/l

0.85

295

Pyoderma gangrenosum

5.64

18.90

2.4

5.2

32.78

28.86

mg/l

0.29

Pain associated with micturition

288

1637

1.80

18.89

3.4

3.5

33.45

51.59

mg/l

1.65

248

1402

Use of pramipexole

562

3767

1.52

18.86

2.5

3.4

44.50

49.01

mg/l

0.24

465

3200

Other disorders of the musculoskeletal system and connective tissue

376

2301

1.67

18.84

3.2

3.5

31.34

52.76

mg/l

2.35

316

1965

Superficial injury of lower leg

533

3526

1.53

18.82

2.7

3.3

33.97

47.35

mg/l

1.87

455

2982

914

5733

1.39

18.82

2.9

3.3

64.01

47.40

mg/l

0.99

760

4879

Generalized skin eruption due to drugs and medicaments

114

461

2.59

18.77

6.0

4.0

41.11

81.48

mg/l

0.80

399

Neuromuscular dysfunction of bladder

235

1260

1.92

18.73

2.5

3.7

37.29

66.43

mg/l

1.48

197

1076

Thyroiditis, ILD-related definition

228

1207

1.93

18.73

2.9

3.5

27.73

50.16

mg/l

1.59

189

1040

Diseases of the ear and mastoid process

2323

9475

1.24

18.61

3.5

3.3

43.15

42.47

mg/l

0.04

1963

8037

COPD, hospital admissions 3, with asthma pneumonia sepsis

793

4854

1.42

18.60

2.2

3.4

42.11

49.06

mg/l

0.97

638

4118

Diabetic maculopathy

369

2131

1.69

18.59

1.9

2.7

58.04

43.56

mg/l

0.77

296

1786

Vitamin D deficiency

175

3.70

18.51

1.9

3.5

32.30

51.07

mg/l

0.57

146

COPD, hospital admission 2, with asthma infections

903

5678

1.39

18.49

2.2

3.4

41.18

47.70

mg/l

1.09

728

4820

Explicit fungal Sepsis, including avohilmo

5.58

18.44

1.4

3.1

55.32

28.76

mg/l

2.84

Sequelae of cerebrovascular disease

1021

6495

1.36

18.42

2.4

3.4

47.45

48.39

mg/l

0.06

885

5484

Duodenal ulcer

307

1793

1.76

18.41

2.1

3.4

53.49

49.36

mg/l

0.13

242

1529

Other chondrocalcinosis

203

3.61

18.40

3.4

4.3

36.45

74.00

mg/l

1.16

174

Psoriasis vulgaris

415

2614

1.62

18.38

2.3

3.5

55.18

51.17

mg/l

0.10

340

2233

Chronic rhinitis, nasopharyngitis and pharyngitis

653

4519

1.46

18.37

2.9

3.4

30.11

45.68

mg/l

3.60

570

3821

Primary biliary cholangitis (PBC)

226

3.33

18.33

1.9

3.6

62.88

67.45

mg/l

0.06

200

Clear cell adenocarcinoma of kidney

137

609

2.35

18.29

2.0

1.6

88.22

33.58

mg/l

0.82

109

516

Gonarthrosis, primary, with knee surgery

1522

9302

1.29

18.28

2.9

3.5

38.86

44.67

mg/l

1.43

1280

7894

Fitting and adjustment of other devices

921

5954

1.38

18.21

3.5

3.0

45.01

38.81

mg/l

0.68

874

5059

Secondary right heart disease

143

650

2.31

18.21

2.4

3.4

42.62

70.15

mg/l

0.83

114

575

Viral and other specified intestinal infections

302

1707

1.74

18.19

4.0

2.9

37.15

53.85

mg/l

1.01

251

1450

Exclusions for E4_PCOS_CONSORTIUM

1257

5975

1.32

18.14

3.4

3.3

36.38

43.70

mg/l

0.98

1071

5058

Other viral diseases, not elsewhere classified, including avohilmo

439

2786

1.58

18.11

5.0

3.2

60.78

44.52

mg/l

0.28

378

2363

Syphilis, including avohilmo

286

3.03

18.09

2.1

3.9

59.47

40.17

mg/l

1.03

241

Syphilis

286

3.03

18.09

2.1

3.9

59.47

40.17

mg/l

1.03

241

Papulosquamous disorders

884

6472

1.38

18.08

2.8

3.4

44.24

44.30

mg/l

0.00

736

5507

Abnormal findings in nipple discharge synovial fluid wound secretions

146

3.98

17.97

4.0

3.7

32.53

46.00

mg/l

0.43

127

Alcohol-induced chronic pancreatitis

168

815

2.14

17.95

2.1

4.0

44.84

60.38

mg/l

0.52

134

682

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

408

2536

1.60

17.84

2.9

3.4

35.49

48.46

mg/l

1.16

336

2191

Hallux valgus (acquired)

644

3168

1.47

17.80

3.3

3.9

52.47

47.59

mg/l

0.16

563

2714

COPD-related respiratory insufficiency

356

2187

1.67

17.75

2.1

3.5

41.70

57.40

mg/l

1.24

290

1872

Mental and behavioural disorders due to alcohol

1100

7935

1.33

17.71

2.0

3.5

41.33

44.00

mg/l

0.46

886

6758

Explicit fungal Sepsis

5.49

17.68

1.4

3.1

56.45

28.96

mg/l

2.90

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

581

3845

1.49

17.67

4.0

1.6

58.79

36.05

mg/l

0.57

483

3230

Barrett oesophagus

158

756

2.18

17.63

2.9

4.1

38.40

62.07

mg/l

0.88

141

653

Poisoning by drugs, medicaments and biological substances

384

2394

1.62

17.60

3.1

3.3

34.84

48.52

mg/l

1.20

316

2036

Fracture of forearm

1172

8047

1.32

17.52

2.9

3.5

36.59

44.20

mg/l

1.25

996

6842

Other pulmonary heart/vessel disease

152

720

2.21

17.45

2.4

3.4

43.34

67.71

mg/l

0.79

118

635

Disorders of oesophagus in diseases classified elsewhere

305

2.95

17.38

4.4

4.0

57.17

37.23

mg/l

0.47

260

Secondary thrombocytopenia

141

4.02

17.34

6.2

3.9

35.07

47.09

mg/l

0.37

120

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

355

2166

1.66

17.30

3.0

1.5

48.77

36.84

mg/l

1.15

294

1805

Vascular diseases of the intestine

133

599

2.33

17.29

2.4

3.3

49.04

66.88

mg/l

0.41

111

518

Coronary artery bypass grafting

692

3612

1.44

17.26

2.1

3.6

53.48

47.71

mg/l

0.36

601

3101

Drug-induced cataract

262

3.08

17.17

4.6

4.0

37.02

55.93

mg/l

0.63

224

Other hearing loss

789

5546

1.40

17.11

3.3

3.2

50.18

47.73

mg/l

0.12

636

4702

Sequelae of other external causes

150

710

2.18

17.08

3.3

3.9

38.99

80.89

mg/l

1.12

132

609

Combinations of oral blood glucose lowering drugs

689

4895

1.43

17.02

2.3

3.9

44.35

44.53

mg/l

0.01

586

4174

Internal derangement of knee

690

4841

1.42

17.01

3.3

3.9

41.07

44.44

mg/l

0.25

548

4155

Thoracic aortic aneurysm

397

2530

1.61

16.97

3.6

3.7

47.70

54.12

mg/l

0.23

322

2165

Left ventricular outflow tract obstruction (LVOTO), broad definition

208

1107

1.92

16.93

2.7

3.8

37.90

61.82

mg/l

0.95

177

940

Subjective visual disturbances

562

3847

1.48

16.91

3.8

3.4

35.76

45.70

mg/l

0.83

485

3264

Hepatic failure, not elsewhere classified

118

510

2.43

16.91

2.2

3.8

57.43

72.10

mg/l

0.26

440

Cervicalgia

432

2799

1.57

16.90

3.0

3.2

57.37

49.96

mg/l

0.11

379

2362

Drug-induced neutropenia

191

995

1.98

16.76

4.3

3.9

35.37

70.06

mg/l

1.25

137

859

Other condition

303

1806

1.71

16.76

3.2

3.4

33.95

56.34

mg/l

1.70

263

1537

Intestinal adhesions without obstruction

221

1206

1.88

16.73

4.0

3.5

38.73

51.37

mg/l

0.58

187

1024

Chronic sinusitis

868

6403

1.37

16.72

3.5

31.65

44.83

mg/l

3.93

721

5404

Diseases of male genital organs

1073

4053

1.35

16.72

3.1

3.5

44.19

49.13

mg/l

0.46

919

3406

Rash and other nonspecific skin eruption

229

1263

1.86

16.71

2.6

3.5

40.11

53.76

mg/l

0.67

194

1071

Benign neoplasm: Ascending colon

397

2542

1.60

16.66

3.1

3.5

42.21

52.65

mg/l

0.83

363

2170

Recurrent aphthous stomatitis , including avohilmo

319

1931

1.68

16.66

3.4

41.62

54.26

mg/l

0.72

278

1646

Adverse effects, not elsewhere classified

359

2236

1.63

16.62

3.1

3.4

34.48

50.16

mg/l

1.29

302

1906

Other and unspecified effects of external causes

477

3166

1.52

16.61

3.2

35.69

46.96

mg/l

1.22

393

2688

Benign neoplasm: Adrenal gland

216

1176

1.90

16.58

3.0

3.9

37.58

66.30

mg/l

1.32

176

1016

Recurrent and persistent haematuria

5.07

16.54

2.4

3.9

45.64

28.85

mg/l

0.74

Cervical disc disorders

767

5569

1.39

16.54

3.3

3.2

30.48

45.22

mg/l

6.64

667

4699

Other blood glucose lowering drugs, excl. Insulins

412

2663

1.58

16.51

2.4

3.6

50.41

50.62

mg/l

0.01

348

2265

Abnormal involuntary movements

312

1884

1.69

16.49

3.5

38.83

56.25

mg/l

0.94

271

1617

Carrier of infectious disease

235

3.13

16.49

1.6

3.8

44.45

38.91

mg/l

0.24

201

Infarction of spleen

4.99

16.39

1.2

3.9

42.61

51.62

mg/l

0.16

Malignant neoplasm, without specification of site, including Hilmo

132

604

2.26

16.37

2.9

1.5

31.75

35.56

mg/l

0.76

109

505

Fissure and fistula of anal and rectal regions

487

3260

1.51

16.36

3.2

3.4

32.86

41.87

mg/l

1.54

407

2764

Gingival hyperplasia

101

413

2.55

16.29

4.0

4.1

89.09

48.72

mg/l

0.67

356

Respiratory disorders in diseases classified elsewhere

172

3.60

16.24

3.4

4.0

43.70

52.87

mg/l

0.18

145

Diplopia

320

1955

1.67

16.21

3.2

3.4

47.38

53.97

mg/l

0.19

277

1657

Covid-19 suspected case

357

2235

1.62

16.15

3.3

3.2

40.95

43.43

mg/l

0.14

334

1892

Carcinoma in situ of skin of scalp and neck

116

512

2.42

16.11

3.3

3.6

61.27

75.99

mg/l

0.20

442

Fracture of lower leg, including ankle

1182

8998

1.30

16.10

2.7

3.5

39.29

43.26

mg/l

0.35

1000

7655

Mantle cell lymphoma, including Hilmo

158

3.69

16.09

2.1

1.3

30.42

36.57

mg/l

0.58

136

Other anxiety disorders

711

4334

1.41

16.06

2.5

3.4

31.54

43.66

mg/l

2.23

629

3675

Anxiety (asthma-related co-morbidities)

994

5691

1.34

16.06

2.7

3.6

31.91

41.79

mg/l

2.39

866

4858

Mucosal proctocolitis

233

1305

1.82

16.04

2.8

3.7

37.12

62.89

mg/l

1.31

196

1119

Paracetamol or NSAID medication

266

749

1.81

15.98

4.0

2.7

43.41

58.10

mg/l

0.67

228

637

Systemic sclerosis (FG)

229

3.12

15.96

2.5

4.5

30.72

65.19

mg/l

1.31

210

Lichen simplex chronicus and prurigo

165

832

2.05

15.90

2.8

4.0

41.81

69.65

mg/l

0.80

135

718

Symptoms and signs involving speech and voice

770

5640

1.38

15.83

3.2

3.3

37.06

46.33

mg/l

1.34

657

4756

Viral warts

196

1046

1.91

15.81

2.6

3.6

42.74

64.19

mg/l

0.75

163

901

Impacted cerumen

313

1917

1.67

15.80

2.9

3.5

43.54

53.18

mg/l

0.40

275

1632

Visual impairment including blindness (binocular or monocular)

193

1029

1.93

15.79

2.3

3.1

61.55

68.68

mg/l

0.09

178

881

Corns and callosities

173

890

2.00

15.74

3.7

48.29

74.15

mg/l

0.64

159

767

Asthma and allergy

156

757

2.06

15.74

3.1

2.3

23.46

34.29

mg/l

2.21

136

647

Iron deficiency

163

3.47

15.72

1.7

4.0

26.05

27.77

mg/l

0.19

140

Herpesviral [herpes simplex] infections

247

1418

1.78

15.71

4.8

3.5

46.77

56.78

mg/l

0.25

198

1212

Complications of cardiac and vascular prosthetic devices, implants and grafts

294

2.87

15.63

2.3

4.1

57.25

43.68

mg/l

0.79

250

Crohn's disease NAS

134

628

2.19

15.60

1.9

3.6

36.61

69.14

mg/l

1.04

106

537

Artificial joint re-operation

211

1166

1.88

15.56

2.1

3.4

36.68

68.00

mg/l

1.48

180

998

Aortic valve malfunction, age under 60 years

196

1054

1.90

15.52

2.8

3.8

38.45

63.31

mg/l

0.93

167

897

Disorders of muscles

218

1212

1.84

15.46

2.4

3.5

31.74

58.18

mg/l

1.82

182

1005

Primary gonarthrosis, bilateral

1323

8753

1.28

15.35

2.8

3.5

40.18

44.34

mg/l

0.69

1113

7425

Anxiety disorders

1734

9645

1.24

15.32

3.4

3.5

33.08

42.52

mg/l

3.77

1476

8203

Malignant neoplasm of other connective and soft tissue

285

2.84

15.28

7.6

1.5

42.72

34.33

mg/l

0.17

240

Other extrapyramidal and movement disorders in other diseases

594

4197

1.44

15.21

2.7

3.3

39.52

47.97

mg/l

0.76

515

3559

Neurotic, stress-related and somatoform disorders

1707

9531

1.24

15.14

3.4

33.12

42.22

mg/l

3.49

1460

8098

Poisoning by medicine

339

2130

1.61

15.14

2.9

3.3

35.42

49.82

mg/l

1.09

278

1809

malignant neoplasm of male genital organs, including Hilmo

675

2890

1.42

15.11

3.1

1.6

71.42

41.14

mg/l

0.66

556

2436

Injury of unspecified body region

191

1029

1.91

15.11

2.2

3.5

37.40

72.19

mg/l

1.45

167

876

Enthesopathies of lower limb, excluding foot

427

2830

1.53

15.07

3.1

3.2

34.86

45.45

mg/l

1.15

369

2392

Other abnormal uterine and vaginal bleeding

455

2173

1.52

15.07

3.1

3.4

44.26

48.44

mg/l

0.23

374

1844

Unspecified contracted kidney

5.74

15.06

2.3

3.9

42.86

28.54

mg/l

0.70

Migraine without aura

250

1452

1.74

15.06

3.7

3.4

26.09

42.69

mg/l

1.31

208

1251

Acute gastritis

191

1033

1.90

14.95

3.0

3.7

46.23

53.24

mg/l

0.24

163

886

Fracture of skull and facial bones

444

2975

1.51

14.92

3.5

3.3

36.08

48.63

mg/l

1.07

390

2551

Urticaria

515

3550

1.47

14.89

4.2

3.2

34.50

44.52

mg/l

1.29

439

3016

Ulcerative colitis, NAS

263

1560

1.71

14.85

2.4

3.6

35.72

57.98

mg/l

1.37

219

1337

Coxibs

606

2219

1.45

14.74

2.8

3.2

53.61

53.03

mg/l

0.01

516

1856

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

195

1067

1.88

14.73

3.0

3.5

56.45

69.80

mg/l

0.32

170

917

Cachexia

6.15

14.71

3.6

3.3

27.54

32.90

mg/l

0.53

Infective dermatitis

261

1554

1.72

14.64

2.1

3.7

49.30

56.29

mg/l

0.26

195

1332

Mental and behavioural disorders due to alcohol, excluding acute intoxication

951

7207

1.32

14.55

2.0

3.5

42.13

44.05

mg/l

0.27

776

6125

Polycystic ovarian syndrome, consortium definition

1201

5369

1.29

14.52

3.1

3.3

37.32

38.23

mg/l

0.10

1008

4576

Bacterial, viral and other infectious agents, including avohilmo

172

906

1.94

14.49

3.9

3.6

64.31

56.67

mg/l

0.09

143

768

Disorders of conjunctiva

1652

10412

1.24

14.45

3.6

3.3

35.99

42.54

mg/l

1.12

1415

8842

Herpesviral [herpes simplex] infections, including avohilmo

443

2986

1.50

14.41

4.2

3.1

62.40

41.52

mg/l

0.36

372

2531

Status post-ami

675

3710

1.40

14.39

2.2

3.5

44.55

47.96

mg/l

0.24

604

3184

Localized swelling, mass and lump of skin and subcutaneous tissue

690

5046

1.38

14.35

3.6

3.3

57.73

43.10

mg/l

0.43

618

4228

Other general symptoms and signs

389

2.45

14.30

1.6

3.5

25.40

52.65

mg/l

2.76

341

Disorders of magnesium metabolism

4.44

14.29

1.3

4.2

46.56

33.49

mg/l

1.50

Unspecified urinary incontinence

224

1290

1.78

14.26

1.9

3.4

32.06

53.55

mg/l

1.60

209

1110

Superficial injury of abdomen, lower back and pelvis

308

1924

1.62

14.21

2.8

3.4

36.16

56.64

mg/l

1.58

257

1637

Transient ischemic attack

1344

8549

1.26

14.21

2.9

3.5

36.06

46.94

mg/l

3.84

1159

7239

Other inflammation of eyelid, including avohilmo

788

5883

1.35

14.20

3.9

3.4

46.92

42.31

mg/l

0.12

687

5007

Disorders of adult personality and behaviour

403

2671

1.52

14.18

2.5

3.4

33.82

46.37

mg/l

1.21

340

2272

Type 1 diabetes, definitions combined

113

512

2.23

14.08

2.5

3.6

44.69

34.33

mg/l

0.75

435

Benign neoplasm: Sigmoid colon

494

3431

1.47

14.04

3.5

3.4

40.96

48.88

mg/l

0.73

449

2915

Total colectomy

103

455

2.35

14.01

3.8

4.1

46.62

49.63

mg/l

0.11

388

Total colectomy operation

103

455

2.35

14.01

3.8

4.1

46.62

49.63

mg/l

0.11

388

Moderate visual impairment, binocular

432

2.40

13.96

1.6

3.1

86.61

44.32

mg/l

0.43

369

Personality disorders

387

2553

1.53

13.94

2.5

3.3

35.66

46.58

mg/l

0.92

327

2171

Monoarthritis, not elsewhere classified

424

2.39

13.93

1.9

4.6

37.98

74.89

mg/l

0.76

372

Phobic anxiety disorders

162

843

1.94

13.91

2.9

3.4

33.92

36.27

mg/l

0.17

138

720

Excessive earwax

1493

10973

1.24

13.87

3.6

3.4

38.83

44.39

mg/l

1.24

1253

9356

Type 1 diabetes, strict (exclude DM2)

112

509

2.22

13.87

2.5

3.6

44.34

34.56

mg/l

0.68

432

Varicose veins

1407

8543

1.25

13.85

3.2

3.4

41.72

44.11

mg/l

0.33

1160

7279

Disorders of vitreous body and globe

1254

9449

1.27

13.81

3.7

3.5

42.53

42.69

mg/l

0.01

1061

8076

Artificial opening status

149

764

2.02

13.81

3.7

3.4

40.15

73.57

mg/l

0.94

117

666

Tobacco use

125

601

2.14

13.74

2.1

3.8

67.21

59.67

mg/l

0.09

103

508

Olecranon bursitis

158

827

1.97

13.73

2.9

3.6

45.39

66.17

mg/l

0.69

138

687

Hernia of abdominal wall

1048

8188

1.29

13.72

3.2

3.4

59.47

43.26

mg/l

0.73

900

6937

Polyarteritis nodosa

5.31

13.68

2.4

4.8

34.07

65.66

mg/l

0.43

Other bursopathies

300

1884

1.62

13.65

3.7

3.5

38.72

51.59

mg/l

1.10

254

1571

Kela reimbursement Agammaglobulinemia (D80-84)

4.93

13.60

9.2

4.4

17.35

29.33

mg/l

1.38

Lesion of ulnar nerve

299

1880

1.62

13.52

2.9

3.4

33.25

49.62

mg/l

1.79

253

1595

Neuralgia and neuritis, unspecified

121

579

2.15

13.47

4.3

3.7

32.78

73.62

mg/l

1.19

105

489

Faecal incontinence

238

1418

1.72

13.42

2.4

3.3

35.37

47.14

mg/l

0.72

197

1199

Disorders of skin appendages

891

6797

1.31

13.32

3.2

3.4

38.53

41.23

mg/l

0.31

774

5769

Other enthesopathies

566

4055

1.41

13.30

2.9

3.7

30.48

45.92

mg/l

4.01

470

3388

Injuries to the ankle and foot

1321

9059

1.25

13.26

2.9

3.4

37.74

41.58

mg/l

0.60

1152

7658

Malignant neoplasm of prostate, including Hilmo

663

2846

1.39

13.23

3.1

1.6

71.91

41.18

mg/l

0.66

548

2401

Thyrotoxicosis

516

3646

1.43

13.22

2.7

3.4

55.02

42.15

mg/l

0.25

444

3084

Autoimmune hepatitis, wide definition

103

466

2.28

13.20

2.0

3.7

39.01

75.42

mg/l

0.81

404

Radiculopathy

361

2382

1.54

13.19

3.4

3.1

30.38

51.62

mg/l

3.50

290

2005

Thyrotoxicosis, other and/or unspecified

398

2678

1.51

13.18

2.8

3.3

32.85

42.82

mg/l

1.34

345

2248

Fall on and from stairs and steps

569

4092

1.41

13.18

3.1

3.4

32.99

46.32

mg/l

2.50

487

3469

Hyperhidrosis

226

2.87

13.13

2.0

3.8

25.42

35.72

mg/l

1.05

198

Acute bronchiolitis

211

2.82

13.06

9.8

2.3

40.24

51.94

mg/l

0.29

181

Other Crohn's disease

125

612

2.09

13.03

1.7

3.5

40.55

62.32

mg/l

0.57

101

518

Other inflammation of eyelid

326

2111

1.57

13.02

4.5

3.3

41.18

52.93

mg/l

0.42

285

1795

Coeliac disease

238

1428

1.70

12.98

3.7

3.6

38.87

58.23

mg/l

0.91

190

1228

Spontaneous rupture of synovium and tendon

196

1117

1.80

12.95

2.4

3.6

38.52

61.15

mg/l

1.06

159

928

Prurigo nodularis

311

2.60

12.92

2.2

4.5

41.77

40.21

mg/l

0.05

273

Oter anti-inflammatory and antirheumatic agents, non-steroids

546

2114

1.44

12.90

3.2

3.3

43.82

53.74

mg/l

1.05

466

1764

Cardiomyopathy, Hypertrophic obstructive

197

3.05

12.90

3.0

3.8

42.33

108.38

mg/l

0.59

172

Asthma and opportunity respiratory infection

142

737

2.00

12.83

2.5

3.9

40.75

63.22

mg/l

0.73

117

641

Other symptoms and signs involving the urinary system

250

1527

1.67

12.82

3.5

3.7

43.84

55.67

mg/l

0.52

218

1312

Acetic acid derivatives and related substances

598

2209

1.41

12.81

3.0

3.2

32.89

53.07

mg/l

5.85

506

1846

All anxiety disorders

998

6030

1.29

12.81

2.7

3.4

31.87

41.68

mg/l

2.55

870

5107

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

372

2485

1.52

12.80

4.2

3.4

38.27

51.60

mg/l

1.15

331

2118

Arterial embolism and thrombosis

163

883

1.90

12.80

2.2

3.5

49.68

75.41

mg/l

0.73

133

747

Other nonthrombocytopenic purpura

103

4.00

12.74

2.2

3.7

45.41

31.89

mg/l

0.97

Bacterial, viral and other infectious agents

158

846

1.91

12.74

3.8

3.6

67.74

57.31

mg/l

0.11

131

716

Overexertion and strenuous or repetitive movements

202

1166

1.77

12.73

4.6

3.6

32.19

65.50

mg/l

1.68

184

1004

Disorders of vitreous body

1213

9253

1.26

12.71

3.8

3.5

42.81

42.67

mg/l

0.01

1024

7907

Primary Sclerosing Cholangitis, IBD and UDCA required

182

3.09

12.69

2.4

3.5

35.90

32.92

mg/l

0.31

156

Malignant neoplasm of bladder, including Hilmo

293

1840

1.60

12.67

3.0

1.5

53.85

38.05

mg/l

1.95

247

1549

Cardiac murmurs and other cardiac sounds

160

850

1.89

12.66

4.0

3.3

36.21

53.70

mg/l

0.65

134

732

Glaucoma

1428

9887

1.24

12.66

3.2

3.4

42.69

45.48

mg/l

0.25

1152

8457

Viral warts, including avohilmo

375

2514

1.51

12.62

2.9

3.2

35.49

48.19

mg/l

1.14

315

2137

IBD patients in KELA-register

387

2611

1.50

12.62

2.9

3.4

36.86

49.27

mg/l

1.13

321

2214

Other abnormal immunological findings in serum

162

3.22

12.56

3.8

4.0

36.34

37.26

mg/l

0.03

137

Ankylosing spondylitis, ICD10

174

967

1.84

12.49

2.2

3.8

32.54

69.36

mg/l

1.48

142

827

Conjunctivitis

1408

9221

1.24

12.46

3.7

3.3

36.35

42.14

mg/l

0.78

1204

7831

Disorders of phosphorus metabolism and phosphatases

6.09

12.45

3.3

3.4

50.98

36.72

mg/l

0.59

Emphysema

207

1215

1.75

12.43

2.8

3.9

40.41

58.28

mg/l

1.03

165

1046

Protein-energy malnutrition of moderate and mild degree

105

3.93

12.41

2.6

3.5

39.56

50.81

mg/l

0.21

Deficiency of other B group vitamins

258

2.73

12.40

4.4

3.8

45.37

59.20

mg/l

0.40

222

Other specified disorders of kidney and ureter

385

2.38

12.35

2.7

4.2

48.81

50.71

mg/l

0.06

329

Other shoulder lesions

185

1050

1.79

12.34

2.0

3.6

30.88

59.09

mg/l

1.63

156

864

Oxicams

537

2164

1.42

12.29

3.2

35.58

53.41

mg/l

3.54

466

1807

Drug-induced hypoglycaemia without coma

181

3.10

12.29

2.3

3.9

53.94

32.30

mg/l

1.92

158

Arthropathic psoriasis

236

1437

1.67

12.23

2.2

3.8

58.50

60.14

mg/l

0.02

188

1231

Other disorders of eyelid

1106

8320

1.27

12.22

2.9

3.4

37.84

46.00

mg/l

1.99

934

7063

Psoriasis (vulgaris), strict definition

355

2.42

12.21

1.6

4.1

59.86

76.80

mg/l

0.20

296

Other and unspecified nerve root and plexus disorders, also in other diseases

415

2864

1.47

12.14

3.1

3.4

33.28

44.95

mg/l

1.65

351

2426

Alcohol use disorder, ICD-based

866

6712

1.30

12.12

2.0

3.5

41.97

44.28

mg/l

0.32

708

5694

Postzoster neuralgia

205

2.96

12.09

4.7

3.5

47.03

68.20

mg/l

0.44

176

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

327

2154

1.54

12.07

4.2

3.4

38.24

53.92

mg/l

1.21

294

1836

Chronic hepatitis, not elsewhere classified

389

2.35

12.04

1.7

4.1

41.03

48.58

mg/l

0.31

343

Infections with a predominantly sexual mode of transmission

398

2717

1.47

12.03

2.7

3.2

36.22

44.65

mg/l

0.68

335

2307

Hodgkin lymphoma, hilmo

297

2.56

12.02

2.0

4.0

37.82

54.65

mg/l

0.59

261

Benign neoplasm: Stomach

248

1543

1.65

11.92

3.2

3.5

40.94

59.11

mg/l

0.93

225

1313

Nonorganic sleeping disorders, excluding more controls

320

2102

1.54

11.87

2.5

3.4

32.67

53.00

mg/l

1.78

277

1828

Other specified/unspecified inflammatory spondylopathies

352

2.38

11.86

2.6

3.5

25.13

75.40

mg/l

0.87

297

Superficial injury of thorax

323

2132

1.54

11.84

2.5

3.3

40.78

54.49

mg/l

0.94

270

1818

Idiopathic pulmonary fibrosis

224

1363

1.69

11.83

2.5

3.4

37.82

66.38

mg/l

1.66

179

1178

malignant neoplasm of male genital organs

644

2863

1.37

11.81

3.1

1.6

72.77

41.14

mg/l

0.66

531

2412

Cholecystitis

350

2353

1.51

11.81

3.2

59.58

52.31

mg/l

0.23

298

1987

Ventral hernia

553

4038

1.39

11.78

3.3

3.4

41.47

41.71

mg/l

0.02

467

3375

Voice disturbances

576

4233

1.38

11.77

3.6

3.4

37.03

45.13

mg/l

0.80

503

3597

Wet age-related macular degeneration

515

3589

1.41

11.73

2.7

3.1

81.22

51.33

mg/l

1.09

433

3030

Carcinoma in situ of skin

245

1528

1.65

11.73

3.7

3.4

37.10

62.31

mg/l

1.48

202

1320

Benign neoplasm: Rectum

460

3266

1.43

11.69

3.2

3.4

62.41

46.20

mg/l

0.30

412

2777

Post-traumatic stress disorder

397

2.27

11.68

1.9

3.3

23.54

39.63

mg/l

1.41

337

N06DA Anticholinesterases

640

6554

0.74

11.66

2.3

3.2

41.95

50.89

mg/l

1.04

523

5543

Use of anticholinesterases

640

6554

0.74

11.66

2.3

3.2

41.95

50.89

mg/l

1.04

523

5543

Presbycusis

425

2940

1.45

11.65

3.1

2.9

48.82

54.19

mg/l

0.20

310

2491

Other disorders of nervous system

170

962

1.82

11.64

3.5

3.9

28.79

74.75

mg/l

2.06

136

822

Systemic sclerosis

273

2.61

11.57

2.5

3.8

30.72

55.07

mg/l

0.98

232

Inflammatory diseases of the central nervous system

174

991

1.79

11.56

3.5

3.6

52.87

68.78

mg/l

0.30

149

847

Orchitis and epididymitis

219

1329

1.68

11.55

3.4

3.5

52.04

64.84

mg/l

0.40

177

1105

Mixed and other personality disorders

120

605

2.02

11.55

3.2

3.4

32.42

34.01

mg/l

0.12

101

513

Fall involving bed

109

536

2.12

11.53

3.1

3.5

46.99

78.97

mg/l

0.77

463

Chronic laryngitis and laryngotracheitis

315

2082

1.54

11.52

2.4

3.2

42.98

54.49

mg/l

0.48

270

1768

Retinal vascular occlusion

328

2193

1.53

11.47

3.3

3.4

43.94

53.94

mg/l

0.63

275

1861

Benign neoplasm: Caecum

292

1906

1.57

11.46

4.0

3.6

38.92

57.68

mg/l

1.28

262

1625

Malignant neoplasm of digestive organs, including Hilmo

919

5288

1.29

11.44

2.7

1.5

51.54

36.33

mg/l

0.64

785

4449

Mixed connective tissue disease

183

2.99

11.43

1.9

4.4

40.46

57.07

mg/l

0.38

158

Psoriatic arthropathies, ICD10

214

1296

1.68

11.37

2.3

3.9

61.89

61.77

mg/l

0.00

171

1117

Benign neoplasm: Rectum, anus and anal canal

508

3686

1.40

11.35

3.2

3.4

60.50

45.80

mg/l

0.29

448

3127

Other psoriatic arthropathies

209

1260

1.69

11.31

2.3

3.9

62.27

62.30

mg/l

0.00

166

1085

Malignant neoplasm of other connective and soft tissue, including Hilmo

103

498

2.14

11.29

7.6

1.5

38.78

34.17

mg/l

0.12

413

Inguinal hernia

1287

6956

1.24

11.27

3.8

3.2

47.97

41.16

mg/l

0.35

1108

5838

Drug-induced systemic lupus erythematosus

4.90

11.25

1.3

3.0

35.04

28.57

mg/l

0.50

Other degenerative diseases of the nervous system

637

3466

1.35

11.24

3.1

3.6

34.30

47.97

mg/l

4.00

537

2961

Right bundle-branch block

433

2.22

11.22

3.1

3.5

38.36

73.23

mg/l

0.70

374

Allergic purpura

277

2.54

11.15

1.9

4.0

38.04

47.11

mg/l

0.34

233

Adhesive capsulitis of shoulder

346

2347

1.50

11.14

2.5

3.7

66.43

49.58

mg/l

0.22

293

1973

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

138

3.32

11.13

2.5

4.0

166.52

43.71

mg/l

0.43

116

Other/unspecified reactive arthropathies

139

749

1.90

11.12

3.2

3.7

33.71

59.83

mg/l

0.97

121

641

Other peripheral vascular diseases

178

1033

1.76

11.11

2.3

3.5

27.33

67.23

mg/l

1.88

151

892

Background retinopathy and retinal vascular changes

273

2.58

11.10

2.3

3.9

41.13

42.09

mg/l

0.03

231

Dermatophytosis

313

2084

1.53

11.10

3.4

3.5

39.81

55.06

mg/l

1.09

264

1775

Specific personality disorders

322

2151

1.51

11.06

2.2

3.4

34.10

43.70

mg/l

0.89

270

1823

Inflammatory bowel disease, strict (require KELA)

387

2683

1.46

11.05

2.9

3.4

36.86

49.32

mg/l

1.18

321

2275

Recurrent or chronic depression

646

3352

1.35

11.03

3.2

3.8

29.25

46.36

mg/l

3.03

550

2919

Bullous disorders

156

876

1.84

11.02

3.4

3.6

33.79

78.42

mg/l

1.72

130

756

Oesophagitis

140

760

1.90

11.01

2.5

3.8

39.57

59.26

mg/l

0.67

112

647

Other/unspecified synovitis and tenosynovitis

225

1391

1.64

10.99

2.1

3.6

32.38

54.85

mg/l

1.71

184

1156

Retinal detachments and breaks

859

6748

1.29

10.95

3.7

3.5

46.69

43.43

mg/l

0.31

726

5731

Migraine

753

4494

1.31

10.94

3.1

3.7

28.51

43.90

mg/l

3.40

644

3858

Mental and behavioural disorders due to tobacco

183

1075

1.74

10.93

2.4

3.9

41.68

63.69

mg/l

0.78

163

916

Myositis

305

2.46

10.92

2.3

3.7

31.30

97.60

mg/l

1.00

259

Smoking dependency

183

1076

1.74

10.90

2.4

3.9

41.68

63.44

mg/l

0.77

163

916

Mantle cell lymphoma

105

3.71

10.89

1.3

1.2

36.88

40.03

mg/l

0.16

Coxarthrosis, primary, with hip surgery

1206

9124

1.24

10.88

3.0

3.5

38.05

46.49

mg/l

2.03

1030

7744

Leukaemia of unspecified cell type

115

3.58

10.88

4.5

4.0

104.69

36.07

mg/l

0.44

101

Paralytic ileus

103

506

2.11

10.87

4.3

3.5

37.76

74.58

mg/l

0.92

430

Other localized connective tissue disorders

211

2.78

10.85

4.0

3.9

48.04

52.76

mg/l

0.10

182

Infection due to other mycobacteria, including avohilmo

200

2.85

10.84

1.7

3.6

37.36

52.92

mg/l

0.49

175

Umbilical hernia

577

4298

1.36

10.83

3.1

3.5

77.00

40.51

mg/l

1.04

501

3623

629

4430

1.34

10.83

2.9

3.1

53.02

52.23

mg/l

0.03

515

3777

Benign thyroid growths and nodules

706

5022

1.32

10.83

3.2

3.5

48.58

46.22

mg/l

0.05

612

4280

Infection due to other mycobacteria

189

2.91

10.83

1.7

3.5

38.16

54.46

mg/l

0.49

166

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

4.15

10.79

7.6

1.3

47.94

31.29

mg/l

0.30

Epilepsy

617

4626

1.34

10.79

2.7

3.5

43.36

48.47

mg/l

0.35

536

3937

Hypopituitarism

129

684

1.92

10.78

3.6

3.7

36.20

81.87

mg/l

1.19

104

580

Early onset COPD

500

3649

1.39

10.77

2.1

3.5

35.65

47.78

mg/l

1.82

417

3100

Other specified/unspecified disorders of bone/cartilage

276

2.52

10.77

3.2

3.6

26.73

41.59

mg/l

1.22

233

Other noninfective disorders of lymphatic vessels and lymph nodes

421

2.21

10.76

1.4

3.6

35.34

53.83

mg/l

1.14

367

Extrapyramidal and movement disorders

928

7374

1.27

10.75

2.5

3.4

36.91

45.60

mg/l

1.53

790

6225

Unspecified misadventure during surgical and medical care

146

810

1.86

10.73

3.1

3.7

43.10

80.47

mg/l

1.14

128

700

Fibroblastic disorders

523

3848

1.38

10.66

2.9

3.5

37.11

48.92

mg/l

1.99

450

3202

ILD-related respiratory insufficiency

109

553

2.06

10.65

2.9

3.9

64.82

95.53

mg/l

0.49

484

Colectomy operation

411

2910

1.44

10.65

2.9

3.4

43.61

52.03

mg/l

0.68

364

2473

Retinal vascular disorders

329

2236

1.50

10.65

3.2

3.4

43.87

53.81

mg/l

0.64

276

1896

Malignant neoplasm, without specification of site

410

2.22

10.65

2.6

1.5

35.00

36.59

mg/l

0.18

340

Transport accidents

797

5156

1.29

10.61

2.6

3.4

42.16

44.42

mg/l

0.11

689

4404

Flat foot [pes planus] (acquired)

184

1091

1.72

10.59

2.5

4.2

35.05

53.29

mg/l

0.97

155

936

!Aliquae complicationes praecoces traumatis

104

517

2.07

10.59

2.9

3.6

39.55

64.99

mg/l

0.58

435

Early complications of trauma

104

517

2.07

10.59

2.9

3.6

39.55

64.99

mg/l

0.58

435

Other specified/unspecified spondylopathies

310

2.42

10.56

3.7

3.1

27.96

51.72

mg/l

1.48

277

Other congenital malformations

127

674

1.91

10.54

2.7

3.6

34.90

44.92

mg/l

0.72

108

576

Hyperaldosteronism

361

2.31

10.54

3.1

4.1

36.96

84.05

mg/l

0.82

311

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

408

2883

1.43

10.48

2.9

3.2

35.49

45.84

mg/l

0.96

336

2447

Generalized anxiety disorder

198

1195

1.67

10.48

2.4

3.6

28.06

51.17

mg/l

1.61

176

1028

Keratitis

701

5392

1.31

10.47

3.1

3.3

37.18

45.52

mg/l

1.50

590

4586

Pulmonary oedema

257

2.58

10.46

4.5

3.9

67.28

51.21

mg/l

0.60

226

Other secondary gonarthrosis

134

730

1.89

10.46

2.3

4.1

42.59

64.70

mg/l

0.64

106

625

Post-traumatic wound infection, not elsewhere classified

299

2.43

10.41

2.4

3.7

36.09

45.09

mg/l

0.41

255

Suicide or other Intentional self-harm

381

2665

1.44

10.39

3.0

3.3

36.48

47.37

mg/l

0.93

316

2266

Fracture of neck

165

960

1.77

10.35

4.7

3.4

40.50

78.39

mg/l

1.28

135

807

Renal agenesis and other reduction defects of kidney, including avohilmo

5.46

10.29

1.5

4.0

51.78

31.76

mg/l

1.23

Erosion of teeth , including avohilmo

421

3003

1.41

10.28

3.1

3.3

34.08

46.83

mg/l

1.46

359

2559

Seborrhoeic dermatitis

221

1386

1.62

10.28

3.1

3.7

40.10

59.93

mg/l

0.95

193

1191

Other inflammatory liver diseases

148

835

1.82

10.26

2.2

3.9

43.56

72.83

mg/l

0.78

127

716

Postprocedural musculoskeletal disorders, not elsewhere classified

187

1129

1.70

10.23

3.7

3.6

31.13

67.50

mg/l

1.86

157

971

Fracture of foot, except ankle

427

3058

1.41

10.22

3.2

3.3

37.74

47.41

mg/l

0.75

363

2588

Pure hyperglyceridaemia

247

2.57

10.21

2.5

3.3

41.80

44.09

mg/l

0.07

210

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

548

4026

1.35

10.21

2.9

3.4

32.36

43.25

mg/l

1.56

490

3407

Urolithiasis

747

5823

1.30

10.17

2.8

3.4

40.10

46.92

mg/l

1.09

620

4928

Organic, including symptomatic, mental disorders

1390

8119

1.21

10.15

2.8

3.4

43.52

46.89

mg/l

0.38

1138

6951

Acquired absence of limb

115

3.45

10.14

2.6

3.9

52.06

33.64

mg/l

0.93

101

Systemic sclerosis, icd10

285

2.46

10.12

2.5

3.6

30.98

53.83

mg/l

0.96

244

Malignant neoplasm of prostate

632

2822

1.34

10.11

3.1

1.6

73.35

41.30

mg/l

0.66

523

2381

Fall on same level involving ice and snow

1214

9986

1.22

10.07

2.9

3.5

34.11

42.39

mg/l

3.29

1038

8472

Other disorders of eye and adnexa

268

1762

1.54

10.07

2.8

3.5

42.80

54.13

mg/l

0.35

238

1502

Restless leg syndrome

310

2104

1.50

10.05

2.1

3.4

40.53

52.45

mg/l

0.58

274

1788

Synovial cyst of popliteal space [Baker]

167

981

1.74

10.05

3.4

3.5

34.02

60.93

mg/l

1.37

144

818

Carcinoma in situ of skin of upper limb, including shoulder

471

2.13

10.00

3.1

3.8

47.53

85.23

mg/l

0.81

413

Other bacterial agents as the cause of diseases classified to other chapters

116

3.42

10.00

2.6

4.2

191.06

46.05

mg/l

0.43

Benign neoplasm of urinary organs

127

691

1.90

9.99

2.3

3.8

37.52

87.19

mg/l

1.42

103

602

Other encephalitis

286

2.43

9.99

3.0

4.0

80.19

40.77

mg/l

0.44

243

Crohn's disease of large intestine

480

2.07

9.97

1.6

3.8

57.95

42.12

mg/l

0.32

411

Assault

180

1077

1.69

9.97

2.6

3.4

41.92

50.44

mg/l

0.32

150

907

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

459

2.08

9.94

1.9

3.2

32.38

37.76

mg/l

0.36

379

Abnormal findings on diagnostic imaging of central nervous system

105

536

2.01

9.92

3.0

4.1

24.73

45.50

mg/l

3.08

465

Other congenital malformations, including avohilmo

193

1179

1.66

9.87

2.5

3.7

35.47

61.52

mg/l

1.16

170

1020

Benign neoplasm: Duodenum

392

2.22

9.87

3.2

4.0

98.31

46.91

mg/l

0.56

338

Secondary polycythaemia

270

2.47

9.84

2.7

4.1

48.38

46.93

mg/l

0.03

234

Other/unspecified enthesopathies of lower limb, excluding foot

129

706

1.86

9.82

3.1

3.2

38.46

62.94

mg/l

0.68

108

596

Persistent mood disorders

351

2448

1.45

9.80

2.5

3.3

38.25

51.08

mg/l

1.02

312

2083

Ulcer of oesophagus

177

1066

1.70

9.78

3.2

3.7

101.82

54.88

mg/l

0.32

148

905

Ovarian cyst

544

2301

1.36

9.78

3.1

3.3

30.41

45.23

mg/l

2.47

461

1949

Alcohol abuse, main dg, excluding more controls

260

1709

1.54

9.77

1.9

3.8

35.74

58.32

mg/l

1.66

214

1492

4.44

9.71

1.2

4.4

61.86

28.75

mg/l

0.55

Erythema nodosum

309

2.35

9.68

3.0

4.1

54.43

49.43

mg/l

0.09

263

Injuries to the neck

401

2870

1.41

9.67

4.3

3.3

36.79

49.39

mg/l

1.09

339

2452

Encephalitis

303

2.36

9.65

3.0

4.0

78.51

39.98

mg/l

0.44

257

Alcohol-induced acute pancreatitis

434

2.12

9.63

2.9

3.9

80.48

65.92

mg/l

0.11

361

Other and unspecified haemorrhagic conditions

167

2.89

9.61

4.5

3.5

39.74

44.55

mg/l

0.14

147

ILD and respiratory illness in diseases classified elsewhere

4.25

9.60

1.2

4.2

63.70

28.33

mg/l

0.65

Carcinoma in situ of skin of trunk

109

575

1.98

9.57

4.5

3.6

45.22

76.55

mg/l

0.75

494

Other and unspecified injuries of lower leg

137

770

1.81

9.57

2.7

3.8

32.07

65.34

mg/l

1.41

110

651

Other specified/unspecified bacterial intestinal infections

154

899

1.75

9.53

5.2

3.4

43.52

75.73

mg/l

1.04

133

769

Left bundle-branch block

161

951

1.73

9.50

2.6

3.4

33.75

52.87

mg/l

0.89

135

825

Use of donepezil

334

4509

0.70

9.48

2.3

3.0

44.09

54.26

mg/l

0.82

278

3796

Calculus of kidney and ureter

681

5297

1.30

9.47

2.8

3.4

40.27

47.21

mg/l

1.03

563

4490

Disorders of vestibular function (Vertigo)

1069

8520

1.23

9.45

3.2

3.4

37.66

43.54

mg/l

0.98

932

7213

Other symptoms and signs involving general sensations and perceptions

103

533

1.99

9.43

1.9

3.7

33.15

55.79

mg/l

1.80

463

Lung cancer and mesothelioma

420

2575

1.40

9.42

2.5

2.7

39.20

37.97

mg/l

0.11

337

2233

Abnormal blood-pressure reading, without diagnosis

477

2.04

9.41

3.4

32.39

43.43

mg/l

0.95

418

Benign neoplasm: Small intestine

116

628

1.92

9.37

3.1

3.8

82.93

86.98

mg/l

0.04

108

548

Speech therapy

567

4311

1.33

9.36

2.9

3.4

44.88

47.26

mg/l

0.15

550

3645

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

227

1463

1.57

9.32

3.5

34.51

47.63

mg/l

0.88

188

1242

Intracranial and intraspinal abscess and granuloma

143

3.06

9.29

3.7

4.9

34.33

43.48

mg/l

0.30

126

Rare circulating lymphoid malignancy

4.45

9.25

6.0

1.4

138.57

35.53

mg/l

0.41

Exposure to other and unspecified inanimate mechanical forces

141

808

1.78

9.25

2.9

3.8

36.45

77.36

mg/l

1.31

126

691

Other and unspecified urticaria

326

2268

1.45

9.25

3.8

3.2

34.85

50.07

mg/l

1.28

280

1920

Nummular dermatitis

191

1189

1.64

9.24

3.1

3.8

47.88

63.39

mg/l

0.42

152

1023

KRA_PSY_EATING, excluding more controls

260

2.38

9.23

3.3

3.2

93.17

35.24

mg/l

0.58

235

Malignant neoplasm of endocrine gland, including Hilmo

151

883

1.74

9.23

3.9

1.5

31.87

32.09

mg/l

0.03

126

739

Type 1 diabetes, strict definition, subgroup 1

244

2.44

9.22

1.7

2.7

37.10

27.99

mg/l

1.08

208

Sequelae of injuries, of poisoning and of other consequences of external causes

440

3226

1.38

9.22

3.5

3.4

34.36

47.77

mg/l

1.65

386

2740

Cholecystectomy

1534

11026

1.19

9.22

3.3

3.4

44.06

43.67

mg/l

0.04

1302

9373

Viral hepatitis, including avohilmo

121

664

1.85

9.15

2.5

3.4

39.58

61.05

mg/l

0.60

105

556

Heartburn

226

1464

1.57

9.15

3.0

3.3

29.48

49.92

mg/l

1.62

212

1233

Benign paroxysmal vertigo

667

5199

1.30

9.15

3.2

3.3

35.11

46.03

mg/l

2.01

570

4394

Viral hepatitis

117

637

1.87

9.09

2.4

3.5

40.31

61.66

mg/l

0.56

102

535

Hepatocellular carcinoma, including Hilmo

364

2.19

9.07

2.4

1.4

38.73

35.79

mg/l

0.36

308

Panic disorder

181

1113

1.64

9.04

2.5

3.6

32.60

41.51

mg/l

1.08

152

955

Open wound of forearm

190

1186

1.63

9.04

2.6

3.5

33.69

67.41

mg/l

1.71

156

1013

Complications of other internal prosthetic devices, implants and grafts

109

584

1.92

9.04

3.4

53.29

69.36

mg/l

0.33

501

Familial hypercholesterolemia, with ischemic heart disease

245

1626

1.54

9.02

2.1

3.6

33.93

55.79

mg/l

2.16

216

1398

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

259

1732

1.51

9.01

3.3

3.5

37.35

56.66

mg/l

1.23

217

1472

Type 1 diabetes, strict definition

278

2.32

8.97

1.7

2.8

38.32

28.81

mg/l

1.22

236

Other abnormal findings in urine

197

2.67

8.97

4.4

3.9

41.39

59.83

mg/l

0.58

170

Carcinoma in situ of skin of lower limb, including hip

368

2.21

8.96

4.1

3.9

39.67

59.92

mg/l

0.82

321

Migraine without aura and triptan purchases

184

1139

1.63

8.94

2.6

3.3

24.17

36.53

mg/l

2.37

153

970

Other specified/unspecified soft tissue disorders

110

592

1.90

8.94

3.0

3.6

37.90

75.65

mg/l

1.13

506

therapeutic use

441

2.07

8.93

2.5

4.0

44.05

58.62

mg/l

0.71

382

Scabies, including avohilmo

201

1273

1.59

8.91

2.7

3.5

47.71

51.01

mg/l

0.09

161

1095

Otitis externa

434

3194

1.37

8.91

3.6

3.2

50.63

45.51

mg/l

0.21

390

2704

Agoraphobia

150

2.85

8.90

2.1

3.1

31.81

29.51

mg/l

0.07

126

Arterial embolism and thrombosis of lower extremity artery

101

531

1.97

8.89

2.5

3.9

41.60

96.08

mg/l

1.11

463

Primary coxarthrosis, bilateral

733

5809

1.28

8.86

2.5

3.5

38.53

47.33

mg/l

1.33

622

4910

Other diseases of oesophagus

223

1454

1.56

8.85

3.1

3.6

31.57

49.02

mg/l

1.41

181

1242

Unknown and unspecified causes of morbidity

121

672

1.83

8.83

3.1

3.2

35.61

61.26

mg/l

0.84

103

578

Metatarsalgia

179

1108

1.64

8.81

2.7

3.5

27.09

55.92

mg/l

1.89

153

921

Trigger finger

274

1864

1.49

8.80

2.4

3.6

35.48

50.13

mg/l

1.27

237

1565

Acute suppurative otitis media

293

1875

1.47

8.76

4.8

3.2

35.30

45.76

mg/l

0.80

246

1600

Lung diseases due to external agents

341

2423

1.43

8.75

2.9

3.3

43.44

56.68

mg/l

0.98

259

2055

Redundant prepuce, phimosis and paraphimosis

383

2725

1.40

8.75

2.8

3.6

49.55

51.11

mg/l

0.07

331

2283

Cerebral palsy and other paralytic syndromes

218

1417

1.56

8.73

3.2

3.4

35.84

61.83

mg/l

1.49

191

1208

Other enthesopathy of foot (+metatarsalgia)

189

1190

1.61

8.68

2.7

3.5

27.83

54.63

mg/l

1.88

162

992

Otitis externa, unspecified

203

1301

1.58

8.64

4.0

3.6

46.25

58.74

mg/l

0.35

180

1110

Migraine with aura

326

2294

1.43

8.64

3.1

3.7

26.42

46.28

mg/l

2.12

284

1963

Ulcerative colitis (strict definition, require KELA)

267

1813

1.49

8.63

3.3

3.6

37.12

55.65

mg/l

1.23

222

1540

Other and unspecified mononeuropathies, also in other diseases

366

2.15

8.56

2.5

4.0

32.39

95.65

mg/l

1.27

315

Other sleep disorders

218

1424

1.55

8.54

2.4

3.9

36.18

59.72

mg/l

1.32

174

1228

Schizophrenia or delusion, excluding more controls

477

3535

1.34

8.54

2.7

3.5

48.62

46.20

mg/l

0.07

398

3051

Disorders of parathyroid gland, other and/or unspecified

3.50

8.53

1.9

4.0

35.86

48.21

mg/l

0.24

Conjunctivitis (acute, non atopic), including avohilmo

2059

10792

1.16

8.52

3.5

3.4

33.72

43.96

mg/l

5.45

1772

9146

Other viral hepatitis

487

1.96

8.51

2.6

3.4

41.79

37.95

mg/l

0.23

406

Golimumab

281

2.30

8.49

2.4

3.5

28.68

39.20

mg/l

0.76

238

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.52

8.46

1.7

4.3

33.05

31.91

mg/l

0.08

Sacroiliitis, not elsewhere classified

287

2.27

8.46

2.4

3.2

27.79

41.62

mg/l

0.75

245

Menorrhagia

544

2295

1.33

8.46

3.2

3.3

29.64

47.37

mg/l

3.27

475

1946

Cholangitis (primary sclerosing, PSC), with reimbursement 202

167

2.74

8.44

2.7

4.1

35.13

29.04

mg/l

0.71

142

Atopic dermatitis, strict definition with reimbursement

362

2502

1.40

8.42

2.9

3.3

33.86

43.98

mg/l

0.82

297

2122

Hyperosmolality and hypernatraemia

168

2.76

8.41

2.6

3.1

39.79

47.54

mg/l

0.18

143

COPD, hospital admissions 1, only main diagnosis

880

6145

1.24

8.34

2.1

3.4

42.85

46.96

mg/l

0.43

718

5206

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

289

2007

1.45

8.34

3.2

3.5

37.19

53.89

mg/l

1.21

240

1699

Other salmonella infections

403

2.07

8.33

3.4

3.5

34.61

44.41

mg/l

0.51

343

Emotionally unstable personality disorder

134

779

1.74

8.32

2.3

3.4

27.26

34.61

mg/l

0.81

109

666

Temporomandibular joint disorders, including avohilmo

656

4992

1.28

8.31

3.5

3.4

27.86

41.95

mg/l

3.57

564

4245

Excessive, frequent and irregular menstruation

572

2330

1.32

8.29

3.1

3.3

30.44

46.95

mg/l

3.03

493

1975

Alzheimer’s disease, strict definition

458

4885

0.75

8.28

2.6

3.0

45.02

53.94

mg/l

0.65

401

4114

Lesion of lateral popliteal nerve

111

615

1.85

8.28

4.3

3.6

40.83

75.00

mg/l

1.03

520

Other and unspecified glaucoma

187

1193

1.60

8.28

2.2

3.3

33.43

66.26

mg/l

1.71

153

1026

Abscess of anal and rectal regions

144

858

1.70

8.24

2.3

3.8

37.33

56.82

mg/l

0.78

116

733

Personal history of other diseases and conditions

130

748

1.75

8.23

6.2

3.3

41.06

49.57

mg/l

0.18

116

658

Raynaud syndrome

162

997

1.65

8.21

2.1

3.6

26.42

58.01

mg/l

2.03

139

864

Disorders of optic nerve and visual pathways

170

1059

1.63

8.20

3.7

3.5

32.94

69.19

mg/l

1.65

144

911

Neovascular glaucoma

104

568

1.88

8.16

2.9

3.5

69.58

67.25

mg/l

0.03

490

Other diseases of biliary tract

209

1370

1.56

8.16

2.8

3.4

42.35

60.18

mg/l

0.55

163

1157

severe traumatic brain injury, does not include concussion

540

4163

1.31

8.15

3.3

3.1

49.95

49.76

mg/l

0.01

451

3504

Enteropathic arthropathies

188

2.58

8.10

1.5

4.2

29.13

56.35

mg/l

0.91

169

Malignant neoplasm of endocrine gland

130

758

1.75

8.10

3.8

1.5

32.65

32.20

mg/l

0.05

108

635

Implicit parasitic Sepsis

4.42

8.04

2.4

4.4

113.98

28.52

mg/l

0.56

Other viral hepatitis, including avohilmo

519

1.90

8.00

2.7

3.5

41.17

37.37

mg/l

0.23

433

Macular pucker

415

3096

1.36

8.00

3.1

3.6

42.12

47.89

mg/l

0.37

344

2644

Glaucoma secondary to other eye disorders

104

572

1.87

7.99

2.9

3.7

69.58

75.28

mg/l

0.07

492

Endometriosis

520

2296

1.33

7.95

2.7

3.3

30.02

43.01

mg/l

2.29

446

1945

Other ulcerative colitis

103

564

1.86

7.94

1.9

3.8

43.92

68.68

mg/l

0.59

475

Diseases of inner ear

1212

9770

1.19

7.92

3.3

3.4

39.21

44.20

mg/l

0.80

1060

8286

Acquired absence of organs, not elsewhere classified

145

2.84

7.88

4.0

4.6

62.09

31.91

mg/l

1.40

124

Other benign neoplasms of skin

816

6631

1.24

7.88

4.3

3.3

42.07

45.14

mg/l

0.31

714

5590

Other and unspecified nonorganic psychotic disorders

260

1790

1.46

7.85

2.4

3.6

33.91

46.34

mg/l

1.06

216

1524

Other disorders of iris and ciliary body

359

2.10

7.82

2.4

3.9

44.93

54.19

mg/l

0.33

308

Thyrotoxicosis with toxic multinodular goitre

147

898

1.68

7.80

1.9

3.4

110.54

46.37

mg/l

0.40

129

779

Paralytic strabismus

163

1021

1.63

7.80

2.7

3.6

39.24

69.06

mg/l

1.13

140

874

6-mercaptopurine

197

2.48

7.78

1.7

4.2

30.59

40.08

mg/l

0.43

173

Mental and behavioural disorders due to sedatives or hypnotics

111

626

1.80

7.76

1.6

3.3

27.41

45.56

mg/l

1.96

527

Visual field defects

193

1258

1.56

7.76

2.8

3.4

29.67

63.88

mg/l

1.99

167

1067

Mental and behavioural disorders due to opioids

216

2.40

7.73

2.2

3.2

29.94

41.78

mg/l

0.62

179

Other salmonella infections, including avohilmo

456

1.95

7.71

3.2

3.6

34.01

68.55

mg/l

0.73

385

Kyphosis

147

2.79

7.66

4.1

3.0

37.65

62.09

mg/l

0.49

123

Necrosis of pulp, including avohilmo

1020

8387

1.21

7.64

3.9

3.4

47.99

39.46

mg/l

0.34

844

7138

Benign neoplasm: Kidney

488

1.93

7.62

2.3

4.0

38.96

52.00

mg/l

0.72

427

Unspecified/other endometriosis

106

579

1.81

7.61

2.9

3.2

28.79

41.50

mg/l

0.92

497

378

2.07

7.59

2.1

3.8

35.14

85.97

mg/l

0.95

329

Cervicobrachial syndrome

369

2720

1.37

7.56

3.4

3.2

33.13

47.30

mg/l

1.84

328

2290

Dermatophytosis, including avohilmo

1291

10757

1.18

7.55

3.2

3.4

38.73

42.86

mg/l

0.41

1105

9133

Juvenile rheumatoid arthirtis

119

2.93

7.55

1.4

4.1

36.64

28.30

mg/l

0.46

105

Cholangitis (primary sclerosing, PSC)

142

867

1.67

7.53

1.9

3.2

55.97

71.61

mg/l

0.27

113

727

Syndrome of inappropriate secretion of antidiuretic hormone

3.81

7.53

2.1

5.9

27.92

93.05

mg/l

0.74

Contact with and exposure to communicable diseases

324

2326

1.39

7.52

4.3

3.2

37.78

41.61

mg/l

0.25

229

1982

Acute lymphadenitis

517

1.87

7.48

2.8

3.8

55.27

47.42

mg/l

0.16

443

Central retinal artery occlusion

346

2.11

7.48

4.7

3.4

51.52

79.88

mg/l

0.36

294

Biomechanical lesions, not elsewhere classified

117

680

1.76

7.48

3.0

3.8

30.22

82.49

mg/l

1.53

592

Striking against or struck by other objects

559

4366

1.29

7.47

2.8

3.3

38.91

45.39

mg/l

0.78

483

3699

Abscess of lung

191

2.52

7.45

2.7

4.5

36.75

56.20

mg/l

0.65

166

Cluster headache, wide

317

2.13

7.44

1.6

4.8

27.49

43.31

mg/l

1.01

276

Benign neoplasm of mouth and pharynx

231

1577

1.49

7.44

4.3

3.6

36.33

59.24

mg/l

1.29

196

1339

Hyperfunction of pituitary gland

378

2.02

7.42

3.7

28.92

49.31

mg/l

1.16

327

Pre-eclampsia or eclampsia

283

2006

1.42

7.34

3.4

3.3

34.90

34.64

mg/l

0.02

240

1713

Viral infections of the central nervous system

129

774

1.70

7.28

2.9

3.5

40.75

49.56

mg/l

0.32

104

670

Benign neoplasm: Descending colon

177

1151

1.57

7.27

2.6

3.7

38.31

68.52

mg/l

1.38

159

991

Speech and linguistic disorders, excluding more controls

440

1.89

7.26

2.6

3.6

31.95

83.84

mg/l

1.26

393

Xerosis cutis

231

2.35

7.26

2.5

4.1

32.63

49.51

mg/l

0.74

200

Other and unspecified tonsillitis

391

2420

1.35

7.25

3.0

2.9

35.87

46.69

mg/l

0.86

313

2061

Infections with a predominantly sexual mode of transmission, including avohilmo

465

3254

1.31

7.24

2.7

3.1

35.87

42.57

mg/l

0.62

394

2748

Postprocedural disorders of digestive system, not elsewhere classified

418

1.97

7.24

1.8

4.0

48.27

50.41

mg/l

0.07

365

Special screening examination for neoplasms

131

791

1.68

7.23

4.0

3.3

39.92

55.71

mg/l

0.46

119

610

Chronic viral hepatitis

369

2.01

7.17

2.2

3.2

44.15

37.54

mg/l

0.34

307

Renal agenesis and other reduction defects of kidney

5.94

7.15

1.5

4.5

50.37

30.30

mg/l

0.99

Colonic or urogenital fistula

524

4097

1.29

7.12

3.4

3.3

33.34

46.76

mg/l

2.50

439

3471

Pre-eclampsia or poor fetal growth

336

2451

1.37

7.12

3.2

33.10

33.75

mg/l

0.07

281

2083

Restrictive cardiomyopathy

4.61

7.09

7.6

4.0

28.49

73.36

mg/l

0.45

Aspergillosis

114

3.00

7.07

1.9

4.2

40.35

51.83

mg/l

0.28

101

Other erythematous conditions

436

1.93

7.05

3.0

3.9

32.24

56.84

mg/l

1.70

378

Congenital malformations of gallbladder, bile ducts and liver

103

3.08

7.03

2.1

4.0

47.22

30.37

mg/l

0.90

Seborrhoeic keratosis

568

4497

1.28

7.01

3.9

3.4

44.43

48.05

mg/l

0.26

482

3795

Paraplegia, diplegia of upper limbs

234

2.30

7.00

2.7

3.9

40.14

63.51

mg/l

0.73

206

Malignant melanoma, including Hilmo

356

2647

1.36

7.00

4.4

1.5

53.88

34.45

mg/l

1.07

298

2213

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

886

7028

1.21

6.99

3.1

3.3

37.17

41.74

mg/l

0.34

755

5976

Entropion and trichiasis of eyelid

229

1584

1.47

6.98

3.2

3.4

39.58

62.51

mg/l

1.36

196

1354

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

183

2.44

6.97

5.1

3.6

39.63

26.16

mg/l

1.17

154

Ulcerative ileocolitis

353

2.03

6.97

2.9

3.6

46.93

39.64

mg/l

0.38

294

Viral agents as the cause of diseases classified to other chapters, including avohilmo

247

2.25

6.97

4.9

4.0

33.15

50.29

mg/l

0.80

214

Pediculosis, acariasis and other infestations, including avohilmo

243

1693

1.45

6.96

2.6

3.4

46.05

53.67

mg/l

0.25

196

1448

Other and unspecified erythematous conditions

389

1.98

6.95

3.1

4.0

30.88

57.18

mg/l

1.60

336

Necrotizing fasciitis

3.79

6.93

1.9

3.0

35.33

58.75

mg/l

0.34

Implicit parasitic Sepsis, including avohilmo

3.88

6.92

2.4

4.2

113.98

28.20

mg/l

0.56

Other and unspecified vascular occlusions

237

1652

1.46

6.92

3.2

3.5

40.23

56.55

mg/l

0.92

202

1396

Other and unspecified disorders of skin and subcutaneous tissue

135

833

1.65

6.90

2.4

3.8

35.19

77.94

mg/l

1.49

124

725

Malignant neoplasm of breast, HER-positive

544

3180

1.28

6.86

3.1

1.5

30.82

30.36

mg/l

0.08

454

2680

Malignant neoplasm of breast, ER-positive, including Hilmo

545

3183

1.28

6.85

3.1

1.5

30.84

30.37

mg/l

0.08

455

2682

Disorders of ocular muscles, binocular movement, accommodation and refraction

804

6558

1.22

6.84

3.2

3.4

38.40

42.35

mg/l

0.37

649

5587

Malignant neoplasm of thyroid gland, including Hilmo

128

780

1.67

6.84

4.2

1.5

32.85

32.19

mg/l

0.07

106

649

Malignant neoplasm of mesothelium and soft tissue

498

1.85

6.83

6.8

1.5

41.61

34.27

mg/l

0.17

417

Type1 diabetes, definitions combined, early onset

227

2.26

6.83

1.7

2.1

35.60

27.15

mg/l

1.04

187

Ulcerative enterocolitis

282

2.15

6.80

2.2

3.9

35.17

38.75

mg/l

0.19

241

Hyperkinetic disorders, excluding more controls

348

1.97

6.80

1.4

3.2

34.07

34.86

mg/l

0.03

306

Benign neoplasm: Liver/bile ducts

256

2.21

6.80

4.5

3.9

43.98

41.66

mg/l

0.07

220

Corneal ulcer

323

2375

1.37

6.80

2.9

3.3

35.12

51.93

mg/l

1.60

274

2026

Pemphigoid

436

1.93

6.80

2.4

3.4

32.63

84.40

mg/l

1.17

373

Ulcerative colitis (strict definition, all Crohn cases excluded)

221

1522

1.47

6.77

3.6

36.19

58.88

mg/l

1.30

187

1300

Later onset COPD

794

5247

1.23

6.75

2.1

3.4

47.30

50.19

mg/l

0.23

639

4466

Seronegative juvenile rheumatoid arthritis

3.28

6.75

2.2

2.8

38.77

26.38

mg/l

0.56

Iridocyclitis in diseases classified elsewhere

206

2.37

6.75

1.9

4.2

37.40

39.86

mg/l

0.09

179

Rosacea

234

1633

1.45

6.72

2.8

3.5

37.35

55.59

mg/l

0.93

193

1393

Malignant neoplasm of breast, including Hilmo

661

3401

1.25

6.69

3.2

1.5

32.64

30.05

mg/l

0.50

557

2865

Crohn's disease of small intestine

111

655

1.72

6.69

2.2

3.6

54.15

68.19

mg/l

0.24

560

Malignant neoplasm of thyroid gland

117

701

1.70

6.68

3.9

1.4

33.44

32.10

mg/l

0.14

589

Disorders of orbit

494

1.84

6.68

4.8

3.7

36.42

49.75

mg/l

0.74

431

Diseases of tongue

126

770

1.67

6.68

4.1

2.7

35.22

46.24

mg/l

1.06

110

651

Mature T/NK-cell lymphomas, hilmo

183

2.48

6.67

1.5

4.2

56.10

43.36

mg/l

0.40

156

Malignant melanoma

318

2343

1.37

6.66

4.7

1.5

55.93

34.59

mg/l

1.03

265

1964

Superficial injury of shoulder and upper arm

224

1553

1.46

6.66

3.4

31.10

60.44

mg/l

2.02

194

1305

Other noninflammatory disorders of uterus, except cervix

424

2156

1.32

6.65

3.2

3.4

37.64

48.78

mg/l

0.99

357

1832

Ulcerative colitis (strict) with PSC

3.98

6.64

3.1

4.4

33.37

26.03

mg/l

0.97

Primary adrenocortical insufficiency

112

2.91

6.63

1.4

4.4

22.40

46.51

mg/l

0.68

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

489

1.85

6.62

3.4

3.7

42.91

56.16

mg/l

0.55

424

Hydrocele

260

1856

1.42

6.62

2.5

3.6

44.32

58.77

mg/l

0.84

229

1544

Other and unspecified psoriasis

142

897

1.61

6.61

2.2

4.0

42.66

75.73

mg/l

1.08

111

768

Malignant neoplasm of breast, HER2-negative, including Hilmo

660

3401

1.25

6.61

3.2

1.5

32.64

30.05

mg/l

0.50

556

2865

Strabismus

443

3415

1.30

6.58

3.0

3.3

34.57

47.14

mg/l

1.63

369

2896

Attention to artificial openings

556

1.79

6.57

2.6

3.3

39.71

35.54

mg/l

0.50

478

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1001

8138

1.19

6.56

3.3

3.5

44.84

45.43

mg/l

0.03

843

6887

Aspergillosis, including avohilmo

119

2.87

6.55

1.9

4.1

40.35

50.85

mg/l

0.26

106

Other disorders of patella

228

1589

1.45

6.55

2.7

3.9

33.63

47.76

mg/l

1.06

198

1368

Cluster headache, strict

280

2.11

6.50

1.7

5.0

27.28

43.50

mg/l

0.89

245

Cystic disease of liver

3.16

6.49

2.1

4.2

49.55

31.05

mg/l

0.85

Asthma mixed form (mode), excluding more controls

418

1.89

6.48

2.1

2.3

27.75

41.17

mg/l

1.34

362

Hyphaema and other vascular disorders of iris and ciliary body

269

2.16

6.47

2.6

3.9

42.52

58.56

mg/l

0.52

233

Cramp and spasm

521

1.80

6.47

4.4

3.6

51.60

48.83

mg/l

0.05

446

Pre-eclampsia

252

1795

1.41

6.42

3.7

3.2

35.11

33.34

mg/l

0.17

211

1530

Other follicular disorders

119

724

1.67

6.41

2.5

3.8

33.97

59.91

mg/l

0.93

623

Otalgia

149

958

1.58

6.40

3.0

3.4

34.54

54.21

mg/l

0.86

130

825

Malignant neoplasm of renal pelvis, including Hilmo

132

2.70

6.37

3.4

1.3

72.25

33.72

mg/l

1.21

111

Hypotension due to drugs

206

2.34

6.36

4.2

4.0

54.21

56.87

mg/l

0.05

175

Respiratory conditions due to other external agents

271

2.15

6.36

4.8

3.5

56.49

58.17

mg/l

0.03

235

Other disorders of penis

197

1345

1.48

6.36

2.3

3.6

31.98

64.49

mg/l

1.95

176

1124

Other/unspecified enthesopathies, not elsewhere classified

163

1072

1.54

6.34

2.4

3.6

37.61

60.22

mg/l

1.08

138

889

Pleural plaque

256

1842

1.42

6.33

2.7

3.4

45.17

57.69

mg/l

0.85

202

1577

Other drug-induced secondary parkinsonism

133

2.71

6.32

2.1

3.6

48.85

44.10

mg/l

0.10

116

Malignant neoplasm of breast

649

3379

1.25

6.31

3.2

1.5

32.62

30.12

mg/l

0.47

547

2846

Unspecified protein-energy malnutrition

3.63

6.31

1.4

3.6

54.65

62.52

mg/l

0.08

Superficial injury of forearm

160

1049

1.54

6.28

2.8

3.6

31.32

67.47

mg/l

1.62

136

893

Chronic conjunctivitis

312

2.04

6.28

2.6

3.9

25.58

53.87

mg/l

1.51

267

Event of undetermined intent

105

622

1.71

6.27

3.8

3.4

35.90

76.86

mg/l

0.90

530

Malignant neoplasm of breast, HER2-negative

648

3377

1.24

6.27

3.2

1.5

32.58

30.13

mg/l

0.46

546

2844

Benign neoplasm: Liver

219

2.25

6.26

4.3

4.1

47.05

43.01

mg/l

0.11

188

Bronchitis, not specified as acute or chronic

163

1075

1.54

6.26

2.9

3.7

35.48

55.11

mg/l

1.06

141

915

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

545

4355

1.26

6.22

3.6

3.2

39.42

45.83

mg/l

0.68

463

3665

D07AA Corticosteroids, weak (group I)

216

1504

1.45

6.21

2.3

3.5

35.59

58.18

mg/l

1.25

181

1282

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

374

1.91

6.21

4.1

3.2

37.90

29.80

mg/l

0.87

317

Nonorganic sleeping disorders

320

2384

1.35

6.20

2.5

3.4

32.67

50.55

mg/l

1.68

277

2028

Other specified and unspecified personality disorders

122

753

1.64

6.20

2.5

3.7

37.74

56.56

mg/l

0.58

105

639

Other noninflammatory disorders of vagina

135

855

1.60

6.20

2.6

3.4

35.52

41.10

mg/l

0.37

128

730

Alzheimer’s disease (Late onset)

441

4627

0.78

6.19

2.7

3.0

56.27

54.54

mg/l

0.05

386

3903

Speech and linguistic disorders

475

1.79

6.18

2.6

3.3

31.95

46.79

mg/l

0.95

405

Alcohol abuse, main dg

260

1878

1.40

6.16

1.9

3.6

35.74

55.93

mg/l

1.54

214

1593

Sudden idiopathic hearing loss

218

1531

1.45

6.14

3.1

3.5

40.09

49.32

mg/l

0.52

194

1306

Urethral stricture

143

923

1.58

6.14

2.6

3.8

38.87

74.81

mg/l

1.25

123

778

Primary open-angle glaucoma, strict

664

5424

1.23

6.13

3.4

3.3

42.60

49.85

mg/l

0.36

531

4601

Varicella [chickenpox]

384

1.91

6.12

10.5

3.2

71.12

32.87

mg/l

0.77

318

Benign neoplasm: Skin of eyelid, including canthus

335

2525

1.34

6.10

4.5

3.3

43.68

51.82

mg/l

0.40

299

2147

Inflammatory diseases of female pelvic organs

980

5659

1.19

6.10

2.8

3.5

30.90

37.46

mg/l

1.93

832

4834

Other and unspecified mood [affective] disorders

456

1.82

6.07

2.5

3.6

29.35

39.44

mg/l

0.83

389

Benign neoplasm: Pancreas

424

1.88

6.06

3.0

4.3

36.47

79.18

mg/l

0.89

367

Secondary parkinsonism, excluding more controls

324

2.00

6.04

2.6

4.1

38.55

53.87

mg/l

0.79

286

Ingrowing nail

547

1.75

6.02

2.4

3.6

43.43

46.64

mg/l

0.13

465

Allergic conjunctivitis

918

7448

1.19

6.02

3.1

3.4

37.07

41.22

mg/l

0.31

780

6332

Testicular dysfunction

387

1.90

6.01

3.2

3.7

35.24

68.66

mg/l

0.56

321

Additional codes for the location of defect, injury or illness

117

723

1.65

6.00

1.8

3.7

39.36

82.83

mg/l

1.19

112

626

Hidradenitis suppurativa

262

2.10

6.00

2.4

3.5

37.98

38.69

mg/l

0.03

221

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

4.13

6.00

3.5

3.4

42.28

30.60

mg/l

0.39

Other disorders of optic [2nd] nerve and visual pathways

125

786

1.62

5.97

3.8

3.7

31.63

79.47

mg/l

1.62

106

675

Impingement syndrome of shoulder

447

3512

1.28

5.94

3.6

3.7

34.63

45.77

mg/l

1.88

417

2941

Other other unspecified disorders of the circulatory system

478

1.80

5.89

3.5

3.7

55.98

50.87

mg/l

0.14

411

Other injuries of lower limb, level unspecified

2.92

5.86

2.8

3.3

39.50

50.43

mg/l

0.19

Other epidermal thickening

591

1.71

5.84

2.6

3.9

39.84

91.65

mg/l

1.20

514

Presence of other devices

553

4393

1.25

5.82

3.4

3.1

44.45

48.78

mg/l

0.26

535

3776

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

108

660

1.67

5.82

2.1

1.6

39.00

35.18

mg/l

0.67

558

Superficial injury of wrist and hand

314

2359

1.34

5.79

2.7

3.3

33.52

51.34

mg/l

1.72

275

1996

Brain meningioma, including Hilmo

101

608

1.69

5.76

3.8

1.4

35.31

33.08

mg/l

0.22

517

Campylobacter enteritis

281

2.05

5.75

3.4

4.0

39.39

48.14

mg/l

0.26

246

Alzheimer disease

661

5723

0.82

5.73

2.8

3.2

44.73

51.86

mg/l

0.61

548

4827

Other and unspecified rosacea

172

1171

1.49

5.72

3.1

3.6

33.66

63.54

mg/l

1.41

140

1008

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

101

608

1.68

5.71

2.7

3.5

84.47

50.04

mg/l

0.31

517

Colitis, primary sclerosing

2.85

5.71

2.5

3.7

36.63

30.82

mg/l

0.73

Nail disorders

151

1001

1.53

5.71

2.5

3.5

38.78

68.10

mg/l

1.06

139

855

Specific development disorders of speech and language

378

1.86

5.69

1.9

3.5

30.55

52.19

mg/l

1.23

325

Suggestive for eosinophilic asthma

187

1296

1.46

5.69

2.6

3.7

32.94

54.90

mg/l

1.65

146

1110

Demyelinating diseases of the central nervous system

115

717

1.62

5.66

2.9

3.5

27.79

44.27

mg/l

1.85

102

612

Acute pharyngitis

177

1199

1.47

5.65

4.9

3.2

34.76

56.61

mg/l

0.92

155

1033

Palmar fascial fibromatosis [Dupuytren]

347

2662

1.32

5.62

2.9

3.4

40.69

53.39

mg/l

1.39

298

2206

Corticotropin deficiency

2.92

5.61

1.4

4.6

24.10

30.13

mg/l

0.61

Brain meningioma

590

1.69

5.60

3.7

1.4

35.77

33.17

mg/l

0.26

500

Speech disturbances, not elsewhere classified

202

1426

1.44

5.58

2.1

3.5

36.31

62.45

mg/l

1.44

163

1220

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

134

863

1.56

5.57

2.4

3.4

54.26

55.24

mg/l

0.01

119

742

Delivery

502

3302

0.80

5.57

3.9

3.0

39.95

40.23

mg/l

0.02

439

2816

Psychotic depression

101

613

1.67

5.55

3.3

4.0

35.49

85.10

mg/l

1.25

549

Amputation of thigh

480

1.78

5.55

1.8

3.5

120.84

75.95

mg/l

0.30

412

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

189

1320

1.45

5.54

3.5

3.8

36.74

61.16

mg/l

1.17

159

1133

Assault by bodily force

567

1.69

5.54

2.9

3.5

37.55

37.05

mg/l

0.03

476

Varicella [chickenpox], including avohilmo

426

1.81

5.53

10.1

3.0

68.40

32.77

mg/l

0.77

352

Malignant neoplasm of eye and adnexa, including Hilmo

160

2.40

5.53

5.3

1.3

24.65

31.63

mg/l

1.04

136

Melanocytic naevi

527

4256

1.25

5.53

3.8

3.3

34.19

44.93

mg/l

1.71

450

3610

Papilloedema, unspecified

211

2.19

5.53

1.4

3.8

26.53

51.13

mg/l

1.10

179

Other and unspecified acute skin changes due to ultraviolet radiation

328

1.95

5.53

3.0

3.7

44.56

48.03

mg/l

0.10

284

Single spontaneous delivery

501

3300

0.80

5.52

3.8

3.0

40.06

40.24

mg/l

0.01

437

2815

UC patients in KELA-register (code 208), prior to 1994

540

1.72

5.52

3.0

4.0

31.06

68.79

mg/l

1.03

455

Chronic iridocyclitis

570

1.70

5.50

2.4

3.6

32.18

71.99

mg/l

1.19

494

Sixth [abducent] nerve palsy

467

1.78

5.47

3.8

4.0

47.31

70.67

mg/l

0.42

398

Sequelae of injuries of upper limb

170

1165

1.48

5.47

3.3

3.9

33.67

64.71

mg/l

1.47

143

1002

Chorioretinal inflammation

329

1.93

5.45

3.6

3.5

39.41

29.55

mg/l

0.82

284

Thyroiditis

123

788

1.58

5.45

3.0

3.7

28.56

45.64

mg/l

1.84

105

685

Exfoliative dermatitis

125

2.60

5.42

2.7

4.4

35.32

33.11

mg/l

0.18

106

Scabies

437

1.79

5.42

4.5

3.5

74.60

43.56

mg/l

0.49

363

Viral infections of the central nervous system, including avohilmo

130

845

1.56

5.40

2.9

3.5

40.58

61.29

mg/l

0.61

105

731

Use of rivastigmine

260

3463

0.74

5.37

2.7

3.1

49.53

57.26

mg/l

0.33

213

2929

Algoneurodystrophy

240

2.08

5.36

1.4

3.9

25.41

42.29

mg/l

1.25

209

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

131

856

1.56

5.35

6.3

1.5

37.20

33.83

mg/l

0.11

113

720

Use of antiglaucoma preparations and miotics

193

1364

1.44

5.35

2.9

3.2

39.17

64.50

mg/l

1.32

160

1174

Other female pelvic inflammatory diseases

262

1943

1.36

5.35

2.7

3.6

36.21

35.85

mg/l

0.02

222

1663

Guillain-Barre syndrome

182

2.28

5.34

4.9

4.0

39.20

55.58

mg/l

0.49

159

Eating disorders

595

1.66

5.31

3.0

3.1

39.82

40.92

mg/l

0.04

509

Complications of genitourinary prosthetic devices, implants and grafts

283

2.00

5.30

3.1

3.2

45.25

49.40

mg/l

0.12

239

Disorders of optic nerve, not elsewhere classified

277

2.02

5.30

3.6

3.9

34.35

57.04

mg/l

0.88

238

Other congenital malformations of skin

382

1.84

5.29

2.1

4.0

30.37

53.26

mg/l

1.34

330

Chondrocostal junction syndrome [Tietze]

419

1.80

5.29

3.2

3.7

38.02

59.55

mg/l

0.78

357

Testicular hypofunction

339

1.90

5.29

3.5

34.09

40.86

mg/l

0.38

280

Kela-code for severe mental illness

579

4748

1.23

5.27

2.4

3.3

37.80

45.26

mg/l

1.04

482

4034

Childhood asthma (age<16), excluding more controls

288

1.85

5.24

3.6

1.8

36.03

26.56

mg/l

0.85

242

Residual foreign body in soft tissue

524

1.71

5.24

3.6

4.0

46.44

73.24

mg/l

0.55

438

Cutaneous lupus erythematosus

285

1.99

5.22

2.2

4.2

33.95

62.29

mg/l

1.33

249

Impetigo

355

1.86

5.18

3.7

4.0

26.62

43.37

mg/l

1.23

304

Manic episode

264

2.01

5.18

3.3

4.3

35.38

46.54

mg/l

0.48

225

Erythema multiforme

258

2.03

5.18

3.4

3.9

34.12

56.88

mg/l

0.81

223

Myocardial infarction, with ST-elevation

412

3268

1.27

5.17

2.0

3.2

52.32

56.32

mg/l

0.13

345

2756

Other and specified injuries of hip and thigh

293

1.97

5.17

2.4

4.0

43.37

53.71

mg/l

0.35

257

Vasomotor and allergic rhinitis

549

4380

1.23

5.17

3.2

3.4

32.42

44.91

mg/l

1.97

477

3711

Atypical mycobacterium lung infection

166

2.34

5.17

1.9

3.8

31.44

54.98

mg/l

0.71

138

Other and unspecified injuries of head

149

1008

1.50

5.16

2.1

3.5

33.25

73.66

mg/l

1.83

137

869

Bullous pemphigoid

337

1.91

5.15

1.4

3.8

29.07

65.54

mg/l

2.18

288

Spontaneous abortion

430

3613

0.79

5.15

3.1

3.5

27.76

34.68

mg/l

2.32

363

3099

Melanocytic naevi of trunk

211

1522

1.40

5.14

3.6

3.8

36.87

61.07

mg/l

1.45

179

1300

Vascular dementia (other)

105

2.74

5.14

1.1

4.5

28.96

59.23

mg/l

0.74

Other aneurysm

127

834

1.55

5.12

2.6

3.6

63.99

77.12

mg/l

0.23

106

718

Nonsuppurative otitis media

280

1824

1.34

5.11

3.3

3.2

33.40

55.63

mg/l

1.68

236

1558

Colitis, primary sclerosing, strict definition

3.00

5.11

2.8

4.3

36.96

27.59

mg/l

1.15

Malignant neoplasm of bladder

149

1010

1.50

5.11

2.2

1.5

44.59

37.98

mg/l

0.66

124

842

Other disorders of bone density and structure

218

2.11

5.10

2.7

3.9

23.22

41.97

mg/l

1.35

190

Other endocrine disorders

348

1.84

5.10

3.6

3.8

34.72

50.32

mg/l

0.68

305

Achilles tendinitis

179

1258

1.44

5.07

3.2

3.3

36.18

53.97

mg/l

0.98

160

1046

Viral agents as the cause of diseases classified to other chapters

226

2.09

5.06

4.7

3.9

34.30

51.07

mg/l

0.68

194

Crohn disease (strict definition, require KELA, min 2 HDR)

552

1.67

5.05

2.1

3.4

37.35

42.30

mg/l

0.31

469

Volvulus

338

1.88

5.05

2.4

3.5

31.22

56.14

mg/l

1.48

289

Alzheimer disease, including avohilmo

775

6328

0.84

5.05

2.6

3.2

43.46

50.27

mg/l

0.69

652

5343

Dislocation of lens

200

2.18

5.04

3.3

3.6

35.11

99.58

mg/l

0.58

172

Other surgical follow-up care

316

1.90

5.04

2.1

3.4

32.37

36.98

mg/l

0.32

290

Cluster headache, wide,, including avohilmo

470

1.73

5.01

1.5

3.7

28.88

46.47

mg/l

1.19

398

Chromophobe cell carcinoma of kidney

3.70

5.01

3.4

1.2

67.81

33.31

mg/l

0.72

Atopic dermatitis, strict definition

325

2450

1.30

5.00

3.0

3.1

33.82

45.72

mg/l

0.99

273

2085

Carcinoma in situ of skin of ear and external auricular canal

256

2.04

5.00

3.0

3.5

34.31

105.81

mg/l

0.93

223

Exophthalmic conditions

118

2.57

5.00

5.3

4.1

37.05

62.62

mg/l

0.51

101

Abdominal aortic aneurysm (AAA)

242

1783

1.36

4.96

2.2

3.4

51.25

64.28

mg/l

0.68

189

1512

Pneumonitis due to solids and liquids

191

1367

1.42

4.94

2.5

3.2

42.66

67.19

mg/l

1.13

150

1147

Ethmoidectomy

215

1567

1.39

4.94

3.4

3.7

29.32

58.82

mg/l

2.12

162

1344

Migraine with aura and triptan purchases

168

1171

1.44

4.93

2.8

3.2

24.04

39.04

mg/l

3.14

143

994

Disorders of psychological development

102

591

1.61

4.93

2.5

3.0

32.85

43.05

mg/l

0.71

496

Other acute skin changes due to ultraviolet radiation

429

1.77

4.93

2.9

3.7

41.68

50.47

mg/l

0.35

372

Injury of muscle and tendon at lower leg level

276

2091

1.33

4.92

3.7

39.69

55.44

mg/l

0.91

239

1779

Carbimazole or st.post thyroidectomy, condition for graves disease

351

2745

1.29

4.92

3.6

3.4

31.62

47.15

mg/l

1.80

309

2329

Other ill-defined and unspecified causes of mortality

223

1640

1.38

4.92

3.2

3.3

62.58

60.80

mg/l

0.04

146

1396

Open wound of abdomen, lower back and pelvis

291

1.93

4.89

2.6

3.8

35.88

40.48

mg/l

0.24

245

Postmenopausal bleeding

515

2183

1.24

4.87

3.2

3.4

41.42

48.79

mg/l

0.51

446

1851

Disorders of adrenal gland, other and/or unspecified

3.48

4.87

1.2

3.8

24.88

25.06

mg/l

0.01

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

138

805

1.50

4.86

2.3

2.5

32.19

31.96

mg/l

0.02

115

677

Gluteal tendinitis

475

1.71

4.86

2.3

3.5

21.48

51.31

mg/l

3.36

418

Unspecified mental disorder

629

5242

1.21

4.86

2.6

3.3

37.22

44.58

mg/l

1.16

528

4452

Other otitis externa (chronic)

127

843

1.53

4.86

3.2

3.7

56.99

70.43

mg/l

0.20

117

722

Malignant neoplasm of renal pelvis

3.12

4.84

1.8

1.3

45.67

34.68

mg/l

0.68

Cervicocranial syndrome

181

1286

1.42

4.84

3.3

3.1

36.08

51.88

mg/l

0.87

160

1065

Alcohol dependence

515

4217

1.23

4.83

2.0

3.6

43.35

46.78

mg/l

0.32

420

3587

Use of memantine

557

5413

0.82

4.83

2.5

3.1

53.76

52.47

mg/l

0.04

470

4571

Use of other anti-dementia drugs

557

5413

0.82

4.83

2.5

3.1

53.76

52.47

mg/l

0.04

470

4571

Colorectal cancer, including Hilmo

548

4205

1.22

4.83

2.9

1.5

40.56

36.35

mg/l

0.84

469

3535

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

307

2334

1.31

4.83

2.8

3.3

38.68

49.28

mg/l

0.68

258

1980

Viral meningitis

271

1.95

4.82

1.5

3.6

34.25

47.17

mg/l

0.51

227

Congenital malformations and deformations of the musculoskeletal system

586

1.63

4.81

2.5

3.4

57.40

43.01

mg/l

0.21

505

Viral encephalitis, not elsewhere classified/unspecified

224

2.07

4.80

4.9

3.9

31.07

41.50

mg/l

0.48

190

Other/unspecified soft tissue disorders related to use, overuse and pressure

286

1.93

4.80

2.7

4.3

27.74

61.00

mg/l

1.63

245

Childhood asthma (age<16)

297

1.79

4.79

3.6

1.8

36.03

26.31

mg/l

0.88

248

Chondropathies

236

1754

1.36

4.79

3.8

3.3

35.86

55.41

mg/l

1.16

206

1495

Oligomenorrhoea

230

2.03

4.78

2.8

4.1

27.91

55.51

mg/l

1.11

210

Paget disease

3.13

4.77

2.6

3.9

34.10

34.45

mg/l

0.01

Schizophrenia or delusion

477

3880

1.24

4.74

2.7

3.3

48.62

44.91

mg/l

0.11

398

3309

Mouth breathing

731

6184

1.19

4.74

3.5

37.22

43.18

mg/l

0.94

600

5275

Allergic urticaria

120

791

1.53

4.72

4.9

3.6

38.33

45.69

mg/l

0.53

107

687

Malignant neoplasm of colon, including Hilmo

379

2998

1.27

4.71

2.9

1.5

43.04

35.53

mg/l

1.29

326

2492

Renal cell carcinoma of kidney

405

1.77

4.71

2.5

1.4

57.90

35.67

mg/l

1.56

336

Lichen simplex chronicus

405

1.77

4.70

3.8

4.3

42.58

64.89

mg/l

0.36

348

Glucosamine medication

1119

7810

1.15

4.69

3.4

37.66

46.70

mg/l

2.04

966

6614

Alport

11.40

4.68

1.4

7.4

49.47

25.59

mg/l

—

Alcohol withdrawal state with delirium

135

916

1.50

4.67

1.6

3.8

46.48

69.48

mg/l

0.67

104

770

Other and unspecified abdominal hernia

574

1.64

4.67

1.9

3.3

36.18

47.82

mg/l

0.90

487

Nontoxic multinodular goitre

394

3149

1.26

4.67

3.4

32.54

46.94

mg/l

2.42

340

2659

Embolic stroke with flimmer

362

1.81

4.66

2.8

2.9

46.61

62.36

mg/l

0.59

318

Crohn disease (strict definition, require KELA)

565

1.63

4.64

2.1

3.5

37.35

41.83

mg/l

0.28

481

Other diseases of spinal cord

355

1.82

4.64

5.3

4.2

32.61

85.40

mg/l

0.93

303

Congenital iodine-deficiency syndrome/hypothyroidism

363

1.81

4.62

4.4

3.5

31.20

59.18

mg/l

1.48

307

Lesion of radial nerve

437

1.73

4.62

3.1

3.7

32.70

82.82

mg/l

1.14

371

Acute drug-induced interstitial lung disorder

105

2.63

4.61

5.3

4.1

53.89

32.51

mg/l

0.59

Complications of labour and delivery

668

4413

0.84

4.61

4.1

3.4

41.79

34.30

mg/l

0.71

563

3785

Scleritis and episcleritis

100

637

1.59

4.61

3.7

3.6

39.09

50.12

mg/l

0.71

551

conjunctival haemorrhage

169

1201

1.43

4.60

2.6

3.5

38.17

65.91

mg/l

1.24

147

1019

Cluster headache, strict, including avohilmo

422

1.73

4.58

1.6

3.7

28.88

43.52

mg/l

0.93

356

Hordeolum and other deep inflammation of eyelid

103

662

1.58

4.57

3.3

3.9

48.96

82.42

mg/l

0.69

575

Anti-inflammatory and antirheumatic products, non-steroids

540

2224

1.23

4.57

3.7

3.2

90.86

52.96

mg/l

0.67

457

1860

IBD (strict) with PSC

2.96

4.56

3.0

3.8

32.44

28.35

mg/l

0.45

Ocular pain

138

944

1.48

4.56

2.2

3.7

28.57

57.87

mg/l

1.65

117

813

Other specific arthropathies, wide

201

2.09

4.55

2.5

4.5

28.91

63.47

mg/l

1.13

180

Other mycoses, not elsewhere classified/unspecified, including avohilmo

195

2.11

4.53

3.4

3.9

51.00

40.31

mg/l

0.25

167

Pediculosis, acariasis and other infestations

625

1.59

4.50

3.8

3.6

67.88

44.94

mg/l

0.45

526

Haemorrhagic disorder due to circulating anticoagulants

217

2.07

4.50

2.4

3.7

37.44

49.05

mg/l

0.50

190

Viral meningitis, including avohilmo

278

1.90

4.49

1.5

3.6

34.25

46.65

mg/l

0.50

233

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

230

2.01

4.49

4.9

3.8

31.07

41.14

mg/l

0.46

195

Malignant neoplasm of digestive organs

781

5101

1.18

4.47

2.7

1.5

39.59

36.40

mg/l

0.74

669

4297

Impotence

121

812

1.52

4.46

2.0

3.8

40.49

75.89

mg/l

1.04

105

685

Amenorrhoea

343

1.79

4.45

1.7

3.7

33.54

44.51

mg/l

0.46

305

Primary open-angle glaucoma

784

6467

1.17

4.44

3.3

43.50

48.32

mg/l

0.26

631

5492

Portal vein thrombosis

211

2.06

4.42

2.5

3.5

32.41

41.31

mg/l

0.38

181

Acute alcohol intoxication, ICD10

335

2643

1.28

4.42

2.1

3.6

39.35

50.35

mg/l

0.99

257

2261

Contraceptive management

358

3143

0.79

4.42

3.9

3.4

27.94

38.22

mg/l

1.59

319

2642

Postpartum haemorrhage

120

1461

0.67

4.41

3.4

23.51

29.03

mg/l

0.81

1245

Social phobias

434

1.69

4.38

3.1

3.5

31.52

35.91

mg/l

0.33

372

Other congenital malformations of skin, including avohilmo

119

797

1.51

4.38

2.3

3.7

33.40

74.98

mg/l

1.33

105

688

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

614

1.58

4.36

2.1

3.6

36.79

63.91

mg/l

0.77

519

Sequelae of injuries of neck and trunk

333

1.81

4.34

3.8

4.1

48.67

54.65

mg/l

0.13

285

Focal brain injury

121

816

1.50

4.32

3.4

3.9

56.62

47.57

mg/l

0.23

696

Asthma mixed form (mode)

475

1.66

4.32

2.1

2.5

27.75

46.33

mg/l

2.14

411

FESS (DNB20)

203

1502

1.36

4.30

3.2

3.7

30.24

57.22

mg/l

1.73

150

1287

Schizophrenia, schizotypal and delusional disorders

476

3916

1.22

4.29

2.7

3.3

48.45

45.00

mg/l

0.10

397

3336

Rheumatic valve diseases

284

1.88

4.28

5.5

3.3

41.18

62.45

mg/l

0.80

241

Other problems related to primary support group, including family circumstances

110

707

1.52

4.27

2.5

3.7

39.81

41.75

mg/l

0.06

605

Carcinoma in situ of other and unspecified digestive organs

105

692

1.55

4.26

3.2

3.9

52.47

80.40

mg/l

0.55

594

Traumatic subarachnoid haemorrhage

494

1.65

4.25

3.5

4.4

57.99

50.89

mg/l

0.12

425

Eating disorder

355

1.75

4.24

3.3

3.0

93.17

26.75

mg/l

0.71

315

Hypothyroidism due to medicaments and other exogenous substances

148

2.25

4.19

2.3

3.9

29.75

66.19

mg/l

0.85

124

Other secondary gout

3.64

4.19

6.9

3.3

36.84

33.96

mg/l

0.12

Leiomyoma of uterus

1030

5045

1.15

4.19

3.5

3.3

36.12

39.35

mg/l

0.41

882

4291

Sequelae of injuries of lower limb

152

1078

1.43

4.18

3.2

3.6

33.08

66.18

mg/l

1.45

138

925

Hypermobility syndrome

292

1.83

4.17

3.7

22.54

47.17

mg/l

1.34

255

Other specified and unspecified retinal disorders

490

1.65

4.16

3.5

3.6

30.07

67.63

mg/l

0.94

421

Endocrine disorders, other/unspecified

202

2.04

4.15

3.1

4.0

40.62

40.90

mg/l

—

177

Benign neoplasm: Rectosigmoid junction

649

1.56

4.13

3.3

3.9

46.30

85.55

mg/l

0.87

557

Malignant neoplasm of oral cavity, including Hilmo

513

1.63

4.13

2.6

1.5

43.75

32.72

mg/l

0.56

433

Other and unspecified trigeminal disorders

155

2.19

4.13

3.7

3.8

26.18

55.51

mg/l

0.94

135

Unspecified human immunodeficiency virus [HIV] disease

2.66

4.13

1.3

2.4

52.58

53.08

mg/l

0.01

Other demyelinating diseases of the central nervous system

272

1.87

4.12

3.4

3.9

25.37

38.83

mg/l

1.07

234

Somnolence

104

2.48

4.12

1.9

3.2

68.34

68.14

mg/l

0.00

Allergic rhinitis

371

2949

1.25

4.10

3.5

3.1

33.52

45.07

mg/l

1.03

324

2498

Other misadventures during surgical and medical care

303

1.83

4.09

2.2

4.6

37.60

55.53

mg/l

0.73

263

Universal erythroderma, KELA reimbursement

163

2.16

4.07

1.8

4.3

29.72

45.93

mg/l

0.70

139

Malignant neoplasm of liver and intrahepatic bile ducts

408

1.70

4.07

2.1

1.4

36.99

35.38

mg/l

0.18

347

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

132

919

1.46

4.06

2.6

1.5

37.13

35.46

mg/l

0.28

111

781

Failure of sterile precautions during surgical operation

4.15

4.06

4.7

2.9

37.02

30.93

mg/l

0.37

Thiamine deficiency

2.88

4.04

4.8

4.6

44.99

57.18

mg/l

0.18

Malignant neoplasm of head and neck, including Hilmo

183

1348

1.37

4.03

3.2

1.5

35.83

36.53

mg/l

0.05

159

1133

Other keratitis

178

1305

1.38

4.02

2.7

3.4

35.24

61.58

mg/l

1.36

142

1120

Nonspecific lymphadenitis

571

1.58

4.02

2.7

3.5

31.02

39.04

mg/l

0.56

483

Diffuse brain injury

348

1.75

4.02

3.1

3.9

27.91

47.83

mg/l

1.92

299

Prolonged pregnancy

664

0.54

4.01

4.5

3.2

31.99

26.83

mg/l

0.33

569

Disorders of speech understanding and production

313

1.78

3.96

1.9

3.5

33.49

55.65

mg/l

0.98

273

Benign neoplasm of major salivary glands

192

1431

1.36

3.95

2.7

3.8

33.91

62.84

mg/l

1.76

158

1221

Follicular lymphoma, hilmo

656

1.54

3.95

2.1

3.8

30.95

89.22

mg/l

1.64

573

Panniculitis affecting regions of neck and back

373

1.72

3.94

3.0

3.4

33.69

84.25

mg/l

0.93

321

Injury of intra-abdominal organs

241

1.91

3.93

3.8

4.0

70.37

48.40

mg/l

0.30

201

Chronic diseases of tonsils and adenoids

1052

7519

0.88

3.93

3.2

3.5

32.50

43.55

mg/l

3.33

933

6377

Atypical facial pain

583

1.57

3.93

3.7

3.8

27.10

71.66

mg/l

1.52

506

Hepatocellular carcinoma

285

1.84

3.93

2.2

1.4

37.61

36.52

mg/l

0.09

240

Labour and delivery complicated by fetal stress [distress]

776

0.63

3.92

1.9

2.9

30.97

26.43

mg/l

0.21

662

Pregnancy hypertension

482

3576

1.21

3.92

3.1

3.4

44.12

32.86

mg/l

0.47

412

3044

100

2.43

3.91

1.6

4.2

18.98

27.93

mg/l

1.58

Pneumonia due to Haemophilus influenzae

3.95

3.91

8.3

1.2

24.18

25.38

mg/l

—

Viral conjunctivitis, including avohilmo

336

1.75

3.91

2.3

3.7

27.36

51.73

mg/l

1.29

290

Injury of muscle and tendon at hip and thigh level

170

1245

1.38

3.90

2.8

3.7

35.26

61.02

mg/l

1.18

152

1058

Crohn disease (strict definition, all UC cases excluded)

466

1.63

3.89

2.1

3.7

34.32

68.19

mg/l

0.74

396

Benign neoplasm of middle ear and respiratory system

156

1129

1.40

3.88

3.1

3.8

35.98

69.69

mg/l

1.56

128

964

Bell's palsy

209

1582

1.33

3.86

3.5

90.98

51.80

mg/l

0.30

172

1331

All dysplastic lesions of the cervix uteri, vagina or vulva

301

2327

1.27

3.83

3.2

3.1

29.33

33.07

mg/l

0.61

262

1980

Superficial injury of ankle and foot

158

1146

1.39

3.82

2.0

3.6

53.76

62.49

mg/l

0.16

137

981

Fenamates

272

1444

1.29

3.81

3.2

34.08

55.90

mg/l

3.25

236

1203

Abnormal spermatozoa

295

2345

1.27

3.80

3.1

3.6

52.37

55.22

mg/l

0.10

178

2007

malignant neoplasm of female genital organs, including Hilmo

303

2296

1.27

3.80

2.8

1.5

45.51

30.87

mg/l

0.73

257

1929

Benign neoplasm: salivary glands, exclude unknown (D119)

173

1278

1.37

3.80

2.7

3.7

33.74

66.42

mg/l

1.79

141

1093

Other acquired deformities of musculoskeletal system and connective tissue

533

1.58

3.79

3.1

3.5

32.18

46.19

mg/l

0.99

455

Cerebral cysts

588

1.55

3.78

3.0

3.5

42.56

64.37

mg/l

0.53

500

Autoimmune hyperthyroidism

604

1.54

3.78

3.3

3.5

37.24

62.54

mg/l

0.68

523

Blepharochalasis

642

5501

1.17

3.77

2.8

3.5

36.96

46.12

mg/l

1.58

538

4671

Suppurative and unspecified otitis media

435

3180

1.22

3.76

4.5

3.1

35.52

46.64

mg/l

1.15

360

2704

Nonalcoholic steatohepatitis

103

2.43

3.76

2.2

3.8

41.10

45.14

mg/l

0.07

Dislocation, sprain and strain of joint and ligaments of hip

535

1.58

3.75

2.8

3.6

34.32

50.05

mg/l

0.90

461

Pollen allergy

176

1284

1.36

3.73

3.9

3.4

32.07

47.15

mg/l

0.85

157

1094

Tonsillectomy and adenotomy

465

3882

0.83

3.73

3.0

3.2

28.61

42.64

mg/l

2.45

403

3286

Other secondary coxarthrosis

434

1.65

3.72

1.5

3.6

25.49

55.05

mg/l

2.38

374

Somnolence, stupor and coma

536

1.57

3.71

2.3

3.9

67.38

96.03

mg/l

0.36

450

Unspecific neurodegenerative disorder

910

7081

0.87

3.70

2.7

3.4

44.47

48.94

mg/l

0.43

746

6022

Special screening examination for infectious and parasitic diseases

232

1297

1.31

3.70

3.1

3.2

31.09

47.02

mg/l

0.93

216

1010

Other arterial embolism and thrombosis

389

1.68

3.69

1.8

3.9

60.60

86.09

mg/l

0.37

338

Status epilepticus

427

1.64

3.68

1.5

4.4

37.96

104.81

mg/l

1.07

359

Focal epilepsy

379

3101

1.23

3.68

2.8

3.3

41.10

50.94

mg/l

0.49

331

2638

Ill-defined and unknown causes of mortality

230

1780

1.31

3.68

3.3

61.22

59.82

mg/l

0.04

150

1516

Corneal scars and opacities

336

1.73

3.67

3.2

4.0

31.56

56.64

mg/l

1.30

289

Other disorders of conjunctiva

297

2371

1.26

3.67

2.9

3.3

33.62

52.63

mg/l

1.89

261

2018

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

101

682

1.50

3.67

2.6

1.5

35.64

35.17

mg/l

0.06

574

Nonsuppurative otitis media, including avohilmo

403

2862

1.22

3.67

3.4

3.1

33.26

48.75

mg/l

1.82

347

2429

Inflammatory diseases of prostate (prostatitis)

259

2035

1.29

3.66

3.0

3.7

36.24

56.03

mg/l

1.48

218

1705

Other and unspecified paralytic syndromes

130

2.21

3.64

9.0

4.0

39.60

30.58

mg/l

0.38

113

Plantar fascial fibromatosis

157

1149

1.38

3.64

3.6

3.5

29.44

55.62

mg/l

1.55

142

962

Other predominantly sexually transmitted diseases, not elsewhere classified

175

1301

1.35

3.63

2.9

3.4

30.55

37.96

mg/l

1.09

147

1102

Benign neoplasm of meninges

209

1601

1.32

3.60

3.3

3.4

30.36

57.02

mg/l

1.94

181

1387

Ptosis of eyelid

245

1917

1.29

3.60

3.2

3.4

36.87

56.33

mg/l

1.25

219

1636

Follow-up examination after treatment for malignant neoplasms

197

1496

1.33

3.59

2.9

3.0

51.74

51.20

mg/l

0.01

172

1146

Hallux rigidus

241

1880

1.29

3.59

3.0

3.9

39.74

53.10

mg/l

0.62

213

1612

Benign neoplasm: Cerebral meninges

190

1437

1.34

3.59

3.5

3.4

31.12

58.88

mg/l

1.75

164

1248

Episcleritis

532

1.56

3.58

3.1

3.7

37.70

46.64

mg/l

0.49

462

Delivery, wide proxy

432

2762

0.83

3.57

3.5

2.9

44.71

41.12

mg/l

0.22

377

2345

Other superficial mycoses, including avohilmo

139

1000

1.40

3.56

2.6

3.5

34.10

55.15

mg/l

0.91

122

861

Pleural plaque with presence of asbestos

186

1407

1.34

3.56

2.7

3.6

44.24

64.97

mg/l

0.99

146

1208

Degenerative diseases of the nervous system

761

6275

0.87

3.56

2.8

3.2

43.50

50.63

mg/l

0.72

629

5304

Follow-up care involving plastic surgery

369

1.68

3.56

4.0

3.2

33.47

35.60

mg/l

0.14

332

Benign neoplasm: Skin of trunk

510

1.58

3.55

5.1

3.9

42.33

47.49

mg/l

0.20

445

Non-small cell lung cancer, including Hilmo

304

2290

1.26

3.54

2.2

1.5

39.12

36.13

mg/l

0.27

243

1918

Disorders of tooth development and eruption

220

1376

1.31

3.54

3.3

2.9

37.25

43.05

mg/l

0.58

182

1166

Hypertension, Pulmonary Arterial

2.56

3.53

3.6

4.3

68.81

47.69

mg/l

0.17

Adenomyosis (Endometriosis of uterus)

220

1697

1.30

3.53

3.3

3.4

31.97

43.24

mg/l

1.10

193

1432

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

113

786

1.45

3.52

3.7

1.5

30.74

34.24

mg/l

0.30

654

Atopic dermatitis

836

5827

1.15

3.51

2.6

3.4

36.96

41.00

mg/l

0.41

720

4972

Ectropion of eyelid

103

707

1.49

3.50

2.1

3.3

42.50

87.86

mg/l

1.18

594

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

195

1482

1.32

3.49

3.0

3.4

31.44

36.75

mg/l

0.72

164

1255

Localized skin eruption due to drugs and medicaments

126

2.22

3.49

3.4

3.9

30.85

44.74

mg/l

0.39

108

Malignant melanoma of skin, including Hilmo

268

2128

1.27

3.48

3.8

1.5

57.54

34.74

mg/l

0.94

230

1781

Malignant neoplasm of oropharynx, including Hilmo

223

1.88

3.48

5.1

1.3

30.90

33.80

mg/l

0.16

189

Other specified/unspecified dorsopathies

364

1.68

3.48

4.7

3.4

29.09

84.51

mg/l

1.07

315

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

2.42

3.47

1.3

2.3

52.58

50.46

mg/l

0.03

Schizoaffective disorder

100

681

1.48

3.47

2.0

3.7

34.27

43.94

mg/l

0.78

576

Bicipital tendinitis

585

1.53

3.47

4.1

4.3

32.64

75.68

mg/l

1.32

495

Disorders of iron metabolism

160

2.05

3.45

1.6

4.0

37.64

31.16

mg/l

0.56

140

Other disorders of pigmentation

594

1.52

3.45

4.0

3.6

37.08

71.15

mg/l

0.93

520

Nasal polyp

369

3037

1.22

3.44

3.4

40.46

51.16

mg/l

0.77

309

2565

Parkinson's disease, excluding more controls

293

2163

1.26

3.44

2.1

3.8

33.90

49.75

mg/l

3.16

247

1856

Ganglion

301

2424

1.25

3.42

3.0

3.6

30.43

47.36

mg/l

2.28

269

2032

Carcinoma in situ of skin, other sites/unspecified

262

1.82

3.42

2.9

3.8

81.30

63.50

mg/l

0.14

225

Non-small cell lung cancer, adenocarcinoma

129

927

1.41

3.40

2.6

1.5

36.65

35.52

mg/l

0.09

104

780

Papillary adenocarcinoma of thyroid gland

515

1.55

3.40

3.5

1.4

33.67

32.14

mg/l

0.13

434

Other and unspecified injuries of shoulder and upper arm

359

1.67

3.39

3.3

3.7

44.80

53.38

mg/l

0.26

303

Brachial plexus disorders

116

817

1.43

3.38

4.2

3.8

27.22

53.88

mg/l

1.16

702

Other congenital malformations of the digestive system, including avohilmo

480

1.57

3.38

2.9

3.9

33.34

49.42

mg/l

1.00

411

Fracture at wrist and hand level

578

4939

1.17

3.38

3.3

3.4

36.53

43.88

mg/l

1.12

501

4177

Obsessive-compulsive disorder

335

1.68

3.37

2.4

3.4

39.40

35.97

mg/l

0.10

287

Congenital malformations of heart and great arteries

174

1270

1.34

3.37

3.2

3.6

58.77

61.33

mg/l

0.04

143

1085

Retinal detachment with retinal break

265

2112

1.27

3.36

4.2

3.5

55.95

50.73

mg/l

0.16

221

1801

Need for immunization against other single infectious diseases

9.52

3.36

1.0

1.1

76.33

21.16

mg/l

—

Morphin

300

1.74

3.35

2.2

33.02

46.86

mg/l

1.23

258

Acne

473

1.56

3.34

3.0

2.7

46.00

31.95

mg/l

1.14

402

Dementia in Alzheimer disease

343

3485

0.82

3.33

2.6

3.0

41.62

57.60

mg/l

1.15

268

2962

Endometriosis of pelvic peritoneum

199

1388

1.31

3.32

2.2

3.4

26.89

39.01

mg/l

1.75

167

1185

Congenital malformations of the circulatory system

200

1494

1.31

3.32

2.7

3.6

54.22

59.23

mg/l

0.09

169

1281

Early lumbar disc prolapse, operated

557

1.52

3.31

3.2

2.8

27.11

32.25

mg/l

0.89

466

LSIL lesion of the cervix uteri, vagina or vulva

150

1107

1.36

3.31

3.7

3.3

28.56

36.84

mg/l

1.08

133

953

Use of galantamine

113

1578

0.71

3.30

2.1

3.0

42.46

61.57

mg/l

0.61

1347

Erythema intertrigo

309

1.72

3.29

2.5

4.5

48.02

40.71

mg/l

0.15

273

Human immunodeficiency virus [HIV] disease

163

2.01

3.29

1.3

2.5

45.19

46.70

mg/l

0.04

130

Conductive hearing loss, unspecified

143

1051

1.38

3.28

4.2

3.4

29.25

53.97

mg/l

1.47

132

889

Gilbert syndrome

2.76

3.28

4.6

4.7

18.53

28.88

mg/l

1.51

Use of disulfiram, acamprosate or naltrexone

129

932

1.40

3.28

1.8

3.8

29.32

51.48

mg/l

1.11

106

783

Meralgia paraesthetica

394

1.63

3.27

1.5

3.9

35.11

55.59

mg/l

1.11

333

Disorders of synovium and tendon in diseases classified elsewhere

235

1.83

3.27

2.2

3.4

42.72

43.43

mg/l

0.02

198

Hyperprolactinaemia

220

1.84

3.25

4.3

3.7

24.88

27.96

mg/l

0.36

195

Rheumatic fever incl heart disease

403

1.62

3.24

6.3

3.6

44.52

57.52

mg/l

0.53

348

Periapical abscess

831

7335

1.14

3.24

3.4

3.5

42.01

41.57

mg/l

0.03

695

6260

Focal epilepsy, strict definition

352

2902

1.22

3.24

2.7

3.3

41.83

51.78

mg/l

0.45

308

2473

Unspecified chronic bronchitis

482

1.56

3.23

1.7

3.9

49.84

73.20

mg/l

0.43

417

All dysplastic lesions of the cervix uteri

237

1839

1.27

3.23

3.3

3.2

28.74

33.56

mg/l

0.85

202

1564

Malignant neoplasm of corpus uteri

161

1210

1.35

3.22

2.1

1.5

38.02

30.41

mg/l

0.92

134

1010

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

318

1.69

3.22

4.3

3.9

26.72

51.58

mg/l

1.25

270

Other specified/unspecified hearing loss

184

1410

1.32

3.21

3.8

3.3

62.49

49.37

mg/l

0.26

169

1202

Other and unspecified visual disturbances

190

1462

1.31

3.20

3.7

3.5

36.63

59.20

mg/l

1.08

168

1247

Dislocation, sprain and strain of joints and ligaments at neck level

197

1522

1.30

3.19

3.8

3.6

34.39

56.80

mg/l

1.21

165

1306

Disturbances of smell and taste

524

1.53

3.19

3.9

4.4

29.92

54.92

mg/l

2.12

462

Malignant neoplasm of corpus uteri, including Hilmo

173

1316

1.33

3.18

2.1

1.5

39.76

30.71

mg/l

1.08

142

1093

341

1.65

3.18

1.7

2.6

18.23

24.54

mg/l

2.47

300

Tularaemia

138

2.09

3.17

5.5

4.1

22.04

43.83

mg/l

0.90

119

Parkinson's disease, strict definition, excluding more controls

273

2049

1.25

3.17

2.0

3.8

34.21

50.90

mg/l

3.11

230

1758

Systemic sclerosis,strict definition

2.41

3.14

3.5

4.1

30.97

25.21

mg/l

0.36

Human immunodeficiency virus [HIV] disease, including avohilmo

166

1.97

3.14

1.3

2.5

45.19

46.25

mg/l

0.03

133

Single delivery by forceps and vacuum extractor

530

0.62

3.14

2.5

2.3

29.70

29.97

mg/l

0.01

459

Other diseases of gallbladder

624

1.48

3.13

3.6

3.4

30.77

44.46

mg/l

1.15

541

Perineal laceration during delivery

703

0.62

3.13

3.4

2.9

36.61

24.76

mg/l

0.59

602

Benign neoplasm: Parotid gland

153

1147

1.35

3.13

2.6

3.6

33.50

67.78

mg/l

1.64

122

979

Focal epilepsy, mode (most common among epilepsy diagnosis)

329

2705

1.22

3.13

3.0

3.4

42.01

52.94

mg/l

0.46

285

2307

Convalescence

558

1.51

3.13

4.3

3.1

39.01

37.81

mg/l

0.05

495

Acute and transient psychotic disorders

159

1197

1.34

3.12

2.4

3.5

70.89

51.69

mg/l

0.21

129

1024

Endometriosis ASRM stages 1,2

204

1589

1.29

3.11

2.3

3.2

27.88

34.47

mg/l

0.89

172

1359

Hyperkinetic disorders

464

1.54

3.11

1.4

2.4

34.07

27.54

mg/l

0.40

392

Crushed, pushed or stepped on by crowd or human stampede

583

1.49

3.09

3.7

3.4

34.18

45.53

mg/l

0.83

491

Secondary parkinsonism

401

1.61

3.09

2.6

3.7

38.55

53.77

mg/l

0.68

343

Propionic acid derivatives

520

2224

1.18

3.09

3.5

3.2

92.23

52.96

mg/l

0.67

440

1860

Irregular menses

580

3752

1.16

3.09

3.4

3.3

34.58

33.99

mg/l

0.05

501

3197

Left ventricular outflow tract obstruction, narrow definition

487

1.54

3.09

3.4

3.7

90.45

45.53

mg/l

0.42

408

Secondary parkinsonism+Parkinsonism in other disease

409

1.60

3.08

2.7

3.8

38.28

48.74

mg/l

0.48

350

Single delivery by caesarean section

732

0.68

3.07

2.9

2.3

20.85

31.60

mg/l

3.62

630

Benign neoplasm: Tongue

370

1.63

3.07

4.9

4.2

31.70

51.48

mg/l

0.91

317

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

106

2.21

3.06

7.8

3.9

27.90

29.51

mg/l

0.09

Injuries involving multiple body regions

401

1.59

3.05

4.0

3.8

30.89

50.95

mg/l

1.24

341

Excessive attrition of teeth

1006

8920

1.12

3.04

3.5

3.4

32.56

41.11

mg/l

1.68

851

7584

Contact with heat and hot substances

521

1.51

3.04

2.4

3.7

46.11

43.46

mg/l

0.11

441

Other and unspecified mononeuropathies of upper limb

324

1.66

3.03

3.3

3.9

35.30

38.23

mg/l

0.14

272

Prepatellar bursitis

538

1.51

3.03

2.1

3.9

35.64

74.28

mg/l

0.96

440

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

433

1.57

3.03

2.1

3.9

22.48

57.72

mg/l

2.91

366

Malignant neoplasm of nasal cavity and sinuses

2.57

3.02

5.7

1.2

77.77

32.48

mg/l

0.73

Acute alcohol intoxication

461

3923

1.18

3.02

2.2

3.6

40.32

48.65

mg/l

1.05

363

3331

Maltreatment syndromes

308

1.67

3.02

3.7

3.3

39.24

40.09

mg/l

0.02

258

Ulcerative rectosigmoiditis

120

870

1.39

3.02

3.7

3.6

40.98

69.27

mg/l

0.81

100

745

Melanoma in situ of other and unspecified parts of face

206

1.87

3.01

3.6

4.2

58.02

57.82

mg/l

0.00

178

Postpartum care and examination

457

0.59

3.01

3.3

2.7

28.80

28.93

mg/l

0.01

386

Amoebiasis, including avohilmo

2.62

3.00

2.5

3.0

139.28

24.43

mg/l

0.57

LSIL lesion of the cervix uteri

106

752

1.42

3.00

4.5

3.6

31.65

34.37

mg/l

0.18

648

Pain and other conditions associated with female genital organs and menstrual cycle

225

1486

1.27

2.99

2.6

3.2

25.46

38.70

mg/l

2.98

194

1268

Tongue abnormality

119

865

1.39

2.98

4.3

3.5

33.21

60.16

mg/l

1.22

104

744

Dronedarone medication

381

1.61

2.98

2.3

3.3

29.86

79.87

mg/l

1.00

332

Epiphora

288

1.70

2.98

4.6

4.2

135.07

60.60

mg/l

0.31

253

Benign neoplasm: Skin of other and unspecified parts of face

206

1620

1.28

2.97

3.7

3.3

38.49

60.76

mg/l

1.37

176

1389

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

192

1.88

2.97

2.4

4.2

60.90

58.28

mg/l

0.03

168

Diphtheria

5.97

2.97

4.6

4.8

26.17

22.70

mg/l

—

Toxic liver disease

170

1.93

2.96

1.7

3.4

26.75

42.26

mg/l

0.64

145

Other intracranial haemorrhages

518

1.52

2.96

4.3

3.6

39.30

92.17

mg/l

1.02

442

Tularaemia, including avohilmo

206

1.84

2.96

5.3

4.4

24.60

50.16

mg/l

1.15

176

Dermatographic urticaria

631

1.46

2.94

4.4

3.8

36.50

47.42

mg/l

0.70

548

HSIL lesion of the cervix uteri, vagina or vulva

191

1489

1.29

2.91

2.7

3.2

30.08

34.69

mg/l

0.51

163

1273

Heterophoria

107

766

1.41

2.90

3.4

3.6

27.82

59.77

mg/l

1.37

663

Maternal care related to the fetus and amniotic cavity and possible delivery problems

339

2395

0.83

2.90

3.9

3.3

36.98

32.03

mg/l

0.23

301

2028

Retinal haemorrhage

376

1.60

2.90

3.6

3.8

40.41

50.71

mg/l

0.49

326

Other lesions of median nerve

360

1.62

2.90

1.9

3.8

36.48

64.55

mg/l

1.44

308

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

214

1694

1.27

2.89

3.1

3.0

25.94

35.77

mg/l

1.71

185

1457

Other and unspecified iridocyclitis

544

1.49

2.89

4.4

3.7

48.39

53.05

mg/l

0.13

468

Nontoxic goitre/thyroid nodule

566

4915

1.16

2.89

3.4

31.72

45.84

mg/l

3.16

493

4165

Striae atrophicae

2.35

2.88

1.8

5.4

24.63

29.06

mg/l

0.42

Carcinoma in situ of colon

441

1.55

2.87

3.9

4.0

58.53

77.30

mg/l

0.26

377

Pilonidal cyst

651

1.44

2.86

2.9

3.4

33.01

52.71

mg/l

0.58

555

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

231

1.77

2.85

3.2

1.3

26.25

30.65

mg/l

0.86

194

Malignant melanoma of skin

218

1736

1.27

2.85

4.1

1.5

62.50

35.33

mg/l

0.90

187

1459

Acute epiglottitis

137

2.01

2.84

9.7

4.1

92.44

43.80

mg/l

0.34

124

Pustular psoriasis

538

1.49

2.84

3.2

3.8

27.32

45.48

mg/l

1.75

470

Obstructed labour due to malposition and malpresentation of fetus

110

1397

0.73

2.84

3.2

3.3

52.23

27.21

mg/l

0.43

1191

Subacute thyroiditis

385

1.58

2.84

3.0

3.6

30.02

56.63

mg/l

1.33

339

Lateral epicondylitis

186

1452

1.29

2.83

2.8

3.6

26.51

50.98

mg/l

2.20

152

1210

Other and unspecified injuries of ankle and foot

353

1.60

2.83

1.9

3.8

25.41

37.24

mg/l

1.18

298

Infective bursitis

370

1.60

2.83

4.2

4.0

51.78

98.13

mg/l

0.73

305

Malignant neoplasm of tongue, including Hilmo

292

1.68

2.83

3.2

1.4

25.88

32.54

mg/l

1.56

246

Anorexia (incl.atypical)

384

1.57

2.83

3.7

3.3

29.72

39.46

mg/l

0.60

332

Melanoma in situ

102

731

1.42

2.83

5.1

3.7

45.60

83.96

mg/l

1.00

639

Muscle strain

323

1.63

2.81

2.5

3.8

32.32

58.47

mg/l

1.25

268

Other and unspecified follicular disorders

442

1.54

2.80

2.5

3.7

31.97

64.70

mg/l

0.68

373

Endometriosis of ovary

239

1811

1.25

2.80

2.4

3.5

31.03

42.82

mg/l

1.25

210

1537

Other retinal artery occlusion

357

1.61

2.77

3.7

3.9

46.27

78.41

mg/l

0.46

306

Emotional disorders starting during childhood or adolecense, excluding more controls

2.40

2.76

1.2

2.5

26.55

24.68

mg/l

0.12

Urethritis and urethral syndrome

218

1.78

2.76

2.9

4.1

35.84

63.27

mg/l

0.76

184

Mixed conductive and sensorineural hearing loss

252

2049

1.24

2.76

3.8

3.4

44.49

47.83

mg/l

0.16

218

1753

Dislocation, sprain and strain of joints and ligaments of thorax

388

1.57

2.75

4.4

3.9

40.98

84.18

mg/l

0.76

332

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

478

3379

1.17

2.75

2.6

1.6

39.93

36.56

mg/l

0.45

390

2837

Other disorders of the genitourinary system

249

2023

1.24

2.74

3.3

39.52

51.03

mg/l

0.61

218

1726

Malignant neoplasm of tonsil, including Hilmo

182

1.86

2.74

5.6

1.3

33.73

34.46

mg/l

0.03

152

Other noninflammatory disorders of vulva and perineum

136

1023

1.34

2.73

2.6

3.3

36.03

42.24

mg/l

0.34

115

863

Disturbance of activity and attention

432

1.52

2.73

1.5

2.4

31.67

27.58

mg/l

0.21

364

Malignant neoplasm of oral cavity

405

1.56

2.73

2.2

1.5

38.72

33.03

mg/l

0.21

336

Hypertrophy of (infrapatellar) fat pad

2.34

2.72

3.6

4.3

15.46

58.64

mg/l

—

Perichondritis of external ear

235

1.75

2.71

5.8

3.5

37.51

44.09

mg/l

0.26

199

Open wound of shoulder and upper arm

212

1.78

2.71

1.5

3.6

26.50

44.52

mg/l

1.13

181

Congenital malformations of the respiratory system, including avohilmo

168

1.88

2.70

2.6

4.1

33.84

59.19

mg/l

0.58

146

Pustulosis palmaris et plantaris

495

1.50

2.70

3.3

3.9

26.64

44.43

mg/l

1.51

431

Other strabismus

299

2466

1.21

2.69

3.2

3.3

31.16

48.94

mg/l

1.87

246

2100

ILD medications: pirfenidone

148

1.96

2.69

2.4

1.9

36.75

49.55

mg/l

0.42

133

Uterine polyps

449

2239

1.18

2.68

3.1

3.4

38.20

45.73

mg/l

0.54

389

1897

Other deformities of toe(s)

399

1.55

2.67

2.9

3.6

24.00

51.32

mg/l

2.38

355

Diphtheria, including avohilmo

5.08

2.67

4.6

5.8

26.17

24.21

mg/l

—

Malignant neoplasm of small intestine, including Hilmo

368

1.58

2.66

4.8

1.5

47.33

33.16

mg/l

0.64

312

Allergic contact dermatitis

184

1448

1.28

2.66

2.5

3.5

35.97

51.13

mg/l

0.69

151

1240

Ulcer of vagina/vulva

274

1.67

2.65

2.9

3.8

46.88

53.45

mg/l

0.12

234

Injury of eye and orbit

204

1626

1.26

2.65

3.0

3.4

44.45

58.39

mg/l

0.59

172

1385

Allergic contact dermatitis due to drugs in contact with skin

244

1.71

2.64

3.1

3.9

33.23

60.12

mg/l

0.91

209

Other orthopaedic follow-up care

646

1.42

2.64

2.2

2.9

30.55

36.86

mg/l

0.91

559

Glaucoma suspect

786

7015

1.13

2.64

3.1

3.4

44.97

45.89

mg/l

0.04

620

5973

Other benign neoplasms of connective and other soft tissue

163

1266

1.30

2.63

4.3

3.5

33.94

63.28

mg/l

1.50

145

1090

Chalazion

183

1442

1.28

2.63

5.0

3.5

54.16

58.52

mg/l

0.07

160

1233

Perforation of tympanic membrane

169

1319

1.29

2.63

3.6

3.5

45.80

65.31

mg/l

0.65

151

1126

HSIL lesion of the cervix uteri

155

1194

1.30

2.62

2.5

3.3

26.44

35.04

mg/l

1.46

131

1021

Vulvovaginal ulceration/inflammation in other diseases

489

1.48

2.62

3.7

24.82

41.48

mg/l

1.48

431

Burn and corrosion of ankle and foot

156

1.91

2.62

2.5

3.4

38.00

44.48

mg/l

0.20

134

Excessive vomiting in pregnancy

555

1.45

2.61

2.8

3.7

26.22

36.16

mg/l

0.79

483

Granulomatous disorders of skin and subcutaneous tissue

260

1.68

2.61

3.3

3.6

26.44

57.15

mg/l

1.29

224

Benign neoplasm of eye and adnexa

201

1605

1.26

2.61

3.3

3.5

35.59

58.45

mg/l

1.37

174

1365

Any prescribed medicine buy

6.94

2.60

1.7

3.8

33.72

200.54

mg/l

—

Car occupant injured in other and unspecified transport accidents

253

2069

1.23

2.60

3.1

3.4

56.36

52.47

mg/l

0.06

215

1762

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

269

1.68

2.60

2.9

4.0

35.24

57.67

mg/l

0.83

227

Congenital malformations of the respiratory system

149

1.92

2.59

2.8

4.4

35.05

64.51

mg/l

0.60

127

Amoebiasis

2.83

2.59

2.9

3.5

172.82

23.62

mg/l

0.54

Colorectal cancer

466

3861

1.16

2.58

3.1

1.5

41.39

36.22

mg/l

0.97

403

3228

MS-disease / Multiple Sclerosis

582

1.44

2.57

2.9

3.6

25.84

42.94

mg/l

1.98

500

Idiopathic urticaria

171

1.84

2.57

3.5

3.8

31.65

28.91

mg/l

0.18

147

Pigmented purpuric dermatosis

129

2.00

2.56

3.3

5.0

28.57

48.58

mg/l

0.63

110

Carcinoma in situ of rectum

187

1.82

2.56

1.9

4.7

36.77

43.51

mg/l

0.21

161

Astigmatism

607

1.43

2.56

2.8

3.8

32.33

62.84

mg/l

0.88

515

Acute laryngitis and tracheitis

106

763

1.37

2.56

3.3

3.1

32.83

44.91

mg/l

1.35

653

Certain zoonotic bacterial diseases, including avohilmo

372

1.56

2.55

4.4

3.9

29.62

51.35

mg/l

1.26

317

Ulcerative proctitis

609

1.43

2.54

2.5

3.7

41.11

44.47

mg/l

0.14

517

Generalized epilepsy

324

1.59

2.53

3.1

3.7

32.63

38.72

mg/l

0.37

274

Unspecified event, undetermined intent

232

1.71

2.52

3.4

4.0

36.13

38.05

mg/l

0.05

201

Procreative management

420

2963

1.17

2.52

3.2

3.3

29.70

44.81

mg/l

1.98

359

2510

Calculus of lower urinary tract

113

841

1.36

2.52

3.2

3.9

46.91

72.66

mg/l

0.65

703

Pneumothorax

128

970

1.33

2.50

3.6

3.5

42.77

62.07

mg/l

0.82

104

830

Optic neuritis

342

1.57

2.48

3.1

3.7

37.37

36.31

mg/l

0.04

295

Other contact dermatitis

119

893

1.34

2.48

2.1

3.7

50.56

63.39

mg/l

0.22

100

782

Malignant neoplasm of head and neck

143

1102

1.31

2.47

2.4

1.5

32.65

36.10

mg/l

0.30

122

927

Melanocytic naevi of upper limb, including shoulder

249

1.68

2.47

4.7

3.7

35.06

50.46

mg/l

0.49

215

Malignant neoplasm of small intestine

265

1.65

2.46

4.3

1.5

53.78

34.02

mg/l

0.70

227

Injury of other and unspecified intrathoracic organs

117

878

1.35

2.46

3.0

3.4

44.03

76.43

mg/l

1.01

747

Medial epicondylitis

375

1.54

2.45

4.1

4.0

27.25

53.66

mg/l

1.49

308

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

546

4145

1.14

2.45

2.9

3.5

43.43

33.36

mg/l

0.49

470

3541

Benign neoplasm of bone and articular cartilage

121

912

1.34

2.45

3.3

3.7

122.20

58.71

mg/l

0.31

108

782

Hereditary angioödema type 1

7.00

2.45

9.2

6.4

15.60

25.58

mg/l

—

Noninflammatory disorders of female genital tract

534

2331

1.15

2.44

3.2

3.3

37.31

46.94

mg/l

0.96

452

1976

Certain zoonotic bacterial diseases

212

1.74

2.44

4.7

3.6

28.52

62.58

mg/l

1.09

179

Arthropathy in hypersensitivity reactions classified elsewhere

6.79

2.43

1.4

6.4

23.34

26.05

mg/l

—

Other appendicitis

129

984

1.32

2.41

3.9

3.8

33.26

58.30

mg/l

1.27

108

837

Melanocytic naevi of lower limb, including hip

483

1.47

2.41

5.4

3.7

35.88

48.00

mg/l

0.59

416

Maternal care for known or suspected abnormality of pelvic organs

136

1192

0.77

2.39

4.2

3.5

24.77

36.27

mg/l

1.84

113

1020

Arthropod-borne viral fevers and viral haemorrhagic fevers

160

1258

1.28

2.39

4.9

3.7

38.73

67.28

mg/l

1.35

127

1070

Examination and encounter for administrative purposes

149

1161

1.29

2.39

4.0

3.2

37.12

53.73

mg/l

0.74

137

886

Pleural plaque without asbestos

653

1.40

2.39

2.6

3.7

44.77

93.75

mg/l

1.15

563

Small cell lung cancer, helper endpoint

385

0.51

2.38

1.6

3.7

50.01

51.61

mg/l

0.04

334

Perioral dermatitis

183

1.77

2.38

1.7

3.6

29.22

52.79

mg/l

0.61

153

Traction detachment of retina

2.16

2.38

1.5

2.7

55.80

29.38

mg/l

1.40

Trigeminal neuralgia

711

1.38

2.37

3.3

3.6

60.95

65.21

mg/l

0.04

617

Degenerative macular diseases

259

2150

1.22

2.37

2.4

3.3

43.45

51.91

mg/l

0.47

209

1820

Malignant neoplasm of pancreas

1007

0.70

2.36

1.7

1.5

29.61

35.20

mg/l

0.93

846

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

584

1.41

2.35

3.4

3.9

65.48

61.38

mg/l

0.05

501

Abscess of Bartholin gland

199

1.73

2.34

3.7

29.96

27.17

mg/l

0.14

171

Ménière disease

177

1414

1.26

2.33

3.0

3.6

44.14

61.95

mg/l

0.59

159

1212

Postpartum hemorraghe, parous women as controls

120

1316

0.76

2.33

3.4

3.5

23.51

30.65

mg/l

1.08

1126

Polyp of the female genital tract

461

2260

1.16

2.33

3.3

3.4

38.85

47.90

mg/l

0.66

399

1913

Sequelae of infectious and parasitic diseases

117

886

1.33

2.32

3.1

3.3

33.45

74.64

mg/l

1.53

758

Malignant neoplasm of other and unspecified parts of tongue

156

1.84

2.30

2.4

1.3

25.81

31.63

mg/l

0.95

133

Anogenital herpesviral [herpes simplex] infection

405

1.49

2.29

3.6

3.5

33.48

43.72

mg/l

0.45

344

Postpartum hemorraghe, all women as controls

120

1528

0.76

2.29

3.4

3.2

23.51

29.54

mg/l

0.93

1302

Dystonia

614

1.40

2.29

1.9

4.1

30.65

46.48

mg/l

1.27

535

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

531

1.43

2.28

3.8

39.44

93.50

mg/l

1.04

452

Thyrotoxicosis with diffuse goitre

203

1650

1.24

2.27

3.4

3.1

33.01

46.32

mg/l

1.04

165

1391

Persons encountering health services in circumstances related to reproduction

658

4944

0.89

2.26

3.6

3.5

30.82

41.27

mg/l

2.09

575

4177

Myopia

144

1125

1.29

2.25

2.8

3.5

55.11

48.24

mg/l

0.11

110

963

Shoulder region

172

1.79

2.25

1.4

4.0

31.73

33.37

mg/l

0.11

149

Follicular adenocarcinoma of thyroid gland, including Hilmo

2.10

2.25

4.8

1.4

32.16

30.13

mg/l

0.09

Acne vulgaris

341

1.53

2.25

2.6

2.8

44.70

33.48

mg/l

0.63

293

Respiratory tuberculosis, confirmed, including avohilmo

233

1.66

2.24

1.4

3.9

32.90

51.00

mg/l

0.79

198

Tuberculosis of other organs, strict, including avohilmo

328

1.55

2.24

2.0

3.7

32.89

64.82

mg/l

1.61

289

Acute nasopharyngitis (common cold)

150

1171

1.28

2.22

3.6

3.2

37.66

38.80

mg/l

0.09

131

1001

Salpingitis and oophoritis

258

2154

1.20

2.22

2.6

3.5

29.92

36.41

mg/l

1.34

212

1846

Other menopausal disorders

314

2064

0.84

2.21

3.5

29.07

44.09

mg/l

2.18

279

1755

Acne, including avohilmo

145

916

1.28

2.21

2.2

2.9

36.93

35.31

mg/l

0.11

123

769

Malignant neoplasm of colon

292

2468

1.19

2.20

3.1

1.5

44.84

34.88

mg/l

1.46

254

2058

Hypertrophic scar

459

1.45

2.19

2.8

3.7

26.77

52.73

mg/l

2.26

399

Premature rupture of membranes

933

0.74

2.19

2.7

3.3

27.84

29.79

mg/l

0.18

792

Disorder of external ear, unspecified

419

1.48

2.19

3.8

3.9

36.06

41.57

mg/l

0.19

355

Malignant neoplasm of tonsil and base of tongue, including Hilmo

258

1.62

2.18

5.1

1.4

32.44

34.68

mg/l

0.13

215

Tuberculosis of other organs, strict

322

1.55

2.18

2.0

3.7

30.52

65.15

mg/l

1.81

283

Other disorders of optic disc

137

1.86

2.17

4.4

4.0

34.00

61.77

mg/l

0.68

121

Other forms of systemic lupus erythematosus

2.16

2.17

1.7

5.1

31.04

26.93

mg/l

0.29

Oesophageal obstruction

537

1.42

2.17

3.2

3.9

34.80

65.56

mg/l

0.82

459

Other congenital malformations of the digestive system

392

1.48

2.15

3.4

3.8

36.12

50.21

mg/l

0.64

331

Calcific tendinitis of shoulder

638

1.38

2.15

3.8

3.9

25.33

69.85

mg/l

1.57

527

Dislocation, sprain and strain of joints and ligaments of head

330

1.53

2.15

3.6

3.2

31.85

43.81

mg/l

0.68

285

Anankastic personality disorder

290

1.57

2.15

2.3

4.2

27.14

36.90

mg/l

0.64

252

Sequelae of infectious and parasitic diseases, including avohilmo

119

915

1.31

2.14

3.1

3.3

33.57

73.41

mg/l

1.52

783

Ankylosing spondylitis, strict definition

371

1.50

2.14

2.0

4.0

33.87

38.33

mg/l

0.28

307

Separation of retinal layers (serosa)

504

1.43

2.14

2.5

3.8

35.13

61.95

mg/l

0.60

425

109

1421

0.76

2.13

1.6

3.6

60.11

63.96

mg/l

0.11

1195

Mental disorders, not otherwise specified

656

1.37

2.12

3.3

3.5

28.95

38.92

mg/l

1.04

564

Respiratory tuberculosis, confirmed

229

1.65

2.12

1.4

3.6

33.38

51.52

mg/l

0.77

194

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

4.44

2.11

3.7

1.3

37.98

26.08

mg/l

—

Hypertrophic disorders of skin

513

1.42

2.11

2.7

3.8

27.07

54.24

mg/l

2.52

447

Supervision of normal pregnancy

115

856

0.76

2.11

3.9

3.3

19.65

28.58

mg/l

3.26

106

726

Macular hole

126

981

1.30

2.10

3.5

3.6

36.17

67.40

mg/l

1.18

103

840

Burns and corrosions

187

1522

1.24

2.10

2.8

3.5

42.67

59.88

mg/l

0.82

160

1293

Benign neoplasm: Other and unspecified parts of mouth

440

1.45

2.09

5.2

4.0

42.53

49.57

mg/l

0.18

381

Human immunodeficiency virus [HIV] disease resulting in other conditions

146

1.81

2.09

1.2

2.7

43.51

45.45

mg/l

0.05

114

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

146

1.81

2.09

1.2

2.7

43.51

45.45

mg/l

0.05

114

Other specified disorders of muscle

333

1.52

2.09

2.6

3.6

31.65

66.04

mg/l

1.71

273

Endometriosis ASRM stages 3,4

312

2664

1.18

2.09

2.4

3.2

29.25

35.91

mg/l

0.89

269

2270

Tuberculosis of other organs

278

1.58

2.07

2.0

4.0

32.66

70.98

mg/l

1.67

242

Other neurotic disorders

592

1.38

2.07

1.7

3.8

42.03

72.19

mg/l

0.82

505

Peritonsillar abscess

266

2244

1.19

2.05

3.8

3.4

30.72

52.58

mg/l

2.28

219

1902

Malignant neoplasm of accessory sinuses, including Hilmo

2.60

2.05

4.4

1.2

68.62

33.57

mg/l

0.46

Benign neoplasm: Long bones of lower limb

302

1.54

2.05

2.0

3.6

37.12

46.08

mg/l

0.29

258

Intermittent heterotropia

415

1.45

2.05

4.2

3.6

33.37

41.44

mg/l

0.34

355

Benign neoplasm: Skin of ear and external auricular canal

560

1.39

2.04

2.0

3.6

33.46

73.90

mg/l

1.19

489

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

424

1.45

2.04

1.6

3.5

28.70

26.92

mg/l

0.20

368

Other superficial mycoses

200

1.67

2.04

3.7

4.1

64.80

41.11

mg/l

0.36

172

Acute appendicitis, with complications

328

2820

1.17

2.03

3.5

3.4

31.43

50.76

mg/l

2.70

275

2397

Disorders of globe

344

1.51

2.03

3.6

3.8

33.85

49.61

mg/l

0.95

300

Disorders of refraction and accommodation

377

3260

1.16

2.03

3.2

3.3

40.52

44.39

mg/l

0.15

287

2786

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lambda light chains.free [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS